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 Calcium Channel Regulators..... 1
Introduction and Literature Survey
Among the cardiovascular drugs known as Calcium Channel Antagonists,
1,4-dihydropyridines (DHPs), (I) , a mammoth group, has proved its
efficacious biological activity in the field of Medicinal Chemistry. 1,4-
dihydropyridine nucleus serves as the scaffold for important drugs which
surmounts a variety of disorders in humans. Dihydropyridines hold a unique
evolutionary history over this past century. First synthesized in laboratory
by Hantzsch1, DHPs were later discovered to be the active part of NADH,
the essential reducing coenzyme in animals. It was discovered in 1930’s
that a dihydropyridine (NADH, a dihydronicotinamide derivative) was a
“hydrogen transferring coenzyme”2 and consequently of utmost importance
in biological systems. Since then a veritable flood of papers and patents
appeared on the chemistry and pharmacology of these unique “Calcium
Antagonists”.
 
4
35
26
N
H
1
R1R4
R2R3
R H
R = CH 3, H, Sub. Phenyl,     R 1 , R 2 = COCH3, COOC 2H 5,
       Heterocyclic ring                            COOCH3,  CN
       system     R 3, R 4  = H, CH 3, Phenyl,
     Alkyl chains, etc
    General Structure of 1,4-Dihydropyridine
1.   Hantzsch, A.; Justus Liebigs Ann. Chem., 215, 1, (1882).
2.   Shinde, D. B., Shinde, N. D. & Shingare, M. S., Dubey, M. P., Patnaik, G. K.; Ind. J.
Chem., 34B, 920-922 (1995).
(I)
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This method is extensively used for the
preparation of DHPs where R is an
aliphatic 3, aromatic4,5a,5b or heterocyclic5a-
5d,4a,6a-6d res idue.  a ,  b- unsa tu ra ted
aldehydes 7,3m, and glyoxylic acid
40,41,42
have also been employed.
 
 Modifications in Dihydropyridines
Original Hantzsch1 Synthesis of Dihydropyridines involved condensation of
an aldehyde, ammonia and ethyl acetoacetate which affords (II).
R = CH3,  C6H 4NO2, H, C6H 5, CH2CN
N
H
H R O
O
C2H5
O
O
H5C2
CH3 CH3
3a. Brignell, P., Eisher, U. and Farrell, P. G.; J. Chem. Soc. B, 1083 (1966).
  b. Engelmann, Justus Liebigs Ann. Chem., 37, 231 (1885).
  c. Jaeckle, A. Justius Liebigs Ann. Chem., 32, 246 (1888).
  d. Kraft, E and Mai, J.; Ber.,  22, 1757 (1889).
  e. Jeanrenaud, A.; Ber., 21, 1783 (1888).
  f.  Gottfried, S. and Ulzer, F.; Wiss. Mitt. Oesterr. Heilmittelstelle, No.1, 1, No.2,1
      (1926); No.3,1;No.4,1 (1927); Chem. Abst. 23,1902 (1929).
  g. Singer, A. and McElvain, S. M.; Org. Syn, 14, 30 (1934).
  h. Schalit J., Wiss. Mitt. Oesterr. Heilmittelstelle, No.11, 11, No.12,6 (1934);
      Chem. Abst. 34,6279 (1940) .
  i. Ayling E.; J. Chem. Soc. 1014 (1938).
  j. Huntress, E. and Shaw, E. ; J. Org. Chem, 13, 674 (1948).
  k. Baliah, V., Gopalkrishnan, V. and Govindarajan, J.; J. Ind. Chem. Soc., 31, 832
      (1954); Chem. Abst. 50, 998 (1956).
  l. Brignell, P., Bullock, E., Eisner, U., Gregory, B., Johnson, A. and Williams, H.; J.
     Chem. Soc., 4819 (1963).
 m. Kamal, A. and Qureshi, A.; Pakistan J. Sci. Res., 15, 35 (1963), Chem. Abst.
      60, 1689 (1964).
4a. Schiff, R. and Puliti, J.; Ber. 16, 1607 (1883).
  b. Lepetit, R.; Ber. 20, 1338 (1887).
  c. Hinkel, E. and Cremer, H. W.; J. Chem . Soc.; 117, 137 (1920).
  d. Hinkel, L. and Madel, W. R.; J. Chem . Soc. 161 (1926).
  e. Mimert, B., Diefenbach, E. and Eck. R.; Ber. 60, 2216 (1927).
  f.  Stein, A. and Ulzer, F.; Wiss. Mitt. Oesterr. Heilmittelstelle, 15 (1928); 1 (1929);
     Chem. Abst. 24, 3511 (1930).
  g. Hinkel, L. and Madel, W. R.; J. Chem. Soc. , 750 (1929).
  h. Hinkel, L., Ayling, E. and Morgan, W.; J. Chem. Soc.,  1835 (1931).
  i.  Hinkel, L., Ayling, E. and Morgan, W.; J. Chem. Soc.,  1112 (1932).
  j. Hinkel, L., Ayling, E. and Morgan, W.; J. Chem. Soc., 816 (1935).
  k.  Borsche, W. and Hahn, H., Justus Liebigs Ann. Chem., 537, 219 (1939).
                                                                                                                                                                           
(II)
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4m. Philips, A. P.; J. Amer. Chem. Soc., 73, 2248 (1951).
  n.  Philips, A. P.; J. Amer. Chem. Soc., 73, 3522 (1951).
  o.  Furdik, M. and Gvozdjakova, A.; Acta Fac. Rerum, Natur. Univ. Comenianae Chim
       8, 581 (1964);  Chem. Abst. 61, 13277 (1964).
5a.  Cook, A., Heilbron, I. and Steger, L.; J. Chem. Soc. 413 (1943).
  b.  Philips, A. and Randall, L. US2359329 (1944); Chem. Abst. 39, 1251 (1944).
  c.  The Welcome Foundation Ltd; GB582254 (1947), Chem. Abst. 41, 1715 (1947)
  d.  Philips, A.; Amer. Chem. Soc. 71, 4003 (1949).
6a.  Heiber, F.; Ber. 25, 2405 (1892).
  b.  Grischkenitsch-T. and Mazurewitsch, I.; J. Russ. Phys.-Chem. Ges., 43, 204; Chem.
      Abst., 11, 1561 (1912).
  c.  Homer, R.; J. Chem. Soc. 1574 (1958).
  d.  Wiley, R. and Ridgeway, J.; J. Org. Chem. 26, 595 (1961).
7.    Epstein W.; Justus Liebigs Ann. Chem., 231, 1 (1885).
8a.  Berson, J. A. and Brown, E.;
  b.  Sugimoto, N.; J. Pharm. Soc.; Jap., 64, 192 (1944); Chem. Abst. 45, 2802 (1951).
  c.  Haley, C. A. C and Maitland, P.; J. Chem. Soc . 3155 (1951).
9a.  Meyer, E.; J. Prakt. Chem., 52, 81 (1895).
  b.  Walther, R. and Von, J. Prakt. Chem. [2], 67, 504 (1903).
  c.   Meyer, E., Verhandl, Sachs, K., Ger. Wiss., Math - Phys. KI., 60, 146 (1908).
       Chem. Abst., 11,591 (1908).
  d.  Meyer, E.; J. Prakt. Chem. [2], 78, 497 (1908).
  e.  Palit, M.; J. Indian Chem. Soc., 10, 529 (1933); Chem. Abst., 28, 1345 (1934).
 
1,3-diketones are also used4m,8,
instead of ethyl acetoacetate to
give 3,5 diacyl 1,4-Dhp (III).
(III)
N
H
H R OO
CH3 CH3
R1R1
R=alkyl residue
s u b s t i t u t e d /
unsubst i tu ted
phenyl ring
 
N
H
H R
CH3 CH3
O
O
CH3
O
O
CH3 Methyl acetoacetate & ammonia or me-
thyl-3-amino crotonate was used to syn-
thesize DHP ( IV)  with methyl ester
groups at C 3 and C 5 positions
5b-5dR = alkyl residue, substituted /
                  unsubstituted phenyl ring
 
N
H
H R
R1 R2
CNNC
(V)
Use of 3-amino crotononitrile leads to
the formation of cyano groups at C3 and
C5 positions
9(V)
R 1 and R 2 may be same or different.
 ie. CH3, C2H3, C6H5, etc
R = alkyl residue,
substituted or
unsubstituted
phenyl ring
(IV)
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   f. Hofmann, D., Kosower, E. M. and Wallenfels, K.; J. Amer. Chem. Soc., 83, 3314
     (1952).
   g. Kametani, T., Ogaswara, K., Kozuka, A.; Yakugaka Zasshi, 86 (9), 815-22v (1966);
      Chem. Abst, 65, 20092h (1966)
   j. Joseph K., Jaroslav, P., Lubos, V.; Collect. Czech. Chem. Commun., 39(3), 854
      (1974); Chem. Abst., 81, 13360q (1974).
  h. Stefan, M. and Joseph K., Collect. Czech. Chem. Commun., 48(11), 3112 (1983);
     Chem. Abst.,  100,85559v (1984).
  i. Courts, A., Petrow, V., J. Chem. Soc., 1 (1952).
  k. Dyachenko, V., Litvino, V., Russ. J. Org. Chem., 34 (4), 554 (1998); Chem. Abst.
     130, 223222c (1999).
10a. Mandal, N. K., Sinha, R., Banerjee, P.; J. Indian Chem. Soc . 12(1), 979 (1984)
   b. Jadhav, G. V., J. Ind. Chem. Soc., 7, 669 (1980)
11.  Sachram, M., Towart, R., Modulation of Calcium Channel by drugs., Life Sci. 37,
      1843 (1985).
N
H
CH3 CH3
O O
NN
Y
XX
Y
R
Use o f  a ldehyde,  ammonia  and
substituted acetoacetanilide(of aryl
amine, primary or secondary alkyl
amine) ,  leads  to  fo rmat ion  o f
ca rbamoy l  g roups  a t  C3 and  C 5
positions 10.
X and Y may
be same or
different (aryl/
alky/H)
VI
 In contrast to symmetry of the above
type of DHP molecules (VI), phenyl
carbamoyl moiety in dihydropyridine
either at C3 or at C5 position resulted
in to an unsymmetr ica l 11  DHP
molecule (VII).
VII
 
N
H
CH3 CH3
NH
O
N N
H3COO
O
CH3
VIII
BMY 428035
In continuation with the study
of  unsymmetr ica l  DHPs
having carbamoyl moiety at
third or fifth carbon atom,
B r i s t o l - M e y e r s - S q u i b b
N
H
CH3CH3
O
O
O
NH
Cl
N
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12. Annual Drug Data Rep. 11 (6), 464 (1989).
13. Annual Drug Data Rep. 12, 714 (1992).
14. Dyachenko, V. D., Krivokalysko, S. G., Litvinov, V. P., Russ. J. Org. Chem., 34 (6),
     876 (1998), Chem .Abst. 130, 296591g (1999); E. Knoevenagel and W. Ruschhaupt,
    Ber, 31, 1025 (1898).
pharmaceutical company successfully prepared12 a compound BMY 428035
(VIII)  and Bayer A. G. Company studied13 further, the structure activity
relationship (SAR).
Majority of 1,4-dihydropyridines synthesized possess symmetrically similar
groups (acetyl, ester, cyano, carbamoyl, benzoyl etc) at C3 and C5 positions.
However very few unsymmetrical 1,4-DHPs having different substitutions
at C3 and C5 positions, have been reported. Knoevenagel
14 synthesized
unsymmetrical DHP by condensation of of an alkylidene or arylidene 1,3-
dicarbonyl compound with a b -amino-a, b -unsaturated carbonyl compound
e.g. ethyl b-amino crotonate.  The study of unsymmetrical dihydropyridines
facilitates obtaining information about the structural activity correlations and
investigating the effects of stereochemistry on the activity. It also affords
an opportunity to expand existing structure-activity relationships and
potentially to discover additional structural modifications required to
effectuate for  enhancing the biological profile..
Unsymmetr ic 3-cyano-5-phenyl
carbamoyl-1,4-dihydropyridine-N-
methyl morpholinium salt (VII)  was
synthesized and studied.14
 
N
H
CH3
CN
X
O
NH
HR
N
H
O
CH3+
VII
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Quantitative Structure Activity Relationships (QSAR) attempt to relate a
numerical description of molecular structure to known biological activity. In
drug design, QSAR methods have often been used to consider qualities
beyond in vitro potency. The in vivo activity of a molecule is often a
composite of many factors. A structure activity can help to decide which
features of a molecule give rise to its overall activity and help to make
modified compounds with enhanced properties.
Stucture Activity Relationships(SAR) of DHPs have been extensively
studied 15-17, since DHPs are striking biological tools for the study of  voltage
activated calcium channel structure and function. A no. of general
conclusions may be drawn cancerning the structural requirements,
contributing to antagonist activity of the molecule.
1 . The 1,4-DHP ring is essential : Oxidation (to pyridine metabolites) or
    reduction leades to abolition of actions.
2 . A  4-phenyl substituent is optimum18-20. Activity increases with 4-
    substitution in the sequence as follows.
    H < Me < cycloalkylphenyl < heterocyclic < phenyl
3 . In the 4-phenyl substituent, incorporation of electron withdrawing groups
    in the ortho  and meta positions is optimum. Any substitution in the para
    position leads to reterogation of activity. Nature, size and position of the
15. Triggle, D. J. in Handbook of Experimental Pharmacology. Calcium In Drug ac
     tions. The Chemistry of Calcium Channel Antagonists and Agonists, G. V. R.
     Born (ed.), pg 115, Springer-Verlag, Heidelberg (1988).
16. Wehinger, E. and Gross, R.; Ann. Rep. Med. Chem., 21, 85 (1986).
17. Janis, R. and Triggle, D.; J. Med. Chem., 26, 775 (1983).
18. Triggle, D., Langs, D. and Janis, R.; Med. Res-Rev, 9, 123 (1989).
19. Z.Hernandez-Gallegos, Lehmann, P., Hong, F., Posadas, F. and E. Hernandes-
     Gallegos; Eur. J. Med. Chem 30, 355-364 (1995).
20. Rodenkirchen, R., Bayer, R., Steiner, R., Bossert, F., Meyer, H., Moller, E. and
      Naunyn-Schmiedeberg's; Arch. Pharmacol, 69, 310 (1979).
Structure Activity Correlation
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substitution in the aryl ring are important determinants of activity15,20-24
4 . Atleast one ester function is required in the 3 / 5 positions of the 1,4-
dihydropyridine and replacement of ester functions with carboxymethyl or
cyano groups leads to degradation of activity. There is structural tolerance
to the size of the ester groups that confer and maintain activity and a certain
amount of evidence exists to suggest that differential recognition of ester
groups may contribute to tissue selectivity. DHP molecules displayed
higher activity when the esterification groups were small.25-27. Changes in
the substitution at third, fourth and fifth carbon atom of dihydropyridine, alters
conformation28,29, tissue selectivity30-36 and potency 37 of the 1,4-DHP ring.
21. Loev, B., Goodman, M. M., Snader, K. M., Tedeschi, R. Macko, E.; J. Med. Chem.
17, 956 (1974)
22. Triggle, A. M., Shefter, E., Triggle, D. J.; J. Med. Chem . 23, 1442 (1984).
23. Mahmoudian, M., Richards, W. G., J. Chem. Soc., Chem. Commun. 739 (1986)
24. Coburn, R., Wierzba, M., Sutu, M., Solo, A., Triggle, A., Triggle, D.; J. Med. Chem.,
31, 2103 (1988)
25. Rowan, K.R. Ph. D. thesis , Oklahoma State University, May 1996.
26. Rowan, K.R.; Holt, E.M. Acta Cryst. 1996, C52, 1565.
27. Rowan, K.R.; Holt, E.M. Acta Cryst. 1996, C52, 2207.)
28. Triggle, A. , Shefter, E. and Triggle, D.; J. Med. Chem . 23, 1442 (1980).
29. Fossheim, R., Svarteng, K., Mostad, A., Romming, C., Shefter, E. and Triggle, D.; J.
     Med. Chem, 25, 126 (1982).
30. Gross. G, Warltier, D.and Hardman, H.; J. Cardivasc. Pharmacol. 6, 61 (1984).
31. Knorr, A., Garthoff, B.; Arch. Int. Pharmacodyn., 269, 316 (1984).
32. Advenier, C., Cerrina, J., Duroux, P., Floch, A. and Renier, A.; Br. J. Pharmacol. 82,
      727 (1984).
33. Itil, Michael, S., Hoffmeister, F., Kunitz, A. and Erlap, E.; Curr. Ther. Res., 35, 405
     (1984).
34. Antman, E., Horowitz, J. and Stone, P; In Calcium Channel Blocking Agents in the
     Treatment of Cardiovascular Disorders; Stone, P., Antman, E., Eds.; Futura: New
     York,p177 (1983).
35. Heusch, G. and Deussen, A.; J. Cardiovasc. Pharmacol . 6, 378 (1984).
36. Meyer, H., Kazda, S. and Belleman, P.; Annu. Rep. Med. Chem. 18, 79 (1983).
37. Fossheim, R., Svarteng, K., Mostad, A., Romming, C., Shefter, E. and Triggle, D.; J.
     Med. Chem., 25, 126 (1982).
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38a. A. Coser Gaudio, Korolkovas, A. and Takahata, Y.; J. Mol. Struct. (Theochem) 303,
       255 (1994).
   b. Bellmann, P., Innovative Approaches In Drug Research; Elsevier: Amsterdam, 23
       (1986).
39.  Goldman, S. and Stoltefuss, J., Angew. Cchem. Int. Ed. Engl. 30, 1559 (1991).
40.  Rovnyak, G., Anderson, N., Gougoutas, J., Hedberg, A., Kimball, S. D., Malley,
      M.,Moreland, S., Porubcan, M. and Pudzianowski, A.; J. Med. Chem. 31, 936 (1988).
41.  Langs, D. and Triggle, D.; Mol. Pharmacol. 27, 544 (1985).
42.  Gaggelli, E., Marchettini, N. and Valensin, G.; J. Chem. Soc. Perkin Trans. 2, 1707
      (1987).
43.  Rovnyak, G., Kimball, S., Beyer, B., Cucinotta, G., Dimarco, J., Gougoutas, J.,
      Hedberg, A., Malley, M., McCarthy, J., Zhang, R. and Moreland, S.; J. Med. Chem.
      38,119-129 (1995).
44.  Seidel, W., Meyer, H., Boern, L. and Kazda, W. Dompert, in J.K.Seidel (Ed.),
      Proceedings of the fifth European Symposium on Quantitative Structure Activity
      Relationships, VCH, Weinheim , p. 366 (1984).
45.  Ramusino, M. and Vari, M.; J. Mol. Struct (Theochem) 492, 257 (1999).
5 . From the theoretical and experimental point of view, the conformational
features of  DHP analogs have been the subject  of  great deal  of
investigation23,38-42. The orientation of C4-aryl group (R or S configuration)
acts as a "Molecular Switch" between antagonist and agonist activity.43.
Seidel et al44 highlighted, the importance of conformation, the synthesis of
conformational restrained analogues which show that the biological activity
decreases when the 4-phenyl substituent deviates from a perpendicular
orientation bisecting the dihydropyridine ring45.
6 . Activity may be enhanced by the presence of bulky groups which cause
the 4-substituent to prefer an orientation perpendicular to the plane of the
dihydropyridine.
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Pharmacological Thrust of Dihydropyridines.
The calcium ion is a critical extra and intracellular messenger that plays
multiple roles in physiological stimulus response coupling processes. It is
a major structural component of bone and related skeletal appendices when
its movements and concentration are uncontrollable; it leads to wreak cell
death and destruction. Calcium ion channel represents an important drug
target that possess specific binding sites for both antagonist and agonist
ligands.  Ion channels can be considered to be multiple-drug binding
receptors, having four to eight discrete binding sites on the channel
proteins 46-49 to which, these activators and inhibitors get bound. Opening
and closing of three channels is regulated by three main groups of calcium
channel  b lockers,  i .e .  d ihydropyr id ines,  phenyla lky l -amines and
benzothiazepines, typical examples of which are nifedipine, verapamil and
diltiazem, respectively. 49-59.
46. Hille, B., Ionic Channels of Excitable Membranes, 2 nd  ed. Sinaveer assoc., Sunderland,
     M. A., 128 (1991).
47. Triggle, D. and Hansch, C. Ed., Comprehensive Medicinal Chemistry, Pergamon
     Press, New York, 1047 1990
48. Putney, J.; Pharmaco. Rev., 30, 209 (1978).
49. Rosenberger, L. and Triggle, D.; “Calcium and Drug Action”, Ed., Plenum Press, New York
(1978).
50. Therapeutic guidelines, cardiovascular, 3rd ed. Victoria: Therapeutic Guidelines; 1998.
51. Robertson, R. and Robertson, D.; Drugs used for the treatment of myocardial is
     chemia. In:Hardman JG, Limbird JG, editors. Goodman and Gilman’s the pharmaco
     logical basis of therapeutics, 9th ed. New York: McGraw-Hill;. p. 759– 78. Chapter
     32 (1996).
52. Calcium channel blocking agents in USP DI. Drug information for the health care
     professional, 22nd ed. Colorado: Micromedex; p. 727– 42. (2002).
53. Antihypertensive drugs. In: Mycek MJ, Harvey RA, Chempe PC, editors. Lippincott’s
      illustrated reviews: pharmacology. Pennsylvania: Lippincott Williams & Wilkins;.
     179– 92. Chapter 19. (2000).
54. Triggle, D. and Rampe, D.; Trends Pharmacol. Sci., 10, 507-511 (1989).
55. Triggle, D.;  Can. J. Physiol. Pharmacol., 68, 1474 (1990).
56. Triggle, D.; J. Cardiovasc. Pharmacol., 18,S1-6 (1991).
57. Triggle, D.; Amer. J. Hypertension, 4,422S (1991).
58. Triggle, D.; Ann. N.Y. Acad. Sci., 15, 267 (1994).
59. Triggle, D.; Chirality, 8,35 (1996).
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60.  Peri, R., Padmanabhan, S., Rutledge, A., Singh, S., and Triggle, D.; J. of  Med.
      Chem., 43, 15, 2906 (2000).
61. Triggle, D., Langs, D. and Janis, R.; Med. Res. Rev., 9, 123 (1989).
62. Zamponi. G. , Stotz. S., Staples, R., Andro, T.,  Nelson, J., Hulubei, V., Blumenfeld,
A., Natale, N. R.,
63. Rojstaczer, N. and Triggle, D.J. Biochem. Pharmacol., 51, 141–150 (1996).
64. Cozzi, P., Carganico, G., Fusar, D., Grossoni, M., Mewichinchero, Pinciroli, V.,
      Tanani, R., Vaghi, F. and Salvati, P.; J. Med. Chem., 36, 2964 (1993).
65. Takenaka, T., Usuda, S., Nomura, T., Maino, H., Sado, T., Arzneim-Forsch. / Drug.
      Res., 26, 2172 (1976).
A long ser ies of molecular model ing
s tud ies  o f  d ihydropyr id ines  were
published in the 1980s and 1990s61 led to
the expectation of a pattern of docking
involving the insertion of ring B of the DHP
molecule into a turn of the protein helix
bounded by two argenine side chains62 (VIII) . These studies appeared to
correlate with physiological activities determined by in vivo studies63.
Calcium Channel “Antagonists” or “Blocking agents” have made their way
into clinical medicine for treatment of umpteen number of disorders. They
are most commonly used for patients with cardiovascular diseases64.  The
predominant pharmacological effects of calcium channel antagonists are
coronary, peripheral and cerebral vasodi lat ion65,
These three class of drugs dif fer in overal l  pharmacological and
pharmakokinetic characteristics, although they do share a fundamental
similarity of action. They are known to bind to three different, but allosterically
linked, sites on the alpha1  subunit of the calcium channel. Molecular
characterization of the binding sites of these drugs was studied60  to
understand their mode of action. DHP class, of the three classes of the
above said drugs are most extensive studied.
(VIII)
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negative ionotropic effect66-68, positive ionotropic agents(particular in
congestive heart failure69),  inhibition of excitation of sinoatrial and
atrioventricular nodes70. These effects explain their remarkable therapeutic
value in angina pectoris71, stable 72 and unstable angina73, hypertension 68,
post hemorrhagic cerebral vasospasm and supraventricular tachycardia1471,
sub arachnoid hemorrhage74, myocardial infarction75, ischemic brain
damage76, nephropathies77, atherosclerosis78.
66. Hoff, R., Scholtysik, G., Loutzenhiser, R., Vuorela, H. and Neumann, P., J. Card.
     Pharm.,  6, 399 (1982).
67. Jamis, R., Silver, P. and Triggle, D.; Adv. Drug. Res., 16, 309 (1987).
68a.Chiarini, A., Rampa, A., Bisi, A., Budriesi, A. and Valenti, P.; Arzneim-Forsch ./
      Drug Res., 42, 797-801 (1992).
   b.Hansson, L., Calcium Antagonists: An Overview. Am. Heart J. 122. 308 (1991).
69a.Takenaka, T., Inagaki, O., Terai, M., Assano, M., Kubo, K., J. Pharmacol. Exp.
      Ther.,  244, 699-708 (1988).
   b.Goldenber, I. F., Cohn, J. N., J. Am. Med. Assoc., 258, 493 (1987).
   c.Erhardt, P. W.; J. Med. Chem . 30, 321 (1987).
   d.Reicher-Reiss, H. and Barasch, E., Drugs 42 (3), 343 (1991).
70a.Takenak, T., Usuda, S., Nomura, Y., Maino, H., Sado, T.; Arzneim- Forsch./ Drug
      Res. , 26, 2172 (1976).
   b.Hachira, S., Kunizo, H., Tadao, S., Hideyuki, A., Yoshiharu, D.; Eur. Pat. EP197,
      488 (1986); Chem. Abst. 106, 32859 (1987).
   c.Wehinger, W., Horst, M., Andres, K. and Yoshiharu, D.; Ger. Offen.  DE3,1544,211
      (1987); Chem. Abst. 107, 217482 (1987).
71. Hof, R., Scholtysik, G. Loutzenhiser, R., Vuorela, H. and Neumann, P.; J. Pharm.,6,
      399-406 (1984).
72a.Subhramaniam, V.; Excerpta Medica (Amsterdam), 97 (1983).
   b.Mueller, H. and Chahine, R.; Am. J. Med., 71, 645 (1981).
73. Antman, E., Muller, J., Goldberg, S., McAlpin, R., Rubenfire, M., Tabatznik, B.,
      Liang, C., Henpler, F., Achuff, S., Reichek, N., Geltman, E., Kerin, N. Z., Neff, R.
     K. and Brainwald, E.; J. Med. 302, 1269 (1980).
74a.Pickard, J., Murray, G., Illingworth, R., Shaw, M., Teasdale, G., Foy, P., Humphrey,
       P., Lang, D., Nelson, R., Richards, P., Sinar, J., Bailey, S., Skene, A., Brit. Med. J .
      298, 636 (1989).
   b. Buchbeit, J. and Tremoulet, M.; Neurosurg. 23, 154 (1988).
75a.Loogna, E., Sylven, C., Groth, T. and Mogensen, L.; Eur., Heart, J ., 6, 114 (1985).
   b.PRINT Study Group; Eur. Heart. J. 9 (suppl, I),  350 A (1988).
76. Gelmers, H. and Henneric, N.; Stroke, 21 (Suppl IV),  21, 81-IV84 (1990).
77.  Di Bona, G., Epstein, M.and Mann. J. and Nordlander, M.; Kidney Int., 41,Suppl. 36
      (1991).
78. Triggle, D.; Drugs Today, 27 (3), 147 (1991).
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Some DHPs inhibit smooth79-81 and cardiac muscle contractions by blocking
the influx of Ca2+  through calcium channels82-86. Apart from these effects,
there are evidences of use of DHPs in the treatment of epilepsy87,
migraine87i and  for  protect ion of  t issues f rom “calc ium-damage”,
Thromboxane A 2 Synthase
64, antiperoxidant activity88.
The interest is growing toward pharmacological activities that are not
connected with their calcium antagonist properties, like neurotropic
(antiamnestic, anticonvulsant, neuroregulatory), antidiabetic, and membrane
protecting as well as anticancer, antibacterial, and antiviral activities.89-92
79. Vaghy, P., Williams, J. and Schwartz, A.; Am. J. Cardiol., 59, 9A-17A (1987).
80. Anginal Pectoris
81. Cupka, P.; Czech. CS243,591 (1987).
82. Fleckenstein, A.;  Annu. Rev. Pharmacol. Toxicol., 17. 149 (1977).
83. Lochner, W., Braasch, W. and Kroneberg, G., Eds, 2 nd  International Adalat
      Symposium, New Therapy of Ischemic Heart Disease, Springer-Verlag, Berlin, (1975).
84. Imai, S.; Trends Pharmacol. Sci., 2, 81 (1979).
85. Love, B., Goodman, M., Snader, K., Tedeschi, R., Macko, E.;  J. Med. Chem.
     17, 956 (1974).
86. Bossert, V., Hertsmann, H., Meyer, H., Vater, W.; Arzneim-Forsch./ Drug Res.
     29(1), 226 (1979).
87a.Heinemann, U. and Lovel, L., Pflugers Arch., 398, 310 (1983).
   b.Heinmann, U. and Pumain, R; Neuro Sci. Lett., 21, 87 (1981).
   c.Shelton, G. and Fried, W.; Brain Res., 402, 399 (1987).
   d.Hoston, J. and Prince, D., Ann. Neurol. 10, 11 (1981).
   e.Pumain, R., Kurcewicz, L. and Louvel, J.; Science 222, 177 (1983).
   f.Katoh-Semba, R. and Takeuchi, I.; J. Neurochem., 77, 71 (2001).
   g.Hassan, H., Grecksch, G., Ruthrich, H. and Krug, M. Effects of nicardipine, an
     antagonist of L-Type voltage-dependent Calcium Channels Neuropharmacology;
     38: 1841 (1999).
   h.Janis, R. and Triggle, D.; In Calcium Channels: Their Properties, Functions,
      Regulations and Clinical Relevance; Hurwitz, L, Partridge, D., Leach, J., Eds.;
      CRC Press, Inc., 195, (1991).
   i. Peroutka, S., Banghart, S. and Allen, G.; Headache, 24, 55-58 (1984).
88. Janero, D. R., Burghardt, B.; Biochem. Pharm., 38, 4344-4348 (1989).
89. Misane, I.; Klusa, V.; Dambrova, M.; Germane, S.; Duburs, G.;Bisenieks, E.;
     Rimondini, R.; Ogren, S. O. Eur. Neuropsychopharmacol. 1998, 8, 329-347.
90. Krauze, A.; Germane, S.; Eberlins, O.; Sturms, I.; Klusa, V.; Duburs, G. Eur. J.
     Med. Chem. 1999, 34, 301-310.
91. Klusa, V. Drugs Future 1995, 20, 135-138.
92. Briede, J.; Daija, D.; Stivrina, M.; Duburs, G. Cell. Biochem. Func. 1999, 17,89-96.
 Calcium Channel Regulators..... 13
93a.Iwanami, M., Shibanuma, T., Fujimato, M., Kawai, R., Tamazawa, K., Takenaka,
      T., Takahashi, K., Murakami, M.; Chem. Pharm. Bull. 27,1426 (1997).
   b.Visencin, S., Rolando, B., Antonella Di. Stilo, Fruttero, R., Novara, M., Carbone,
E., Roussel, C., Vanthuyne, N. and Gasco, A.; J. Med. Chem. 47, 2688 (2004).
94. Pratt, W., Ruddon, R., Ensminger, W. and Maybaum, J., The anticancer Drugs.
     Oxford University Press, Oxford (1994).
95. Cozzi, P., Briatico, G., Giudici, D., Rossi, A., Salle, E. D., Med. Chem. Res., 69,
     611-17 (1996).
 
N
H
CH3CH3
O
O
N
N
O
O
CH3
NO2
.2HCl
Manidipine hydrochloride
Moreover many 1,4-DHPs were
tested for multi drug reversal
activity (mdrr). Manidipine (IX)
was one of the most promising
molecules93. Multi Drug Resis-
tance (MDR), the most common
drug  res i s t ance  i n  Cance r
Chemotherapy, is defined as the
ability of cancer cells exposed to a single drug to develop resistance94 (clini-
cally aquired or nonintrinsic resistance) to a diverse range of structurally
and functionally unrelated drugs, multi drug resistance (mdr) is one of the
main stumbling blocks to long term successful Cancer Chemotherapy. The
use of multi drug resistance reverting (mdrr) agents 93a is a promising ap-
proach to overcome the undesired mdr  phenotype.
 
N
H
NC R1
CH3CH3
N
X
N
R1 = CN, R2= H, CH3,
X = CH
Aromatase inh ib i to ry  ac t i v i t y  ( in
t reatment  o f  Cancer)  o f  the 1 ,4-
dihydropyridine derivative containing
an imidazol-1-yl or 1,2,4-triazol-1-yl
r ing at  C4 posit ion of the pyridine
nucleus (X)  was studied in vitro.95
(IX)
(X)
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96.    Pumain, R., Kurcewicz, L. and Louvel, J.; Science, 222, 177-183 (1983).
97.    Katoh-S. and Takeuchi, I.; J. Neurochem., 77, 71-83 (2001).
98.    Hassan, H., Grecksch, G., Ruthrich, H. and Krug, M.; Neuropharmacology,  38,
        1841(1999)
99.    Marco, F., Andrea, Z., Carmelo, G., Germini, M.; Eur. Pat. EP272693; Chem.
        Abst.  109, 190259 (1988).
100.  Ono, H. and Kimura, M.; Arzneim-Forsch./ Drug Res., 31, 1131 (1981).
101a. Meyer, F., Anderson, R., Surdt, T., Yaksh, T. and Sharbrough, F.; Epilepsia, 28,
         409 (1987).
     b. Palmer, G. , Stagnitto, M. , Ray, R., Knowles, M. , Harvey, R. and Garske, G.;
         Ep i leps ia ,  39, 372 (1993).
      c. Shafiee, A., Rastkary, N. and Jorjani, M.; Arch. Pharm. Pharm. Med. Chem.,
         2 , 69 (2002).
     d. Shafiee, A., Rastkari, N. and Sharifzadeh, M.; Daru volume, 12, 2. (2004).
     e. Shafiee, A., Rastkary, N. and Jorjan, M., Arzneim Forsch, 52, 7, 537 (2002).
102.  Sunkel, C., Casa-Juana, M., Santos, L., Gowez, M., Villarroya, M., Gonzales-
   Morales, M., Piriego, J. and Ortego, M.; J. Med. Chem. 33, 3205 (1990).
Platelet Activating Factor (PAF) is an ether phospholipid which stimulate
the movement and aggregation of neutrophils from which, tissue damaging
enzymes and oxygen radicals are released. Hence action of PAF in vivo
induces inflammatory response with associated pain, accumulation of
inflammatory cells, increased vascular permeability, and allergic skin
reaction. PAF is involved in other medical conditions such as in circulatory
shock, gastric ulceration96, psoriasis. Therefore agents which antagonize
the actions of PAF, holds clinical utility as anticonvulsant agents97-102(XI)
 R = Phenyl, Sub. Phenyl; phenyl fused to a dioxole Ring
Z = C 1 – C 6 alkoxy, aryl (C1 – C 4 ) alkoxy, hydroxyl and NR
4R 5 where in each of
        R4 and R 5 is independently H or C 1 – C 6 or R
4 and R 5 together complete a
        pyrrolidinyl, piperidino, morpholino, piperizinyl or N – (C1 – C 4) alkyl
        piperizinyl group.
X = 5 or 6 membered aromatic heterocyclic group
       With one or more N-atoms in the ring
Y = 1,4 phenylene or pyridine-2,5-diyl.N
H
CH3CH3
OO
Z
RH
N
R2
R1
(XI)
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103.  Cooper, K., Fray, M. J., Parry, J. G., Richardson., K., Steele, J.;  J. Med. Chem.
        35, 3115 (1992).
104.  Fetkowska, N.;  J. Card. Pharm.,  19 Suppl. 3, S25-S28 (1992).
105a. Kelvin Cooper, Michael J. Fray, Kenneth Richardson, John Steele; US4,935430,
        Jun (1990).
     b. Cole, H., Brown, C., Magee, C., Roudebush, R., Bryant, H. U.; Gen Pharmacol.,
        26, 431 (1995)
     c. Meguro, K., Nagaoka, A.; EP 138505, JP 85084269, US 4603135 (1997)
     d. Raunald, H., Brehm, O. and Odenthal, K; Planta Med., 60, 101-105 (1994).
106.   Swamy, S. K., Reddy, T. M. and Reddy, V. M.; Ind. J. Pharm. Sci., 60 (2), 102
         (1998)
107.  Takasugi, H., (Fujisawa Pharm. Co. Ltd.) Diphenyl Pyridine compounds.;
        JP89079155, Ann. Drug. Data Rep. 10B, 546 (1988).
 
  
N
H
CH3 CH3
NH
OO
NH
CH3 CH3
O
N
H
CH3 CH3
NH
OO
NH
CH3 CH3
O
CH3O
CH3
N
H
CH3 CH3
NH
OO
NH
CH3 CH3
R
Compounds (XII) and (XIII)  showed anticonvulsant activity to some extend
as compared to nifedipine and compound (XIVa) and (XIVb)  lowered
carotid blood pressure of tert. animals.106
N
H
CH3
CN
O
NH
NO
NO2
R
In 1988, Takasugi, H. studied107 the
DHP molecules of type (XV) and
embossed their anginal and coronary
vasodilating activity.
i.e. in treatment of allergy103, inflammation104 and and hyper secretary
conditions (asthma, arthritis)105
(XII)
(XIII)
(XIVa), R = OH
(XIVb), R = NO2
(XV)
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N
H
CH3 Y-X
OO
N
R1
R2
Z
RH
R = substituted/unsubstituted phenyl
ring, dioxole ring
X =  5  o r  6  membered  a romat i c
heterocyclic group with one or more N-
atoms in ring.
Y = 1,4-phenylene or pyridine-2,5-diyl.
Z = C 1 - C 6 alkoxy, aryl (C1 - C 4), hydroxy
4-aryl-5-carbamoyl-1,4-DHPs of type (XVI) 108 are useful in treatment of
allergic and inflammatory conditions in humans and animals. Many of these
dihydropyr id ines have a lso been descr ibed as ant i ischemic and
antihypertensive agents, since they are able to inhibit the movement of
calcium into cells and are thus active in many of the cardiovascular disorders
and hypertension.
and NR 4R 5 wherein each of R4 and R 5 is independently H or C1 - C6  alkyl or
R 4
 and R 5 together complete a pyrrolidinyl, piperidino, morpholino, piperazinyl
or N-(C1 - C4 alkyl) piperazinyl group. R2 = H or C1 - C4 and R' is CN C3 - C7
cycloalkyl, aryl, heteroaryl or a C 1 - C 4 alkyl group substituted by one or
more substituents selected from C3 - C7 cyclo-alkyl, C1 - C4 alkoxy carbonyl
aryl or heteroaryl
108.   Cooper, K., Fray, M. J., Richardson, K., Birchington, R., Stele, J.; US 4,935,430,Jun,
        (1990)
109.  Sadanandam, Y., Shetty, M, Ram Mohan Reddy, K. and Leelavathi, P.; Eur. J.
        Med. Chem., 29, 975 (1994).
110.  Takenaka, T. and Maeno; Jpn., J. Pharmacol ., 32, 132 (1992).
 
N
H
CH3CH3
O
N
O
N
Y
XX
Y
R
Incorporation of N-methyl and N,N-diethyl
Carbamoyl moities at C3 and C 5 positions of
1-4-dihydropyridine nucleus (XVII)  resulted
into striking Calcium Channel Inhibition.109,110
Also, these dihydropyridines portrays higher
rate  antiinflammatory and analgesic profile.
(XVI)
(XVII)
(XVII)
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111. Christians, J., Ph. D. Vrije University, Amsterdam, The Netherlands (1994).
112. Neamati, N., Hong, H., Mazumder, A. and Pommier, Y; J. Med. Chem., 40 (6), 942
(1997).
In another case (XVIII)111, unsymmetric DHP, having one phenyl carbamoyl
moiety  thrived as anticonvulsant agent.
A new DHP (XIX) having similar carbamoyl groups at third and fifth carbon
atom of pyridine nulcleus has found its way into anti-HIV activity112.
 
N
H
CH3
O
CH3
O
NHN
Cl
N
NH
CH3
(XVIII)
UK-74,505
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(XIX)
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"DHP Molecule in Space"
N
1
2 3
4
56
O
O
R2
CH3
HH
CH3
O
m
OO
R1
group is introduced in C4 phenyl group, C4 phenyl group (XX) prefers
orientation perpendicular or orthogonal to the plane of the dihydropyridine
ring, which is energetically and biologically important114.
This conformation of DHP molecule was studied in the case of Nifedipine
and related compounds, in which the sol id state exists in a boat
conformation. Here the C4 substituent is phenyl ring, which exists in a
sterically favoured orientation perpendicular to the 1,4-DHP ring. The
nonbonded interactions of C3, C4, C 5 substituents results into strain. This
strain is mitigated by crumpling of 1,4-DHP ring, followed by distortion of
bond angle 115-117. Synthesis of rigid analogs bridged between the phenyl
and 1,4 -DHP rings, proves that act ivi ty increases with increasing
inter-r ing angle118
113a. Rampe, D. and Triggle, D. G.; Prog. Drug. Res., 40, 191 (1993);
    b. Rovnyak, G., Kimball, S., Beyer, B., Cucinotta, G., DiMarco, J., Gougoutas, J.
    c. Hedberg, A. Malley, M., McCarthy, J., Zhang, R. and Moreland, S. J. Med. Chem.,
       38, 119 (1995).
114. Triggle et al, 1980; Fossheim et al. 1982, Golmann and Geiger, 1984
115. Janis, R., Triggle, D.; J. Med. Chem., 26, 775 (1983).
116. Triggle, A., Shefter, E. and Triggle, D.; J. Med. Chem., 23, 1442 (1980).
117. Fussheim, R., Svarteng, K., Shefter, E. and Triggle, D. J.; J. Med. Chem ., 25, 126
      (1982).
118. Seidel, W., Meyer, H., Boern, L. and Kazda, W. Dompert, in J.K.Seidel (Ed.),
      Proceedings of the fifth European Symposium on Quantitative Structure Activity
      Relationships, VCH, Weinheim , p. 366 (1984).
Much research has been carried out to
define the structural and conformational
requ i rements  needed  fo r  the
pharmaco log ica l  ac t i v i t y  o f  these
molecules 113.  A 1 ,4 -D ihyd ropy r id ine
molecule without any substitution on C4
position resides as a planar molecule and
one with C4-phenyl group has prediction for
f l a t  boa t  con fo rma t i on .  When  bu l ky
(XX)
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A Chiral approach to Dihydropyridines
119a. Hof. R., Ruegg, U., Hof, A. and Vogel, A.; J. Cardiovasc. Pharmacol.,7, 689 (1985).
     b. Goldmann, S. and Stoltefuss, J. Angew. Chem. Int. Ed. Engl. 30, 1559 (1991).
120.  Shibamura, T., Iwatani, M., Okudaa, K., Takenaka, T. and Murakami; M. Chem.
        Pharma. Bull., 28, 2809 (1980).
121.  Muto, K., Kuroda, T., Kkawato, H., Karasawa, A., Kubo, K. and Nakamizo, M.;
        Arzneim-Forsch, 38 (II), 1662 (1988).
122.  Kajino, M., Wada, T., Nagai, Y., Nagaoka, A. and Meguro, K.; Chem. Pharm. Bull.,
        37, 2225 (1989).
123.  Ashimori, A., Uchida, T., Ohtaki, Y., Tanaka, M., Ohe, K., Fukuya, C., Vatanabe,
        M., Kagitani , M. and Yokoyama, K.; Chem. Pharm. Bull., 39,108 (1991).
124.  Vo, D., Matowe, W., Ramesh, M., Iqbal, N., Wolowyk, M., Howlett, S. and Knaus,
        E. E. J. Med. Chem., 38, 2851 (1995).
125.  Tamazawa, K., Arima, H., Kojima, T., Isomura, Y., Okada, M., Fujita, M., Furuya,
        T., Takenaka, T., Inagaki, O. and Terai, M.; J. Med.Chem., 29, 2504 (1986).
126.  Holdgrun, X., Sih, C.; Tetrahedron Lett. , 32, 3465 (1991).
Every unsymmetrical 1,4-Dihydropyridine molecule has one or more chiral
centres, i.e carbon atom bearing four different groups.
Pharmaceut ical  evaluat ions of  chira l  1,4-DHPs revealed that  their
s te reo isomers  usua l l y  have  d i f fe ren t  b io log ica l  ac t i v i t i es .119-123
Sometimes the undesired enantiomer caused serious side effects, while
in other cases enanti-omers  caused serious side effects, while in other
cases enantiomers were reported to even have the opposite action profile
(calcium antagonist-calcium agonist; hypotensive activity-hypertensive
activity).124 Ever since the differences in biological  action and toxicity
for a  number of unsymmetrical dihydropyridines were reported for the first
time125, the demand for enantiopure dihydropyridines appeared, and in
1991, the first successful enantioselective chemoenzymatic transformation
of a prochiral dihydropyridine 3,5-dicarboxylic diester was carried out.
126
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Asymmetric synthesis of the two enantiomers of a large number of DHPs
has been achieved by three different strategies.127
a)  Resolution of mixtures by chemical128 or by  enzymatic methods129.  The
chemoenzymatic synthesis of some biological act ive DHPs, (e.g.
Nicardipine, Nilvadipine) was recently achieved in several laboratories.130,131
b) Use of chiral auxiliaries in the carbon framework of the reagents132
c) Use of chiral auxiliaries in the nitrogen atom of the starting enamine.
Methods of acheiving optical resolution is also described in EP 26317, FR
2528431 & FR 2523128 . Many Dihydropyridines were resolved by using
neutral cyclodextrins133
127.  Goldmann, S. and Stoltefuss. J. Angew. Chem. Int. Ed. Engl. 30, 1559 (1991).
128a. Alajarin, R., Alvarez-Builla, J., Vaquero, J., Sunkel, C., Fau de Casa-Juana, M.,
        Statkow, P. and Sanz-Aparicio.; J. Tet. Asymm.,  4, 617 (1993).
     b. Satoh, Y., Okamura, K. and Shikowa, Y.; Chem. Pharm. Bull. 42, 950; Wester, R.
        T; Okamura, K and Shikowa, Y. Chem. Pharm. Bull. 42, 950 (1994).
     c. Wester, R., Mularski, J., Magnus-Ayriety, T., Da Silva Jardine, P., LaFlamme, J.,
         Berke, H., Bussolotti, D., Raauch, A., Hoover, K., Kennedy, Ch. Aa., Burkerd, M.,
        Mangiapare, M., Aldinger, Ch. E., Cooper, K. and Carpino. Ph. A. Biomed. Chem.
        Lett.  4, 133 (1994)
    d. Ogawa, T., Matsumoto, K., Yokoo, C., Hatayama, K. and Kitamura, K.; J. Chem.
        Soc. Perkin Trans., 4, 525 (1993)
129a. Ebikke, H. and Achiwa, K., Tetrahedron Asymm. S, 1447 (1994).
     b. Hirose, Y., Kariya, K., Nakanishi, Y., Kurono, Y. and Achiva, K.; Tetrahedron
         Letters,  36, 1063 (1995).
     c. Yamazaki, Y., Ebiike, H and Achiwa, K. Chem. Pharm. Bull., 42, 1968 (1994).
130.   Achiwa, K.; Kato, T. Curr. Org. Chem., 3,77 (1999).
131.  de Castro, M., Salazar, L. and Sinisterra, J.; Tetrahedron:Asymmetry, 8, 857 (1997).
132a. Davis, R., Kern, J., Kurz, L. and Pfister, J.; J. Am. Chem. Soc., 110, 7973 (1988).
    b. Arrowsmith, J., Campbell, S., Cross, P., Stubbus, J., Burges, R., Gardiner, D. and
        Blackburn, K.; J. Med. Chem., 29, 1696 (1986).
133.  Christians, T., Diewald, D., Wessler, C., Otte, Y., Lehmann, J. and Holzgrabe, U.;
        J. of Chromat. A, 853, 455 (1999).
 Calcium Channel Regulators..... 21
(R)- and (S)-R-phenylethylamine (PEA) have been used separately to re-
solve successfully a  racemate 2-formyl-1,4-DHP derivative (XXI). The pro-
cess was based on the difference of the solubility of both Schiff bases,
since one of them crystallized out from the solution. These imines obtained
by condensation of (R)-R-PEA or (S)-R-PEA with 2-formyl-1,4-DHP were
separated and analyzed by X-ray diffraction, and their exposition to
an hydrochloric hydrolysis conditions led to the enantiopure (4R)-4 or
(4S)-4 in excellent yields.134
134.  Marchalin, S., Cvopova, K., Kriz, M., Baran, P., Oulyadi, H. and Darich, A.; J. Org.
        Chem., 29, 4227 (2004).
135.  Sobolev, A., Franssen, M., Vigante, B., Cekavicus, B., Zhalubovskis, R., Kooijman,
       H., Spek, A. L., Duburs, G. and Aede de Groot; J. Org. Chem., 67, 401 (2002).
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In another such study135 of chemoenzymatic synthesis of chiral dihydropyridine
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the position 3 and 5 of 4-aryl-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylates, presumably because of steric and electronic factors.126,136
To overcome this difficulty, spacers have been introduced at these posi-tions.
The spacer should contain a group that is easily hydrolyzed by enzymes
(e.g., an ester group) in order to allow kinetic resolution or enzymatic
asymmetrization. The ethoxycarbonylmethyl spacer has been used to
asymmetrize a number of 4-aryl-1,4-DHPs137-139  The acyl-oxymethyl
moiet ies were introduced by the groups of Sih140 and Achiwa 141
136.  Ebiike, H., Terao, Y. and Achiwa, K. Tetrahedron Lett. , 32, 5805 (1991).
137.  Sobolev, A. Franssen, M., Makarova, N., Duburs, G. and deGroot, Ae. Tetrahedron:
        Asymmetry , 11, 4559 (2000).
138.  Hirose, Y., Kariya, K., Sasaki, I., Kurono, Y., Achiwa, K. Tetrahedron Lett. , 34,
        3441 (1993).
139.  Hirose, Y., Kariya, K., Sasaki, I., Kurono, Y. and  Achiwa, K. Tetrahedron Lett. , 34,
       5915 (1993).
140.  Salazar, L. and Sih, C.; Tetrahedron: Asymmetry, 6, 2917 (1995).
141.  Ebiike, H., Maruyama, K., Yamazaki, Y., Hirose, Y., Kariya, K., Sasaki, I., Kurono,
        Y., Terao, Y. and  Achiwa, K.; Chem. Pharm. Bull., 45, 863 (1997).
142.  Patel Ian, Ashworth Ian, Levin Daniel; US10333669 (2004).
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CN Asymmetr ic  subs t i tu ted  1 ,4-
dihydropyridines of (XXIII) can be
synthesized by the process in which an
asymmetr ic  v iny logous amide is
synthesized by reacting a 1,3-cyclo
hexanedione with a substantially homo-
chiral phenylethylamine. Followed by
the reaction of the asymmetric vinylogous amide with an a,b -unsaturated
ketone in the presence of a silicon compound resulting into 1,5-diketone,
which is then converted to asymmetric substituted 1,4-dihydropyridine of
type (XXIII) 142
(XXIII)
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In another study143 compound of type,
(XXIV) , which shows cerebrovascular
and card iovascu lar  ac t iv i t y ,  was
synthesized, under Hantzch conditions by
ref luxing b-amino crotonate, 3-ni tro
benzaldehyde and acetoacetic acid in ethanol / methanol. This resulted
into racemic mixture which was then resolved by reacting the racemic
mixture with optically active amine in DMF / Water mixture. The aminated
isomers are than separated by crystallization, followed by esterification or
amidation of individual isomers to get the resolved isomers.
143. Gilles Genain; US4920225 (1990).
144. Goldmann, S., Stoltefuss, J.; Angew, Chem., Int. Ed. Engl., 30, 1559 (1991).
(XXIV)
 
N
H
O
O
R
CH3 CH3
H
NO2
CF3
N
H
O
O
R
O
O
R
CH3CH3
H
   BAYK8644
When an appropriate group such as nitro group is substituted in (XXV)  for
one of the two ester functions, the resulting two enantiomers display
opposite pharmacological profiles144. eg. BAYK8644. In case of BAYK8644,
(-)-S-antipode is a potent agonist at L-type Ca2+  channels, while (+)-R-
antipode is a feeble agonist.
(XXV)
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X-ray Crystallography is a powerful technique giving the complete three
dimensional structure in detail at high resolution including bond distances,
angles, stereochemistry and absolute configuration. Resolution and
accuracy of the coordinates obtained from the X-ray plays important role in
Drug Design.
X-RAY Crystallographic Studies
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Ravikumar and co-workers145,  it was
observed that  in compound of  type
(XXVI), DHP rings are in shallow boat
conformation. The methyl carbamoyl
groups at  th i rd and f i f th carbon atoms
are oriented anticlinal in the compounds, (where R is o-nitro and p-methoxy).
In the third case, the orientation of the C3 and C5 groups, is anticlinal and
synperiplanar, respectively. This may be due to the intermolecular and
synperiplanar interactions.
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145. Sagar, M., Ravikumar, K. and Sadanandam, Y.;  Zeitschrift fur Kristallographie,
       213 (3) (1998).
146. Sagar, M., Ravikumar, K. and Sadanandam, Y.; Zeitschrift fur Kristallographie, 214
      (3) (1999).
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In the present chapter four different types of 1.4 DHP’s are synthesized.
The unsymmetrical 1,4 DHP’s bearing 3-acetyl group is not much explored
in literature and hence is a added novel feature in this class of compounds.
The x-ray crystallographic study of each class of 1.4-DHP synthesized in
this chapter is made and AKP-2, AKPKX-3, and others were studied to get
important information.
Similarly, unsymmetrical 1,4-DHP possessing 3-acetyl and phenyl carbonyl
moiety at position C3 and C5 as well as the DHP’s bearing 3-cyano &
5-phenyl carbomoyl are also structural novelty established for the first
time and synthesized in this chapter.
Similarly the 1,4-DHP’s having both cyano group at C3 and C5 postion
(AKPKX-1) is also studied in current chapter.
All reaction shemes are outlined on page no. 26
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APU-1 - 7, APU-10 - 15, APU-20,21
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Reaction Scheme  2
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Reaction Mechanism
a ,  b-unsaturated carbonyl compound (acetoacetanil ide of different
substituted anil ines) undergo Knoevengel reaction with substituted
aldehydes to give the the condensed product, which further undergoes
Michael addition with enamines (ethyl-3-amino crotonate or methyl 3-
amino crotonate or 3-amino crotononitri le) or it reacts with enolate
(acetyl  acetone or ethyl  acetoacetate or methyl  acetoacetate) in
presence of l iquor ammonia or ammonium carbonate to give the tit le
compounds.
Looking at the proposed retrosynthetic approach, it could be interpreted
that, 1,4-dihydropyridine, a double enamine, may be derived from
enaminone, which in turn should be accessible from 1,5-dicarbonyl system
and ammonia by cylcocondensation. 1,5-dicarbonyl compound would be
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Method of Synthesis
(General Method)  Preparation of Substituted Acetoacetanilides
(Reaction Scheme 1: Step 1)
A mixture of substituted anilines (0.1 m), ethyl acetoacetate (0.1 m, 13.1
ml) in 40 ml toluene was refluxed in presence of catalytic amount of sodium
hydroxide lye in a dry 250 ml-round bottom flask at 120oC for 15 hours.
The toluene was distilled out. Resulting reaction mixture was  then transfered
to a beaker and allowed to cool, which solidified after some time. The solid
product obtained was washed with commercial petroleum ether and LR
diethyl ether for several times till crystalline, free, pale yellow coloured
product isolated. The isolated product was filtered and washed with diethyl
ether to remove traces of starting materials and impurities if present.
The yield of substituted acetoacetanilide ranges from 50 - 70 %. The product
were recrystallized from methanol. The acetoacetanilides were prepared
using various substituted anilines like 2-chloro aniline,  3-chloro aniline,  4-
chloro aniline,  2-fluoro aniline, 4-fluoro aniline, o-toluidine, o-anisidine and
biphenyl amine.
(General method)Preparation of Substituted Arylidine derivatives.
(Reaction Scheme 1:step 2)
A mix ture o f  subst i tu ted acetoacetan i l ide (0 .01 m),  subst i tu ted
benzaldehyde (0.01 m) in 4-5 ml Isopropyl alcohol (IPA) was mechanically
stirred in presence of catalytic amount of glacial acetic acid and piperidine.
The reaction time ranges from 20 min to 12 hrs for different aryl amines.
White solid product isolated was filtered and washed with IPA, so as to
completely remove unreacted aldehyde. The compounds were recrystallized
from methanol.
The yield of these compounds, ranges from 50 - 80 %.
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(General method) Synthesis of Substituted unsymmetrical carbamoyl DHP
(Reaction Scheme 1 and 2)
(Ethyl / Methyl 4-(substituted / unsubstituted phenyl)-5-[(substituted /
unsubstitutedanilino)carbonyl]-2,6-dimethyl-1,4-dihydro-3-pyridinecarboxylate)
OR
(5-acetyl-2,6-dimethyl-N-(substituted / unsubstituted  phenyl)-4-(substituted /
unsubstituted phenyl)-1,4-dihydro-3-pyridinecarboxamide)
Synthesis of AKPKX-3
(1-[4-(3-bromophenyl)-2,6-dimethyl-5-propionyl-1,4-dihydropyridin-3-
yl]propan-1-one) (Reaction Scheme 3)
A mixture of methyl 3-amino crotonate (0.02m, 1.29 g) and 3-bromo
benzaldehyde (0.01 m, 1.85 gm) in 10 ml methanol was refluxed on a steam
bath for 5 hrs. The reaction mixture was cooled and transfered to a beaker.
On cooling crystalline product separated out,  which was recrystallized from
hot methanol. M.P. 189 o C
Mol. Wt., 408; Mol. For. C 19H22O4NBr; M.P., 180 
o C; % Yield, 70-80 %, TLC,
Ethyl acetate : Hexane; 3 : 7
A mixture of substituted arylidene derivative (0.01 m), methyl-3-amino
crotonate (0.01 m, 1.29 g) or 3-amino crotononitrile (0.01 m, 0.82 g) in 10
ml methanol in a 100 ml corkable conical flask was refluxed with stirring for
2-10 hrs. Pale yellow/pale green/white product comes out, which was
isolated,filtered when hot. It was further washed with methanol to remove
the unreacted mass and other impurities. Recrystallization was carried out
in methanol.The yield of title compounds ranges from 40 - 60 %.
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The mixture of benzaldehyde (0.01 m, 1.06 gm) and 3-amino crotononitrile
(0.02 mole, 2 gm) in ethanol was refluxed on water bath for 12-15 hrs. The
reaction was monitored by TLC (Ethyl acetate : Hexane; 3 : 7).  The reaction
mixture was then removed from the waterbath and allowed to cool at room
temperature. The reaction mixture was then kept over night at room
temperature to get thecrystalline compound (AKPKX-1). The product
obtained was recrystallized from hot methanol.
Mol. Wt., 235.28; Mol. For. C15H13N3; M.P., 202 
o C; % Yield, 70 %, TLC,
Ethyl acetate : Hexane; 3 : 7
Synthesis of AKP-2 (Microwave method)
(Methyl 5-acetyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-
carboxylate) (Reaction Scheme 5)
A mixture of 3-nitro benzaldehyde (0.01 mole, 1.5 gm) and acetyl aceton
(0.01 mole, 1 ml) was taken in a 50 ml conical flask and heated for 45 sec
in microwave at 60 power. Then the reaction mass was allowed to cool at
room temperature and washed with hexane for atleast three to four times.
Then to the mixture was added, 3-amino crotononitrile (0.01 mole, 0.96
gm) and heat for another 45 sec in the microwave. Remove it from the oven,
allow it to cool down at room temperature. Wash the reaction mass
exessively with petroleum ether for three to four times. Then wash the mixture
with diethyl ether. And finally the yellow coloured product is obtained on
adding methanol, which was recrystallized using ethyl acetate.
Mol. For.,  C17 H18 N2 O5; Mol Wt.,  330; M.P., 194 
o C; Yield, 60 %
TLC; Acetone : Benzene; 2 : 8
Elemental Analysis, C(61.81%) H(5.49%) N(8.48%) O(24.22%)
Synthesis of AKPKX-1
(1-[4-(3-bromophenyl)-2,6-dimethyl-5-propionyl-1,4-dihydropyridin-3-
yl]propan-1-one) (Reaction Scheme 4)
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Spectral Analysis (IR)
The region of infrared spectrum which is of greatest importance lies between
4000 and 660 cm-1. Absorption bands in the spectrum result from energy
changes arising as a consequence of molecular vibrations of the bond stretching and
bending type. The aromaticity of the compounds is determined from the significant
absorption around 1600-1400 cm-1 and 850-660 cm-1. C=C, C=N, C=C, C=O
show significant absorption between 2500-1600 cm-1. Similarly, various
functional groups shows specificeabsorption in the finger print region
which becomes the key point in their identification.
Spectral data of only key intermediate and final compounds are included.
using the instrument, SHIMADZU FT IR-8400, Sample technique,  KBr
pellet, Frequency  range, 400-4000 cm-1
Looking to the spectral study of the newly synthesized (dihydropyridines)
molecules, the carbonyl (>C=O) of the amidic  functionality stretching was
observed at 1655-1670 cm-1 and another ketonic group (ester, or acetyl)
was observed at approximately at 1670-1690 cm-1 due to the conjugation
with the DHP skeleton. The amide ( >C-N stretching) isobserved at
1300-1400 cm-1.
The stretching of secondary amine (>NH) appears approximately around
3100 - 3400cm-1 which indicates the presence of -NH- in the compound.
Here in almost all the compounds two -NH str vibrations are observed
for since there are two secondary amine groups. One of them shows
absorption at lower frequencies due to the carbonyl group attached to
it. The stretching C-N appears at 1200 - 1400 cm-1 which further adds
up the evidence of the presence of secondary amine group.
 Calcium Channel Regulators..... 38
As far as the aromatic skeletal vibrations are concerned, C-C multiple bond
stretching, C-H inplane bending and out of plane bending were observed at
1400 - 1600 cm-1 and 810 - 730 cm-1 respectively.
 IR spectra with the details of the various frequencies for the compounds coded
APU-1, APU-5, APU-16,APU-21 are on the subsequent pages.
In case of APU-1,  the -CH out of plane bending vibrations are observed at
750 cm-1  and 702 cm-1
In case of APU-16  The cyano group shows a sharp absorption at 2190 cm-1.
While due to aromatic nitro group, two characteristic peaks are observed
due to the asymmetric stretching vibrations at 1504 cm-1 and symmetric
stretching vibrations at 1347 cm-1. The presence of chloro of the carbamoyl
phenyl group gave absortion  (stretching) at 676 and 710 cm-1. The -CH
out of plane bending vibrations are observed at 793 and 773 cm-1 (meta
substitution)
Looking to the IR spectrum of APU-5, The -CH out of plane bending
vibrations are observed at 743 cm-1 and at 701 cm-1.
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In case of APU-21, stretching vibrations due to C-F at 1112 and 1087 cm-1 is
observed. The -CH out of plane bending vibrations are observed at 751
cm-1 and at 698 cm-1 as characteristic frequencies of this moiety.
Finally in case of AKP-2, there are two carbonyl groups (acetyl and esteric)
which shows absorption at 1670 and 1703 cm-1 respectively.  This feature
is a very typical identification of both carbonyl group present in this un-
symmetrical molecule. The secondory amine is indicated by the -N-H
stretching vibrations at 3329 cm-1, the -NH- deformations at 1587 cm-1
and the C-N stretching vibrations at 1334 cm-1.  The aromatic skeletal
vibrations can be seen at 1644, 1567 cm-1, the -CH in plane bending vi-
brations can be observed at 1222 cm-1 the -C-H out of plane vibrations
are observed at 783 cm-1 which clearly indicates the presence of three
adjacent hydrogen atoms. The C-NO2 group shows asymmetric stretch-
ing vibrations at 1527 cm-1.
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APU-1
IR Spectrum of 5-acetyl-N-(2-methoxyphenyl)-2,6-dimethyl-4-phenyl-1,4-dihydro-3-
pyridinecarboxamide
N
H
CH3 CH3
CH3
OO
NH
OCH3
APU-16
IR Spectrum of 5-[1-(3-chloroanilino)ethyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4-
dihydro-3-pyridinecarbonitrile
N
H
CN
CH3CH3
O
NH
NO2
Cl
Type Vibration Mode Frequency (cm-1)
Amine
>NH-str 3411
>NH-deformation 1596
-C-N str 1334
Methyl
C-H str (asym) 2927
C-H str (sym) 2833
Amide
NH-COstr 1658
C-N str 1286
>NH-str 3257
Aromatic
-C-C skeletal
vibrations
1622,1596
1512,1458
-CH in plane 1224
-CH out of  plane 750
APU-1
Type Vibration Mode Frequency (cm-1)
Amine
>NH-str 3323
>NH-deformation 1589
-C-N str 1347
Cyano C=N Str 2190
Amide
NH-COstr 1659
C-N str 1269
>NH-str 3252
Aromatic
-C-C skeletal
vibrations
1618,1504
-CH in plane 1249
-CH out of  plane 793,773
Chloro -C-Cl Str 676,710
APU-16
0.0
20.0
40.0
60.0
80.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmAPU-1
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 642.3
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1224.7
1247.9
1286.4
1334.6
1382.9
1429.2
1458.11481.2
1512.1
1596.9
1622.0
1658.7
1683.7
2339.5
2833.2
2927.7
3006.8
3139.9
3257.5
3354.0
3411.8
20.0
40.0
60.0
80.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmAPU-16(new)
 676.5
 710.5
 738.9
 773.2
 793.21249.1
1269.8
1304.8
1347.2
1424.8
1504.9
1589.0
1618.9
1652.2
1659.1
1698.4
2190.5
3252.7
3323.6
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APU-5
IR Spectrum of 5-acetyl-2,6-dimethyl-N -(2-methylphenyl)-4-phenyl-1,4-dihydro-
3-pyridinecarboxamide
APU-21
IR Spectrum of methyl 4-phenyl-5-[(2-fluoroanilino)carbonyl]-2,6-dimethyl-1,4-
dihydro-3-pyridinecarboxylate
N
H
CH3CH3
CH3
O
NH
O
CH3
N
H
CH3CH3
O
NH
F
O
O
CH3
Type Vibration Mode Frequency (cm-1)
Amine
>NH-str 3398
>NH-deformation 1595
-C-N str 1382
Carbonyl -C=O str 1668
Methyl
C-H str (asym) 2927
C-H str (sym) 2833
Amide
NH-CO str 1651
C-N str 1280
>NH-str 3226
Aromatic
-C-C skeletal
vibrations
1602,1584
1489
-CH in plane 1220
-CH out of  plane 743
Type Vibration Mode Frequency (cm -1)
Amine
>NH-str 3398
>NH-deformation 1595
-C-N str 1382
Carbonyl -C=O str 1673
Methyl
C-H str (asym) 2927
C-H str (sym) 2833
Amide
NH-CO str 1651
C-N str 1280
>NH-str 3301
Aromatic
-C-C skeletal
vibrations
1614,1451
1489
-CH in plane 1225
-CH out of  plane 698,751
Nitro -C-NO2  str
1504(asym)
1347(sym)
Fluoro -C-F str 1112,1087
APU-5 APU-21
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmAPU-5(new)
 407.2
 670.7
 701.3
 743.3
1129.0
1220.6
1249.31455.01489.4
1584.9
1602.5
1651.2
1668.3
2398.8
3226.9
3398.8
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmAPU-21(new)
 403.1
 670.9
 698.4
 751.9
1087.8
1112.1
1188.8
1225.7
1255.8
1306.9
1432.3
1451.6
1494.5
1614.8
1651.9
1673.8
1732.7
2390.4
3301.2
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AKP-2
IR Spectrum of methyl 4-phenyl-5-[(2-fluoroanilino)carbonyl]-2,6-dimethyl-1,4-
dihydro-3-pyridinecarboxylate
N
H
CH3CH3
O
CH3
O
O
CH3
N
+
O
-
O
Type Vibration Mode Frequency (cm-1)
Amine
>NH-str 3329
>NH-deformation 1587
-C-N str 1334
Carbonyl >C=O str (ester) 1703
>C=O str (acetyl) 1670
Methyl
C-H str (asym) 2927
C-H str (sym) 2833
Aromatic
-C-C skeletal
vibrations 1644,1587
-CH in plane 1222
-CH out of  plane 783
Nitro -C-NO2 asym 1527
-20.0
0.0
20.0
40.0
60.0
80.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmAKP-2(new)
 571.6
 675.5
 748.3
 783.8
 799.9
 894.2
 960.2
1022.9
1077.2
1116.5
1222.5
1294.4
1428.4
1527.8
1587.8
1644.7
1670.2
1703.3
2397.1
3329.6
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Spectral Analysis (NMR)
Nuclear Magnetic Resonance (NMR) spectrocopy is a powerful tool for
the organic chemist since instruments are now easily available since
the last decade. The technique is only applicable to those nuclei which
possess a spin quantum number (I) greater than zero. The most impor-
tant of such nuclei as far as the organic chemist is concerned are 1H
and 13C both of which have a spin quantum number of 1/2.
The basis of the NMR experiment is to subject the nuclei to radiation which
will result in  a transition from the lower energy state to higher one. The
value of nmr spectroscopy to the organic chemist is that the precise differnce
between the two energy levels between two spin orientations is dependent
on particular location of the atom in the molecule because each nucleus is
subject to differing effects of the magnetic fields of neighbouring nuclei.
The nuclei which are in the same environment have the same energy
difference between spin orientations. So these energy differences are
detected and interpreted to know the variety of locations of the nuclei
in the molecule.
Instrument used for the NMR spectroscopy of the newly synthesized DHPs
was BRUKER AC 300 MHz FT-NMR, where TMS  was used as the Internal
reference and CDCl3 or DMSO d6 were used as solvent.
The NMR here gives the promising evidences for the elucidation of the
structure of the novel DHP molecules which are unsymmetric with respect
to the C 3 and C 5 carbon atoms of the DHP nucleus.
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Following are the common signals observed in APU compounds.
¨ The methylene protons (-CH3) adjacent to the N1, showed the most
shielded signals and gave a sharp singlet at approximately 1.5 - 4.0 d ppm.
¨  The hydrogen of the chiral carbon (>CH-) in all compounds was observed
at 4.0 - 6.0 d ppm.
¨  The protons of N1, N3 and Nitrogen (N) of the carbamoyl moiety showed
absorptions in the downfields i.e. around  7.0-10.0 d ppm. The signals due
to proton attached to nitrogen atom may not be traceable at times.
Looking to the individual NMR spectrum, i.e in case of APU-1, the four
methyl groups resonates such that two sharp singlets are observed at 2.267
and 3.687 d ppm. The proton at the 5' position of the carbamoyl phenyl,
resonates at 7.33 d ppm. This signal splits into triplet due to the coupling
with the two hydrogen atoms at ortho positions and one proton at the meta
position from the current proton and this is evident from the coupling con-
stant J, 7.1 Hz. The two protons at third and fifth position in the phenyl
residue of chiral carbon, resonates at 7.44 d ppm giving a doublet, with J
value, 7.3 Hz which indicates the ortho coupling. The two protons of sec-
ond and sixth position of the phenyl group attached to the chiral carbon are
highly deshielded and resonates giving a doublet of doublet in the down
field ie. at 8.308 d ppm with coupling constant of 1.8 Hz (for meta coupling)
and 7.8 Hz (for ortho coupling). The two protons attached to the nitrogen
atoms of the DHP molecule resonates at 7.769 d ppm giving a sharp
singlet in the down field of the spectrum.
In case of APU-16, apart from the chiral proton and the methyl protons, it
can be clearly observed that the two protons adjacent to the nitro group are
highly deshielded and resonates in the downfield i.e at 9.663 d ppm. The
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proton at the fifth postion in the phenyl residue attached to the chiral
carbon atom shows a doublet at 7.979 d ppm with coupling constant
equal to 8.1 indicating the ortho coupling.
In case of APU-14, the three protons of the phenyl residue attached to the
carbamoyl group resonate to give  a multiplet at 7.127 d ppm. The two
nitrogen protons shows a sharp singlet at 9.071 d ppm.
In case of APU-5, the two nitrogen protons resonate at 6.91 d ppm. The
proton present at the fourth position in the phenyl residue attached to the
chiral carbon shows a multiplet with coupling constant, 7.3 and 1.2 Hz for
ortho and meta coupling respectively.  There are four methyl groups which
are indicated by the singlets in the upfield since they are highly shielded.
ie at 1.844 and 2.26 d ppm. The proton present at the sixth position of the
carbamoyl phenyl residue resonates at 7.557 giving a doublet due to ortho
coupling (J = 7.8 Hz).
Spectral Analysis (Mass)
The mass spectrometry is  used for  acuurate determinat ion of  the
molecular weight.  I t  a lso provide informat ion about the structure of
compounds by an examination pattern. When the organic compound
molecules are bombarded with the electrons under high vacuum,
each molecule looses electron by var ious f iss ion processes giv ing
r ise to ions and neutral  f ragments.  The posi t ive ions are expel led
from the ionizat ion chamber and resolved by the means of magnetic
field. When these ions arrive at the detector, they are recorded. The inten-
sity of the peak in the spectrum indicates the abundance of the ions. The
most intense peak is called the base peak. When a single electron is
removed from the molecule it give rise to molecular ion peak (M) and  has
the highest mass : charge (m/e) ratio.
 Calcium Channel Regulators..... 46
The base peak is given the arbitary value of 100 per cent and the height of
each other peak is determined relative to that value.
For the current study, Instrument used was JEOL SX 102/DA-6000 for
FAB (Fast atom Bombardenment). The molecular ion peaks  (M+) of  the
compounds  in mass spectra  were in total agreement  with it’s molecular
weight.  The Mass spectra of the compounds were given on page
no.151-153.
In case of APU -16 having molecular weight, 408,  M+2 peak (m/e = 410)
and M+2 (m/e = 354) are indicated.
In case of APU - 14, having molecular weight, 426, M+ peak (m/e = 426)
and M+1 peak (m/e = 427), M+ - *Br peak (m/e = 347) are indicated .
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APU-1
No.
Chemical
Shift Multiplicity No. of Protons
Coupling
Constant(J Hz)
1. 2.267 s 6H (7,18) -
2. 3.687 s 6H (28,26) -
2. 4.817 s 1H (4a) -
3. 7.335 t 1H (24) J = 7.1
4. 7.252 m 1H (13) -
5. 7.437 d 2H (12,14) J = 7.3
6. 7.769 s 2H (1,19) -
7. 8.308 dd 2H (11,15) J = 1.8, J = 7.8
APU-1
1H NMR Spectrum of 5-acetyl-N -(2-methoxyphenyl)-2,6-dimethyl-4-phenyl-1,4-
dihydro-3-pyridinecarboxamide
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APU-16
1H NMR Spectrum of 5-[1-(3-chloroanilino)ethyl]-2,6-dimethyl-4-(3-nitrophenyl)-
1,4-dihydro-3-pyridinecarbonitrile
No.
Chemical
Shift Multiplicity No. of Protons
Coupling
Constant(J Hz)
1. 2.122 s 6H (7,18) -
2. 5.227 s 1H (4a) -
3. 7.639 d 1H (24) J = 7.5
4. 7.745 s 1H (23) -
5. 7.979 d 1H (13) J = 8.1
6. 8.066 s 1H (11) -
7. 8.430 s 1H (1) -
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APU-14
1H NMR Spectrum of 5-acetyl-N -(2-methoxyphenyl)-2,6-dimethyl-4-phenyl-1,4-
dihydro-3-pyridinecarboxamide
No. Chemical
Shift
Multiplicity No. of
Protons
Coupling
Constant(J Hz)
1. 2.164 s 6H (7,18) -
2. 5.101 s 1H (4a) -
3. 7.127 m 3H
(24,25,26)
-
4. 7.184 m
3H
(13,14,23)
J = 3
5. 7.344 m 1H (15)
J = 2.4
J = 8.7
6. 7.433 s 1H (10) -
7. 7.572 m 2H (1,19) -
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APU-5
1H NMR Spectrum of 5-acetyl-2,6-dimethyl-N -(2-methylphenyl)-4-phenyl-1,4-
dihydro-3-pyridinecarboxamide
No.
Chemical
Shift Multiplicity No. of Protons
Coupling
Constant(J Hz)
1. 1.844 s 6H (18,27) -
2. 2.260 s 6H (7,26) -
3. 5.009 s 1H (4a) -
4. 6.981 m 2H (1,19) J = 7.1
5. 7.092 m 4H (12,14,23,24) -
6. 7.242 m 1H (13) J = 7.3, J = 1.2
7. 7.338 m 1H (22) J = 7.8
8. 7.392 m 1H (11) J = 1.8, J = 7.8
9. 7.433 t 1H (15) J = 1.5, J = 8.76
10. 7.557 d 1H (25) J = 7.8
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Oak Ridge Thermal Ellipsoid Plot of the AKPKX-1 Molecule
at 50 % Probability
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Identification code shelxl
Empirical formula C
15
H
13
N
3
Formula weight 235.28
Temperature 293(2) K
Wavelength 0.71073 A
Crystal system, space group Monoclinic,  P21/c
Unit cell dimensions a = 8.7220(7)   A  alpha = 90 deg.
b = 11.4200(11) A  beta = 104.101(5) deg.
c = 13.3070(12) A  gamma = 90 deg.
Volume 1285.5(2) A^3
Z, Calculated density 4,  1.216 Mg/m^3
Absorption coefficient 0.074 mm^-1
F(000) 496
Crystal size 0.2 x 0.25 x 0.3 mm
Theta range for data collection 2.38 to 32.40 deg.
Limiting indices -11<=h<=11, -17<=k<=17, -20<=l<=19
Reflections collected / unique 7541 / 4001 [R(int) = 0.0260]
Completeness to theta = 32.40 86.6 %
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 4001 / 0 / 164
Goodness-of-fit on F^2 0.908
Final R indices [I>2sigma(I)]R1 = 0.0625, wR2 = 0.1755
R indices (all data) R1 = 0.1096, wR2 = 0.2265
Extinction coefficient 0.087(10)
Largest diff. peak and hole 0.373 and -0.330 e.A^-3
Table 1.  Crystal data and structure refinement for cel.
x
N(1) 8655(2)
C(4) 8071(2)
C(3) 7615(2)
C(6) 9281(2)
C(13) 6639(2)
C(2) 7856(2)
C(18) 6409(3)
C(5) 9061(2)
C(14) 5531(2)
C(9) 6853(2)
C(11) 9700(2)
C(8) 7358(3)
C(17) 5119(3)
C(7) 10193(3)
C(15) 4248(2)
C(16) 4045(3)
N(12) 10157(2)
N(10) 6271(3)
z
222(1)
-1240(1)
-208(1)
-626(1)
-2157(1)
 446(1)
-2832(2)
-1311(2)
-2351(2)
 44(2)
-2197(2)
 1439(2)
-3677(2)
-704(2)
-3199(2)
-3860(2)
-2934(2)
  218(2)
U(eq)
68(1)
60(1)
60(1)
62(1)
56(1)
62(1)
69(1)
61(1)
66(1)
69(1)
70(1)
78(1)
79(1)
77(1)
77(1)
79(1)
93(1)
92(1)
y
7875(1)
9791(2)
9758(2)
7818(2)
9876(1)
8854(2)
10823(2)
8709(2)
8985(2)
10789(2)
8649(2)
8798(2)
10863(2)
6732(2)
9035(2)
9969(2)
8649(2)
11632(2)
Table 2. Atomic coordinates ( x 10^4) and equivalent isotropic displacement parameters
(A^2 x 10^3) for cel. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
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N(1)-C(6) 1.370(2)
N(1)-C(2) 1.387(2)
N(1)-H(13) 0.9601
C(4)-C(13) 1.521(3)
C(4)-C(3) 1.522(2)
C(4)-C(5) 1.523(2)
C(4)-H(7) 0.9800
C(3)-C(2) 1.333(3)
C(3)-C(9) 1.431(3)
C(6)-C(5) 1.348(3)
C(6)-C(7) 1.491(3)
C(13)-C(14) 1.384(2)
C(13)-C(18) 1.389(2)
C(2)-C(8) 1.490(3)
C(18)-C(17) 1.384(3)
C(18)-H(1) 0.9599
C(5)-C(11) 1.423(3)
C(14)-C(15) 1.383(3)
C(14)-H(5) 0.9600
C(9)-N(10) 1.139(3)
C(11)-N(12) 1.145(3)
C(8)-H(12A) 0.9601
C(8)-H(12B) 0.9600
C(8)-H(12C) 0.9601
C(17)-C(16) 1.366(3)
C(17)-H(2) 0.9600
C(7)-H(15A) 0.9600
C(7)-H(15B) 0.9600
C(7)-H(15C) 0.9600
C(15)-C(16) 1.367(3)
C(15)-H(4) 0.9601
C(16)-H(3) 0.9599
C(6)-N(1)-C(2) 122.55(17)
C(6)-N(1)-H(13) 119.8
C(2)-N(1)-H(13) 117.7
C(13)-C(4)-C(3) 112.41(14)
C(13)-C(4)-C(5) 111.68(14)
C(3)-C(4)-C(5) 108.21(15)
C(13)-C(4)-H(7) 108.1
C(3)-C(4)-H(7) 108.1
C(5)-C(4)-H(7) 108.1
C(2)-C(3)-C(9) 119.57(18)
C(2)-C(3)-C(4) 125.04(16)
C(9)-C(3)-C(4) 115.39(17)
C(5)-C(6)-N(1) 120.07(16)
C(5)-C(6)-C(7) 124.87(18)
N(1)-C(6)-C(7) 115.06(17)
C(14)-C(13)-C(18) 117.90(17)
C(14)-C(13)-C(4) 120.14(15)
C(18)-C(13)-C(4) 121.95(16)
C(3)-C(2)-N(1) 119.39(17)
C(3)-C(2)-C(8) 125.31(17)
N(1)-C(2)-C(8) 115.30(18)
C(17)-C(18)-C(13) 120.80(18)
C(17)-C(18)-H(1) 119.5
C(13)-C(18)-H(1) 119.7
C(6)-C(5)-C(11) 120.22(17)
C(6)-C(5)-C(4) 124.06(16)
C(11)-C(5)-C(4) 115.63(17)
C(15)-C(14)-C(13) 120.70(17)
C(15)-C(14)-H(5) 119.3
C(13)-C(14)-H(5) 120.0
N(10)-C(9)-C(3) 177.5(2)
N(12)-C(11)-C(5) 176.2(2)
C(2)-C(8)-H(12A)109.3
C(2)-C(8)-H(12B) 109.4
H(12A)-C(8)-H(12B) 109.5
C(2)-C(8)-H(12C) 109.7
H(12A)-C(8)-H(12C) 109.5
H(12B)-C(8)-H(12C) 109.5
C(16)-C(17)-C(18) 120.44(19)
C(16)-C(17)-H(2) 119.1
C(18)-C(17)-H(2) 120.4
C(6)-C(7)-H(15A)108.9
C(6)-C(7)-H(15B) 110.3
H(15A)-C(7)-H(15B) 109.5
C(6)-C(7)-H(15C) 109.2
H(15A)-C(7)-H(15C) 109.5
H(15B)-C(7)-H(15C) 109.5
C(16)-C(15)-C(14) 120.69(19)
C(16)-C(15)-H(4) 119.9
C(14)-C(15)-H(4) 119.4
C(17)-C(16)-C(15) 119.5(2)
C(17)-C(16)-H(3) 119.8
C(15)-C(16)-H(3) 120.7
I II
Table 3.  Bond lengths [A] and angles [deg] for cel.
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U11 U22 U33 U23 U13 U12
N(1) 74(1) 68(1) 65(1) -3(1) 22(1)  7(1)
C(4) 58(1) 56(1) 67(1) -9(1) 18(1) -9(1)
C(3) 56(1) 62(1) 62(1) -15(1) 11(1) -3(1)
C(6) 56(1) 65(1) 64(1) -12(1) 14(1) -2(1)
C(13) 62(1) 51(1) 58(1) -4(1) 22(1) -3(1)
C(2) 57(1) 68(1) 58(1) -11(1) 10(1)  0(1)
C(18) 86(1) 53(1) 72(1)   3(1) 30(1) -6(1)
C(5) 54(1) 66(1) 64(1) -12(1) 16(1) -5(1)
C(14) 68(1) 58(1) 69(1)   6(1) 11(1) -8(1)
C(9) 70(1) 68(1) 68(1) -12(1) 12(1)  2(1)
C(11) 64(1) 76(1) 73(1) -14(1) 23(1) -7(1)
C(8) 79(1) 96(2) 61(1) -4(1) 18(1)  12(1)
C(17) 105(2) 69(1) 65(1)  13(1) 22(1)  12(1)
C(7) 77(1) 74(1) 80(1) -10(1) 18(1)  11(1)
C(15) 72(1) 75(1) 78(1) -4(1) 8(1) -11(1)
C(16) 84(1) 85(1) 63(1)  0(1) 8(1)   8(1)
N(12) 92(1) 114(2) 83(1) -16(1) 40(1) -13(1)
N(10) 103(1) 77(1) 99(1) -14(1) 28(1)  17(1)
Symmetry transformations used to generate equivalent atoms:
Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for cel. The anisotropic displace-
ment factor exponent takes the form:  -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]
x y z U(eq)
H(13) 8752 7217   682 81
H(7) 8731 10484 -1246 72
H(1) 7150 11460 -2710 83
H(5) 5659 8315 -1901 79
H(12A) 6825 9511   1530 94
H(12B) 8273 8703   2004 94
H(12C) 6655 8147   1425 94
H(2) 4963 11522 -4138 95
H(15A) 10584 6774 -1318 93
H(15B) 9529 6055 -740 93
H(15C) 11067 6674 -107 93
H(4) 3485 8413 -3315 92
H(3) 3167 9997 -4457 95
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic
         displacement parameters (A^2 x 10^3) for cel.
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Packing of AKPKX-1 molecules down a axis
Packing of AKPKX-1 molecules down b axis
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Packing of AKPKX-1 molecules down c axis
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The sum of the absolute values of the six successive torsional angles of
the 1,4-DHP ring is 105.85\degree, implying that the pyran ring (ring~1) is
in a flattened boat conformation with puckering amplitude Q = 0.308
angstroms. The atoms N1 and C 4 deviate by  0.149 Angstorms  and  0.195
Angstorms respectively from the least-squares plane formed by N1, C 2, C 3,
C4, C 5, C 6.  The angle  between the least squares planes of DHP ring and
ring-2 is 87.85\degree, which makes them nearly perpendicular to each
other.  The molecule possesses intra-molecular hydrogen bonds of the type
N-H...O:N1-H1...O15 with an angle of 166 degree  about H1.
X-ray Crystallographic Study of AKP-2
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Identification code akp2
Empirical formula C
11.33
 H
11.33
 N
1.33
 O
3.33
Formula weight 219.55
Temperature 293(2) K
Wavelength 0.71073 A
Crystal system, space group Monoclinic, P21/c
Unit cell dimensions a = 12.860(2) A    alpha = 90 deg.
b = 7.4950(6) A    beta = 94.436(3) deg.
c = 16.734(3) A    gamma = 90 deg.
Volume 1608.1(4) A^3
Z, Calculated density 6,  1.360 Mg/m^3
Absorption coefficient 0.101 mm^-1
F(000) 692
Crystal size 0.2 x 0.25 x 0.3 mm
Theta range for data collection 2.98 to 22.46 deg.
Limiting indices -13<=h<=13, -7<=k<=7, -17<=l<=17
Reflections collected / unique 3588 / 1980 [R(int) = 0.0210]
Completeness to theta = 22.46 95.3 %
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 1980 / 0 / 218
Goodness-of-fit on F^2 1.132
Final R indices [I>2sigma(I)] R1 = 0.0852, wR2 = 0.2416
R indices (all data) R1 = 0.0969, wR2 = 0.2677
Extinction coefficient 0.017(7)
Largest diff. peak and hole 0.537 and -0.296 e.A^-3
Table 1.  Crystal data and structure refinement for cell.
x y z U(eq)
C(6) 3474(3) -5559(5) 5055(2) 56(1)
C(5) 3537(3) -3860(5) 5335(2) 56(1)
C(4) 2899(3) -2375(5) 4918(2) 54(1)
C(15) 1901(3) -2018(5) 5328(2) 53(1)
C(16) 1176(3) -3344(6) 5434(3) 71(1)
C(17) 288(4) -3014(7) 5818(3) 83(1)
C(18) 90(3) -1346(6) 6106(3) 71(1)
C(19) 806(3) -24(5) 6003(2) 60(1)
C(20) 1701(3) -334(5) 5619(2) 58(1)
C(3) 2658(3) -2817(5) 4025(2) 55(1)
C(2) 2596(3) -4553(5) 3793(2) 57(1)
N(1) 2884(3) -5876(4) 4341(2) 62(1)
N(21) 641(3)  1742(5) 6328(2) 77(1)
O(22) -144(3)  2047(6) 6657(3) 114(1)
O(23) 1324(4)  2863(5) 6277(3) 115(2)
C(14) 2220(4) -5300(6) 2988(2) 77(1)
C(12) 2523(3) -1223(6) 3522(2) 60(1)
O(24) 2563(2)  252(4) 3826(2) 68(1)
C(13) 2370(4) -1332(7) 2621(3) 82(1)
O(9) 4747(3) -4421(5) 6464(2) 90(1)
C(8) 4219(3) -3393(6) 6047(2) 64(1)
O(10) 4204(2) -1629(4) 6199(2) 79(1)
C(7) 3980(3) -7161(6) 5432(3) 69(1)
C(11) 4861(4) -1053(8) 6874(3) 96(2)
Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic  displacement parameters
(A^2 x 10^3) for cell. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
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C(6)-C(5) 1.356(5)
C(6)-N(1) 1.385(5)
C(6)-C(7) 1.484(6)
C(5)-C(8) 1.466(6)
C(5)-C(4) 1.520(5)
C(4)-C(15) 1.526(5)
C(4)-C(3) 1.539(5)
C(15)-C(16) 1.383(6)
C(15)-C(20) 1.384(5)
C(16)-C(17) 1.376(6)
C(16)-H(5) 0.9600
C(17)-C(18) 1.371(7)
C(17)-H(6) 0.9600
C(18)-C(19) 1.373(6)
C(18)-H(7) 0.9600
C(19)-C(20) 1.381(5)
C(19)-N(21) 1.453(5)
C(20)-H(9) 0.9600
C(3)-C(2) 1.358(5)
C(3)-C(12) 1.464(5)
C(2)-N(1) 1.382(5)
C(2)-C(14) 1.504(5)
N(1)-H(1) 0.8600
N(21)-O(22) 1.208(5)
N(21)-O(23) 1.223(6)
C(14)-H(16A) 0.9600
C(14)-H(16B) 0.9599
C(14)-H(16C) 0.9601
C(12)-O(24) 1.217(5)
C(12)-C(13) 1.506(6)
C(13)-H(19A) 0.9600
C(13)-H(19B) 0.9599
C(13)-H(19C) 0.9601
O(9)-C(8) 1.212(5)
C(8)-O(10) 1.347(6)
O(10)-C(11) 1.423(6)
C(7)-H(23A) 0.9600
C(7)-H(23B) 0.9601
C(7)-H(23C) 0.9601
C(11)-H(24A) 0.9600
C(11)-H(24B) 0.9600
C(11)-H(24C) 0.9600
C(5)-C(6)-N(1) 118.2(3)
C(5)-C(6)-C(7) 126.9(4)
N(1)-C(6)-C(7) 114.9(3)
C(6)-C(5)-C(8) 121.3(4)
C(6)-C(5)-C(4) 120.9(3)
C(8)-C(5)-C(4) 117.8(3)
C(5)-C(4)-C(15) 111.4(3)
C(5)-C(4)-C(3) 110.4(3)
C(15)-C(4)-C(3) 111.2(3)
C(16)-C(15)-C(20) 117.8(4)
C(16)-C(15)-C(4) 122.0(3)
C(20)-C(15)-C(4) 120.2(3)
C(17)-C(16)-C(15) 121.5(4)
C(17)-C(16)-H(5) 118.8
C(15)-C(16)-H(5) 119.7
C(18)-C(17)-C(16) 120.8(4)
C(18)-C(17)-H(6) 120.1
C(16)-C(17)-H(6) 119.1
C(17)-C(18)-C(19) 118.0(4)
C(17)-C(18)-H(7) 122.5
C(19)-C(18)-H(7) 119.5
C(18)-C(19)-C(20) 121.9(4)
C(18)-C(19)-N(21) 119.4(4)
C(20)-C(19)-N(21) 118.6(4)
C(19)-C(20)-C(15) 120.0(4)
C(19)-C(20)-H(9) 120.0
C(15)-C(20)-H(9) 119.9
C(2)-C(3)-C(12) 128.0(3)
C(2)-C(3)-C(4) 119.1(3)
C(12)-C(3)-C(4) 112.9(3)
C(3)-C(2)-N(1) 119.4(3)
C(3)-C(2)-C(14) 128.3(4)
N(1)-C(2)-C(14) 112.3(4)
C(2)-N(1)-C(6) 123.4(3)
C(2)-N(1)-H(1) 118.3
C(6)-N(1)-H(1) 118.3
O(22)-N(21)-O(23) 122.1(4)
O(22)-N(21)-C(19) 119.6(4)
O(23)-N(21)-C(19) 118.2(4)
C(2)-C(14)-H(16A) 109.7
C(2)-C(14)-H(16B) 109.8
H(16A)-C(14)-H(16B) 109.5
C(2)-C(14)-H(16C) 109.0
H(16A)-C(14)-H(16C) 109.5
H(16B)-C(14)-H(16C) 109.5
O(24)-C(12)-C(3) 120.1(3)
O(24)-C(12)-C(13) 117.8(4)
C(3)-C(12)-C(13) 122.1(4)
C(12)-C(13)-H(19A) 110.2
C(12)-C(13)-H(19B) 109.6
H(19A)-C(13)-H(19B) 109.5
C(12)-C(13)-H(19C) 108.7
H(19A)-C(13)-H(19C) 109.5
H(19B)-C(13)-H(19C) 109.5
O(9)-C(8)-O(10) 122.0(4)
O(9)-C(8)-C(5) 126.1(4)
O(10)-C(8)-C(5) 111.8(4)
C(8)-O(10)-C(11) 115.6(4)
C(6)-C(7)-H(23A) 109.8
C(6)-C(7)-H(23B) 109.5
H(23A)-C(7)-H(23B) 109.5
C(6)-C(7)-H(23C) 109.1
H(23A)-C(7)-H(23C) 109.5
H(23B)-C(7)-H(23C) 109.5
O(10)-C(11)-H(24A) 109.0
O(10)-C(11)-H(24B) 109.5
H(24A)-C(11)-H(24B) 109.5
O(10)-C(11)-H(24C) 110.0
H(24A)-C(11)-H(24C) 109.5
H(24B)-C(11)-H(24C) 109.5
Table 3.  Bond lengths [A] and angles [deg] for cell.
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U11 U22 U33 U23 U13 U12
C(6) 58(2) 51(2) 61(2)  2(2)  3(2) -6(2)
C(5) 55(2)      59(3) 54(2)  1(2)  3(2) -6(2)
C(4) 59(2) 52(2) 49(2)  1(2)  0(2)  1(2)
C(15) 56(2)      53(2) 49(2)  1(2) -1(2) -1(2)
C(16) 71(3)      65(3) 79(3) -18(2)  16(2) -11(2)
C(17) 71(3)      77(3) 102(4) -17(3)  21(3) -11(2)
C(18) 61(3)      78(3) 73(3) -4(2)  12(2)  1(2)
C(19) 72(3)      57(3) 50(2) -4(2)  0(2)  9(2)
C(20) 65(2) 57(2) 53(2) -1(2)  3(2) -5(2)
C(3) 61(2) 52(2) 52(2) -2(2)  3(2) -2(2)
C(2) 57(2) 59(2) 55(2) -4(2)  6(2) -2(2)
N(1) 68(2) 48(2) 68(2) -2(2)  1(2) -6(1)
N(21) 90(3) 67(3) 74(2) -6(2)  12(2)  10(2)
O(22) 102(3) 103(3) 142(3) -33(2)  39(3)  16(2)
O(23) 135(3) 64(2) 152(4) -23(2)   58(3) -12(2)
C(14) 105(3) 64(3) 61(3) -12(2) -3(2) -8(2)
C(12) 60(2) 61(3) 59(2) -3(2)  9(2)  1(2)
O(24) 88(2) 52(2) 66(2)  1(1)  6(1) -2(1)
C(13) 96(3) 83(3) 70(3) -10(2)  11(2)  0(2)
O(9) 100(3) 87(2) 78(2)  3(2) -21(2)  10(2)
C(8) 59(2) 75(3) 58(2)  2(2)  3(2) -5(2)
O(10) 90(2) 75(2) 69(2) -9(2) -16(2) -5(2)
C(7) 69(3) 56(3) 81(3)  4(2)  7(2) -4(2)
C(11) 96(4) 98(4) 87(3) -16(3) -27(3) -12(3)
Symmetry transformations used to generate equivalent atoms:
Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for cell. The anisotropic
displacement factor exponent takes the form:  -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]
x y z U(eq)
H(5) 1299 -4532 5248 85
H(6) -208 -3958 5865 99
H(7) -518 -1083 6384 85
H(9) 2181 623 5546 70
H(1) 2688 -6952 4233 74
H(16A) 2274 -6577 2999 92
H(16B) 2635 -4833 2583 92
H(16C) 1505 -4963 2868 92
H(19A) 2349 -2556 2452 99
H(19B) 2935 -733 2389 99
H(19C) 1724 -760 2448 99
H(23A) 3807 -8194 5109 82
H(23B) 3740 -7329 5957 82
H(23C) 4722 -6994 5477 82
H(24A) 4790 215 6931 115
H(24B) 5572 -1337 6792 115
H(24C) 4663 -1635 7350 115
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic
         displacement parameters (A^2 x 10^3) for cell.
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Packing of AKP-2 molecules down a axis
Packing of AKP-2 molecules down b axis
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Identification code shelxl
Empirical formula C
19
 H
22
 Br N O
4
Formula weight 408.29
Temperature 293(2) K
Wavelength 0.71073 A
Crystal system, space group Orthorhombic,  pbca
Unit cell dimensions a = 13.9570(14) A   alpha = 90 deg.
b = 16.3850(9) A    beta = 90 deg.
c = 16.6910(16) A   gamma = 90 deg.
Volume 3817.0(6) A^3
Z, Calculated density 8,  1.421 Mg/m^3
Absorption coefficient 2.176 mm^-1
F(000) 1680
Crystal size 0.3 x 0.25 x 0.3 mm
Theta range for data collection 2.27 to 23.26 deg.
Limiting indices -15<=h<=15, -17<=k<=18, -18<=l<=18
Reflections collected / unique 5033 / 2697 [R(int) = 0.0236]
Completeness to theta 23.26     98.4 %
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 2697 / 0 / 227
Goodness-of-fit on F^21.031
Final R indices [I>2sigma(I)]R1 = 0.0653, wR2 = 0.1810
R indices (all data) R1 = 0.0855, wR2 = 0.2038
Extinction coefficient 0.0109(16)
Largest diff. peak and hole 0.539 and -0.549 e.A^-3
X Y Z U(eq)
Br(24) 2841(1) 2177(1) 3327(1) 87(1)
O(16) 4354(3) 3920(2) 858(2) 72(1)
O(15) 5574(3) 4027(3) -4(2) 92(1)
O(10) 4227(3) 5333(3) 3291(2) 84(1)
O(11) 5496(3) 5899(4) 3842(4) 147(3)
N(1) 7186(3) 4837(2) 2050(3) 62(1)
C(4) 5240(3) 4450(3) 2168(3) 52(1)
C(5) 5795(4) 4379(3) 1381(3) 57(1)
C(14) 5270(4) 4094(3) 671(3) 67(1)
C(17) 3755(4) 3608(4) 225(3) 84(2)
C(18) 2841(5) 3338(6) 611(5) 126(3)
C(19) 5096(4) 3621(3) 2564(3) 52(1)
C(25) 4193(3) 3319(3) 2724(3) 55(1)
C(23) 4089(4) 2567(3) 3092(3) 57(1)
C(22) 4876(5) 2099(3) 3307(3) 69(2)
C(21) 5768(4) 2415(4) 3152(4) 75(2)
C(20) 5883(4) 3154(3) 2785(3) 64(1)
C(3) 5728(4) 5040(3) 2730(3) 59(1)
C(2) 6684(4) 5168(3) 2687(3) 60(1)
C(8) 7317(5) 5618(4) 3257(3) 80(2)
C(6) 6742(4) 4530(3) 1362(3) 60(1)
C(7) 7415(4) 4412(4) 685(3) 80(2)
C(9) 5083(5) 5436(3) 3299(3) 72(2)
C(13) 4927(10) 6219(9) 4839(9) 204(6)
C(12) 4765(9) 6645(11) 4237(7) 179(6)
Table 2. Atomic coordinates (x 10^4) and equivalent isotropic displacement parameters (A^2 x
10^3) for cel. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
Table 1.  Crystal data and structure refinement for cell.
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C(14)-O(16)-C(17)
C(9)-O(11)-C(12))
C(9)-O(11)-C(13)
C(12)-O(11)-C(13)
C(2)-N(1)-C(6)
C(2)-N(1)-H(1)
C(6)-N(1)-H(1)
C(3)-C(4)-C(19)
C(3)-C(4)-C(5)
C(19)-C(4)-C(5)
C(3)-C(4)-H(4)
C(19)-C(4)-H(4)
C(5)-C(4)-H(4)
C(6)-C(5)-C(14)
C(6)-C(5)-C(4)
C(14)-C(5)-C(4)
O(15)-C(14)-O(16)
O(15)-C(14)-C(5)
O(16)-C(14)-C(5)
O(16)-C(17)-C(18)
O(16)-C(17)-H(17)
C(18)-C(17)-H(17)
O(16)-C(17)-H(17)
C(18)-C(17)-H(17)
H(17)-C(17)-H(17)
C(17)-C(18)-H(18A)
C(17)-C(18)-H(18B)
H(18A)-C(18)-H(18B)
C(17)-C(18)-H(18C)
H(18A)-C(18)-H(18C)
H(18B)-C(18)-H(18C)
C(25)-C(19)-C(20)
C(25)-C(19)-C(4)
C(20)-C(19)-C(4)
C(19)-C(25)-C(23)
C(19)-C(25)-H(25)
C(23)-C(25)-H(25)
C(25)-C(23)-C(22)
C(25)-C(23)-Br(24)
C(22)-C(23)-Br(24)
C(21)-C(22)-C(23)
C(21)-C(22)-H(22)
C(23)-C(22)-H(22)
C(20)-C(21)-C(22)
C(20)-C(21)-H(21)
C(22)-C(21)-H(21)
C(21)-C(20)-C(19)
C(21)-C(20)-H(20)
C(19)-C(20)-H(20)
C(2)-C(3)-C(9)
C(2)-C(3)-C(4)
C(9)-C(3)-C(4)
C(3)-C(2)-N(1)
C(3)-C(2)-C(8)
N(1)-C(2)-C(8)
C(2)-C(8)-H(8A)
C(2)-C(8)-H(8B)
H(8A)-C(8)-H(8B)
C(2)-C(8)-H(8C)
H(8A)-C(8)-H(8C)
H(8B)-C(8)-H(8C)
C(5)-C(6)-N(1)
C(5)-C(6)-C(7)
N(1)-C(6)-C(7)
C(6)-C(7)-H(7A)
C(6)-C(7)-H(7B)
H(7A)-C(7)-H(7B)
C(6)-C(7)-H(7C)
H(7A)-C(7)-H(7C)
H(7B)-C(7)-H(7C)
O(10)-C(9)-O(11)
O(10)-C(9)-C(3)
O(11)-C(9)-C(3)
C(12)-C(13)-O(11)
C(12)-C(13)-H(13A)
O(11)-C(13)-H(13A)
C(12)-C(13)-H(13B)
O(11)-C(13)-H(13B)
H(13A)-C(13)-H(13B)
C(12)-C(13)-H(13C)
O(11)-C(13)-H(13C)
H(13A)-C(13)-H(13C)
H(13B)-C(13)-H(13C)
C(13)-C(12)-O(11)
C(13)-C(12)-H(12A)
O(11)-C(12)-H(12A)
C(13)-C(12)-H(12B)
O(11)-C(12)-H(12B)
H(12A)-C(12)-H(12B)
Br(24)-C(23)  1.897(5)
O(16)-C(       1.346(7)
O(16)-C(17)   1.441(6)
O(15)-C(14)   1.209(6)
O(10)-C(9)     1.208(7)
O(11)-C(9)     1.314(7)
O(11)-C(12)   1.725(16)
O(11)-C(13)   1.917(15)
N(1)-C(2)       1.384(7)
N(1)-C(6)       1.398(7)
N(1)-H(1)       0.9601
C(4)-C(3)       1.509(7)
C(4)-C(19)     1.523(6)
C(4)-C(5)       1.530(7)
C(4)-H(4)       0.9599
C(5)-C(6)       1.345(7)
C(5)-C(14)     1.469(7)
C(17)-C(18)   1.496(9)
C(17)-H(17)   0.9599
C(17)-H(17)   0.9600
C(18)-H(18A) 0.9601
C(18)-H(18B) 0.9600
C(18)-H(18C) 0.9599
C(19)-C(25)   1.380(7)
C(19)-C(20)   1.388(7)
C(25)-C(23)   1.384(7)
C(25)-H(25)   0.9599
C(23)-C(22)   1.386(8)
C(22)-C(21)   1.374(9)
C(22)-H(22)   0.9600
C(21)-C(20)   1.367(8)
C(21)-H(21)   0.9601
C(20)-H(20)   0.9600
C(3)-C(2)       1.351(7)
C(3)-C(9)       1.461(7)
C(2)-C(8)       1.493(7)
C(8)-H(8A)     0.9601
C(8)-H(8B)     0.9601
C(8)-H(8C)     0.9600
C(6)-C(7)       1.482(8)
C(7)-H(7A)     0.9600
C(7)-H(7B)     0.9601
C(7)-H(7C)     0.9600
C(13)-C(12)    1.244(15)
C(13)-H(13A)  0.9598
C(13)-H(13B)  0.9601
C(13)-H(13C)  0.9599
C(12)-H(12A)  0.9600
C(12)-H(12B)  0.9599
117.1(4)
114.4(6)
125.0(6)
39.5(5)
123.1(4)
119.4
117.5
111.2(4)
110.7(4)
111.8(4)
107.3
109.1
106.5
122.0(5)
120.2(5)
117.6(5)
122.0(5)
127.2(5)
110.8(5)
106.5(5)
108.4
112.3
109.2
110.8
109.5
110.2
108.4
109.5
109.9
109.5
109.5
118.2(4)
121.6(4)
120.1(4)
120.1(4)
120.9
119.0
121.6(5)
119.2(4)
119.2(4)
117.5(5)
122.7
119.8
121.6(5)
118.4
119.9
121.0(5)
119.6
119.4
125.0(5)
120.8(4)
114.2(4)
118.7(5)
128.8(5)
112.5(5)
108.2
110.3
109.5
110.0
109.5
109.5
118.9(5)
128.0(5)
113.1(5)
110.0
109.3
109.5
109.1
109.5
109.5
121.5(5)
122.7(5)
115.7(5)
61.9(11)
108.6
170.5
110.1
75.7
109.5
109.7
75.3
109.5
109.5
78.6(13)
121.7
109.5
122.1
109.3
109.5
Table 3.  Bond lengths [A] and angles [deg]
I II III
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Br(24)
O(16)
O(15)
O(10)
O(11)
N(1)
C(4)
C(5)
C(14)
C(17)
C(18)
C(19)
C(25)
C(23)
C(22)
C(21)
C(20)
C(3)
C(2)
C(8)
C(6)
C(7)
C(9)
C(13)
C(12)
U11
56(1)
58(3)
77(3)
49(3)
66(3)
41(2)
39(3)
55(3)
66(4)
68(4)
70(5)
46(3)
43(3)
50(3)
67(4)
55(4)
46(3)
56(3)
46(3)
68(4)
52(3)
61(4)
55(4)
136(11)
101(8)
U22
107(1)
106(3)
146(4)
101(3)
202(6)
80(3)
60(2)
69(3)
86(3)
123(5)
216(10)
67(3)
68(3)
71(3)
72(3)
 81(3)
73(3)
59(2)
69(3)
93(4)
73(3)
113(4)
 81(4)
204(11)
304(18)
U33
98(1)
51(2)
52(2)
102(3)
74(5)
65(3)
57(3)
48(3)
48(3)
60(3)
92(5)
43(2)
53(3)
51(3)
67(4)
88(4)
74(4)
61(3)
67(4)
79(4)
55(3)
65(4)
79(4)
270(20)
132(9)
 U23
 31(1)
-4(2)
-10(2)
-34(2)
-134(5)
 2(2)
 0(2)
 2(2)
 5(3)
-11(3)
-37(6)
-5(2)
-4(2)
 4(2)
 5(2)
 15(3)
 7(3)
-3(2)
 0(2)
-12(3)
 11(2)
 7(3)
-26(3)
 26(14)
-54(10)
U13
-10(1)
-4(2)
 6(2)
 13(2)
 27(3)
 0(2)
-1(2)
 6(2)
-2(3)
-15(3)
-10(4)
 2(2)
-7(2)
 0(2)
 7(3)
 12(3)
 5(3)
-1(2)
 1(3)
-8(3)
 2(3)
 15(3)
 5(3)
 25(12)
-8(7)
U12
-20(1)
-14(2)
-13(2)
-6(2)
-21(3)
-4(2)
 1(2)
 2(2)
-1(3)
-13(3)
-39(5)
 5(2)
 4(2)
-12(2)
 4(3)
 21(3)
 5(2)
-1(2)
-7(2)
-15(3)
 3(2)
-5(3)
-9(3)
 30(9)
-68(11)
Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for cel. The anisotropic displace-
ment factor exponent takes the form:-2 pi^2 [h^2 a*^2 U11+...+2 h k a* b* U12]
x y z U(eq)
H(4) 7873 4818 2071 74
H(4) 4626 4677 2036 62
H(17) 3655 4036 -159 101
H(17) 4072 3158 -29 101
H(18A) 2408 3128 214 151
H(18B) 2555 3800 871 151
H(18C) 2972 2922 1001 151
H(25) 3630 3621 2580 66
H(22)      4782 1575 3552 82
H(21) 6331 2114 3303 90
H(20) 6516 3350 2671 77
H(8A) 6925 5831 3681 96
H(8B) 7634 6059 2988 96
H(8C) 7787 5253 3477 96
H(7A) 8050 4570 842 95
H(7B) 7211 4739 240 95
H(7C) 7415 3847 533 95
H(13A) 4595 6452 5288 245
H(13B) 5602 6207 4948 245
H(13C) 4701 5673 4749 245
H(12A) 5060 7169 4165 215
H(12B) 4158 6636 3966 215
Table 5. Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 10^3) for
cel.
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Packing of AKPKX-3 molecules down c axis
Novel  1,3,5-Trithianes...  Efficient
Synthesis, Characterization and X-Ray
Crystallographic Studies
CHAPTER-2
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1. E. Campaigne, Chem. Rev., 39, 1 (1946).
2. Mansfeld, Berichte. 18, 697 (1886).
3. E. Baumann and E. Fromm, Ber., 28, 895 (1895).
Introduction
Mansfelds2 obtained 1,3,5-trithiane from methylene iodide and sodium sulfide.
Reaction of acetophenone with hydrogen sulfide and hydrogen chloride was
described more than a century ago by Baumann and Frommj3. They allowed
acetophenone to react with dry hydrogen sulfide and dry hydrogen chloride
at 0 o C  in alcoholic solution and obtained two compounds. Initially, the
reaction formed a blue violet solution of monomeric thioacetophenone which
rapidly faded to yield white crystalline trimer. Although, theoretically there
should be geometrical isomers of trithio-acetophenone, only one isomer
has been reported and no evidence was found for the existence of a
another isomer in this work.
When the mother liquor from the acetophenone reaction was allowed to
stand at room temperature, a white crystall ine compound of formula,
S
S
S
R R1
RR1
R1 R
R = substituted/
unsubstituted phe-
nyl, H, alkyl
R1 = H, CH3
Trithiane (I) is a six membered non
aromatic cycl ic sulphide containing
three sulphur atoms at f irst, third and
fifth carbon atoms. Trithianes,which are
trithioaldehydes, are usually expected as
products of the acid-catalysed addition of Hydrogen Sulphide to ketones and
aldehydes.1 Trithiane derivatives substituted at C2, C4 and C6 positions with
alkyl, alkenyl, aryl, alcohol, keto, thiol and disulphide groups are used in
manufactur ing f lavour ing agents,  pharmaceut ica ls  and a lso as
photopolymerization initiators.
Literature Survey: The Exploration of Trithianes.
(I)
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C21H22S2 was obtained, which differed from the formula for trithioacetophenone
by the elements of hydrogen sulfide. They proposed the structure (II) or (III)
and called the compound “anhydrotriacetophenone disulfide”.
Chat taway and Ke l le t t 4 prepared 2 ,4 ,6-
tris(trichloromethy1)-s-trithiane (IV) in very low
yield from chloral and hydrogen sulfide; only one
of the two possible isomers was isolated.
Lateron, Chattaway and Kel let t5 proposed cis-trans isomerism of
1,3,5-tr i thiane (V) obtained from acetaldehyde.
 
cis trans 1,3,5-trithiane
4. Chattaway, F. and Kellett, E., J. Chem. Soc., 2908 (1929).
5. Chattaway. F. and Kellett, E; J. Chem. Soc.,53, 2187 (1931).
(V)
 
S
S
H
CH3
CH3
S
S
CH3
CH3
(II) (III)
 
S
S
S
H
H
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
H
(IV)
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 Leonard and Musker 6 prepared several
2,4,6-tr is(methylaminoalkyl)-s-tr i th iane
trihydrochlorides (V, n = 5-7) by mercuric ac-
e ta te  ox ida t ion  o f  1 -methy l -1-
azacycloalkanes followed by treatment with
hydrogen sulf ide and hydrogen chloride.
S
S
S
(CH2)H
H
(CH2)
(CH2)
H
NH
NH
NHCH3
CH3
CH3
n
n
n
n = 5 - 7
 
S
S
S
H
R
R
H
R H
+ H+
SH
+
S
S
H
R
R
H
R H
S
S
S
H
R
R
H
R
H
H
+
S
S
S
H
R
R
H
H R
+ H+
Breslow and coworkers7 have extensively studied the isomerization of
trithiane derivatives (VI)
The conformation of the s-trithiane ring is very interesting, since there is no
possibility of hydrogen eclipsing, even in the boat form. There is little doubt,
from the electron diffraction investigation of Hassel and Viervoll8 that
s-trithiane itself exists predominantly in the chair form. From the evi-
dence in the literature it appears quite reasonable that cis-2,4,6-trialkyl-s-
trithianes should exist in the chair form with three equatorial substituents.
.3HCl
6. Leonard, K. and .Mlusker, W.; J. Amer. Chem. Soc., 81,5631 (1959).
7. Matlack, A., Chien, J. and Breslow, D.;J. Amer. Chem. Soc. 26, 1456 (1961).
8. Hassel, O. and Viervoll, H.; Acta Chem. Scand., 1, 149, (1947)
(V)
(VI)
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Certain reactions of some p-substituted acetophenones with hydrogen
sulfide utilizing hydrogen chloride as catalyst were studied in 19599.
In these acid catalyzed reactions of the p-haloacetophenones with hydrogen
sulfide proceeded in the same manner as acetophenone, so that the trimers
as well as the “anhydro” compounds (VI) have been isolated. At 4-5 oC, the
yield of p-chloro and p-bromo trimers exceeded that of the “anhydro”
compounds but when the reactions were allowed to proceed at room
temperature, the amounts of “anhydro” compound obtained exceeded
that of the trimers.
With p-methylacetophenone, the trimer
was obtained in 31 % yield, but the
(anhydro” compound was not isolated.
The oily product of the reaction yielded a
tar after distillation from which could be
isolated 2,4-di-p-tolylthiophene, undoubtedly
formed by the pyrolysis of the anhydrotri-
p-methylacetophenone disulfide.
In the case of p-ethylacetophenone, neither the trimer nor the “anhydro”
compound was isolated. Here again, however, the residue of a distillation
of an oily product yielded a tar from which was isolated 2,4-di-(p-ethylphenyl)
thiophene.  With p-phenylacetophenone, the trimer was not isolated, but
an 81% yield of the “anhydro tri-p-phenylacetophenone disulfide” (VII) was
obtained.
Benzophenone and substituted benzophenones give highly colored
monomeric thiones10. Campaigne and Moss 11 found that 1-indanone,
l-tetralone, and their 3-methyl derivatives give trithianes.
 
SS
H
CH3
CH3
R
R
R
(VII)
R = 4CH3, 4-halo,
      4-phenyl, 4-ethyl
9.  Campaigne, W., Bradley, W. and Pera, J.; J. Org. Chem., 24, 1229 (1959).
10. Campaigne, E., Chem. Rev., 39, 1 (1946).
11. Campaigne, E. and Moss, R. C.; J . Am. Chem. Soc., 76 , 1269, (1954).
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l,3-diphenyl-2-propanone (dibenzyl ketone) yields a stable crystalline
gem-dithiol on treatment with hydrogen sulfide and hydrogen chloride12.
Gem-dithiols had been prepared only by the action of hydrogen sulfide on
aldehydes and ketones at high pressures (36-8500 atm.) in the absence of
catalysts13.
The various proposed products which could be formed as a result of acid-
catalysed reaction between H2S and aldehyde / ketone are summarised as
follows (VIII).
12. Berchtold, G., Edwards, B., Campaigne, E. and Carmack, M. ; J. Amer. Chem. Soc.,
     81, 3148 (1959).
13. Cairns, T., Cyans, G., Larchar, A. and McKusick, B.; J. Amer. Chem. Soc., 74, 3982
     (1952).
C CR1
SH R3
R2
C HCR1
OH R3
R2
SH
C HCR1
R3
R2O
C HCR1
S R3
R2
S
S
S
R1
R1
R1
R3
R2
R3
R2
R3
R2
C
CH
R1
R2 R3
S HSH
C HCS
OH R3
R2R1
CCH
OHR3
R2 R1
C HCR1
SH R3
R2
SH
C HCR1
S
R2
C HCR1
R3
R3
R2
C HCR1
R3
R2O
-H2O
C HCR1
R3
R2O
+
+ H2S / H+
enethiols
gem-thiols
thiones
trithyianes
bis-a,b-unsaturated
sulphides
bis-a-hydroxysulphides
polysulphides
aldehyde/ketone
VII
( )n
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 The plausible formation of (IX) in
the reaction of 3-methylthio-3-
p h e n y l - 2 - p r o p e n e - 1 - N , N -
dimethyl iminium iodide with
hydrogen sulfide was shown in
the framework of semiempirical
AM1 and PM3 methods.8
S
S
S
S
CH3
S
CH3
S
CH3
3 - m e t h y l t h i o - 1 -
phenyl-2-propene-1-
th ione and 3-
methylthio-3-phenyl-
2-propenethial
(IX)
 
S
S
S
Ph3Si
SiPh3
Ph3Si
(X)
Silyl thioketones are easily converted9 into
the corresponding trimers (1,3,5-trithianes)
under acidic conditions.  Both the a-(cis-
trans)- and the b-(cis,cis)-isomers were
iso la ted .   The b -d ias te reo isomers
predominates over the a-form. X-ray
analysis of  the major  isomer f rom the
trimerization of Me3SiCSPh shows a chair-like conformation with the silyl
groups all equatorial. Desilylation of the a- and b-tr imers of the
trimethylsilylphenyl thioketone with fluoride ion affords, stereospecifically,
the two isomeric 2,4,6-triphenyl-1,3,5-trithianes (X).
S
S
S
CH3
CH3
CH3
N3
N3
N3
Ethanol ic O-azidoacetophenone was
treated with HCl and H2S at -10° to give
(XI). Treatment of (XI) with boiling tert-
bu ty lbenzene gave 3-methy l -2 ,1-
benz iso th iazo le .  Treatment  o f  o -
azidobenzophenone with HCl and H2S  at -
30° C gave o-azidothiobenzophenone, which
14. Shagun, V., Timokhina, L. and Panova, G.;Russian Chemical Bulletin (Translation of
     Izvestiya Akademii Nauk, Seriya Khimicheskaya), 46(7), 1216, (1997).
15. Flavia, B., Comes, F., Mariafrancesca, F., Germana, M., Alfredo, R., Paolo, Z. and
     Zwanenburg, Binne CS; Journal of the Chemical Society, Perkin Transactions 1:
     Organic and Bio-Organic Chemistry, (16), 2039 (1995).
(XI)
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decomposed explosively at room temperature. This decomposition
illustrated the assisted loss of Nitrogen due to a nucleophilic attack of the
thione group on the azide function16.
16. Ashby, J., Suschitzky, H.; Tetrahedron Letters, (18), 1315 (1971); Chem. Abstr.
     75:49038 (1972).
17. Campaigne, E., Reid, W., Bradley, J. and Pera, J.; J. of Org. Chem. 24, 1229 (1959)
18. Hayasaki and Kenjiro; Nippon Kagaku Zasshi, 76, 284 (1955)
19. Campaigne, Ernest; Georgiadis, M. P.; J. of Het. Chem. , 6(3), 339, (1969); Chem.
     Abst., 71:30459 (1970).
 
S
S
S
CH3
CH3
CH3
R
R
R
Treatment  o f  subs t i tu ted
acetophenones (R = OCH3, F, Cl, Br,
I, CH3) with dry H2S in the presence
of dry HCl at 0° C according to
Baumann and Fromm17,  t r imeric
thiones of type (XII) were obtained.
R = F,Cl,Br,I,Me
(XII)
 Trithio-p-bromobenzaldehyde and
trithio-p-chlorobenzaldehyde were
synthesized, both in a and b- forms.
The dipole moments of the      bromo
compounds. were a 2.17 D. and b
3.70 D., whereas those of chloro
compounds were a-2.21 D and
S
S
S
R
R
R
R = Cl,Br,I, etc
(XIII)
b 3.67 D.  The dipole moments of a - compounds were measured in
benzene solution and those of b-compounds in carbondisulphide(CS2).  The
6-membered C-S ring in these compounds takes a chair form.18
Campaigne studied19 the trithiane compounds having halo-groups at ortho,
meta and para position of phenyl groups at 2,4,6 carbon atoms in trithiane
system. Nine pairs of isomeric 2,4,6-tris-(halophenyl)-1,3,5-trithianes (XIII)
were assayed in the crude state by NMR techniques, and
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The preparation of trithioaldehydes by the thiosulfate process of Vanino20
was also investigated14. In this study, a solution of sodium thiosulphate in
water  was added with stirring at 0° over 1 hour to Benzaldehyde in HCl  (d.
1.17). The mixture was stirred for 4 hrs. at 0°, and the precipitates were
filtered off, washed with water and dried to give 38.8% beta isomer.
A similar react ion as above was
car r ied  out  us ing N,N-d imethy l
formamide instead of benzaldehyde at
-15°. The resulting orange filtrate was
mixed with three times water which
resulted into precipitates of the beta
isomer of trithiane (XIV) in  26.8%
yield which melted at 216 o C21
 
S
S
S
N
N
N
CH3
CH3
CH3 CH3
CH3
CH3
An ortho halogen on an axial phenyl group in the alpha isomers causes the
aromatic group to exert an anisotropic deshielding effect on adjacent axial
protons, so as to cause the axial and equatorial proton peaks to appear as
a singlet in some solvents.
20. Ger. Pat. 757, (1999), Chem. Abst. 2, 3154 (1999).
21. El-Hewehi, Zaki; Hempel, Dieter; J. fuer Prakt. Chemie (Leipzig), 21(5-6), 286-94
     (1963); Chem. Abst., 60:23408  CA
22. Douglass, I. and Hydro, W.; J. Amer. Chem. Soc., 16, 3507 (1951)
Irwin and et al22 synthesized 2,4,6-tribenzyl-s-trithiane by slight modifications
in the standard method. In this study, dry hydrochloride gas was passed
(XIV)
seperated and purified by chromatography and it was realised that the
alpha-(cis, trans)-isomers are the major products in most cases. These
compounds exist as puckered chair trithiane structures, even in the more
hindered a-(cis, trans)-ortho-halophenyl cases, by the clear resolution of
axial and equatorial trithiane ring protons in a ratio of 2:1.
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S
Cl
CH3 CH3
OHSH
Cl S
S
S
CH3
CH3
CH3
Cl
Cl
Cl
A thio acetyl, 1-chloro-2-mercapto-propan-2-ol (XII) was isolated from the
treatment of 1-chloro-2-propanethione (XI); in presence of water which
cyclized to form 2,4,6-tris(chloromethyl)-2,4,6-trimethyl-1,3,5-trithiane
(XIII)23
(XV)
23. Shagun, L., Dabizha, O., Shagun, V., Voronkov, M. and Sarapulova, G., Albanov, A.
     and Timokhina, L.; Russ. J. Gen. Chem., 70,917 (2000); Chem. Abst. 134, 237458
     (2001)
25. Linden, A., Fu, C., Majchrzak, A., Mloston, G. and Heimgartner, H.; Acta Cryst.
     C58, o231–o234 (2002).
into absolute ethanol maintained at 0 o C, This solution was then cooled to
-10 o C and hydrogen sulphide gas was then passed into cooled ethanol
containing HCl. It was then followed by drop wise addition of 50 % solution
of phenyl acetaldehyde in ethanol to yield the corresponding trithiane.
 
SiO2, CH2Cl2 / N2
Room Temperature
S
S
S
S
S
S S
+
Greidanus (1970)24. observed that (XIV) undergoes dimerization and
trimerization to give compounds (XV) and (XVI) when treated with
methanesulfonic acid (cf. Ishii et al., 1997). Treatment of (XIV) with silica
gel in dichloromethane at room temperature resulted in a mixture of the
trithiane trimer, (XVI), the 1,2,4-trithiolane, (IV), and unreacted (XIV) in the
ratio 9:25:62, respectively. The trimer was successfully crystallized for the
first time (cf. Greidanus, 1970) from dichloromethane/ hexane25.
(XVI) (XVII)
(XVIII) (XIX) (XX)
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Dieter and coworkers 34 bubbled a strong stream of H2S, at room
temperature into a stirred solution of 100 g. substituted aldehyde in 250 ml
absolute EtOH and 250 ml alcoholic HCl. This resulted into precipitation of
substituted trithianes. Some of the aldehydes gave resins, which by heating
in benzene or xylene  with  AcCl, were depolymerized to trithiane of type.
Following are the details of the reported compounds
R
Isomer
(config.) % Yield M.P. (
o C)
H - 69.5 217
2-OH beta 59.7 208
2-OH,5-Cl beta 208 216-215
3,4diOH beta 74.6 99-100
4-OCH3 beta 59.8 187
3-OCH3,4-OH beta 17.2 236-7
4-OH,3-NO2 beta 59.8 219
Following aldehyde first formed resins which depolymerized to
form trithianes
2-Cl beta 43.7 221-2
3-Cl beta 36.3 158
4-Cl beta 43.3 176-7.5
3,5di-Cl, 2-OH beta 37.8 232-3
34. El-Hewehi, Zaki; Dieter, H.; Journal fuer Praktische Chemie (Leipzig), 21(5-6), 286
     (1963); Chem. Abst. 60:23408.
An unresolvable-resin was formed by N,N-dimethyl formamide ( 4-Me 2N
C6H4CHO).  Passing hydrogen sulphide gas (H2S) into 300 ml paraldehyde
in 800 ml. 1:1 HCl for 8-10 hrs.  resulted into seperation of an oil, which,
after treating with H2S, gradually solidified to give 25.1% a-isomer having
m.p 104 o C.
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Trithiane compounds of type (XXI) were synthesised by reacting the
s-trithiane with n-butyl lithium in THF. This solution was cooloed to 60oC
and then reacted with 4,4’-difluoro benzophenone / 5,4-(4-methylbenzoyl)-
2,5-dimethyl isoxazole / p-toluenesulphonic acid etc35.
and which in the other (m.p 375) two of the
three methy l  groups are in  equator ia l
positions and the third is axial. The former is
designated as b-form while the latter is the
axial. In continuation with this study, Hirokawa
and coworkers37 reported the crystal structure of
b-form of 2,4,6-triphenyl-1,3,5-trithiane(XXIII).
 
 
S
S
S
CH3CH3
CH3
The structures of a- and b-2,4,6-trimethyl-1,3,5-trithiane
(TTA, (XXII)) have been investigated by the X-ray diffraction
method36.  TTA has two stereoisomers: in one isomer  (m.p
399 K) all three methyl groups are in equitorial positions
The s-Trithiane and 1,3-dithiane as well as their alkyl derivatives have been
found to show remarkable stereoselectivity in base catalysed reactions38.
The stereoselectivity is caused by a high equatorial preference of the
resulting carbanions.
36a.Busetti, V., Busetti & Mammi, M.; Acta Cryst. B25, 1631 (1969).
    b.Sekido, O., Noguchi, T. and Hirokawa, S.; Bull. Chem. Soc. Jpn. , 50, 3149 (1977).
    c.Sekido, O., Noguchi, T. and Hirokawa, S.; Bull. Chem. Soc. Jpn., 54, 1881 (1981).
37.  Sekido, O., Noguchi, T. and Hirokawa, S; Acta Cryst. C41,  397 (1985).
38a. Hartman, A. and Eliel, E.,  J. Amer. Chem. Soc., 93, 2572 (1971).
    b. Eliel, E.,  Abatjoglou, A., and  Hartman, A.,  J. Amer. Chem. Soc., 94,4785 (1972).
    c. Eliel, E., Hartman, A. and Abatjoglou, A.; J. Amer. Chem. Soc., 98, 1897 (1974).
    d. Fukunaga, M., Sugawara, T. and Oki. M.; Chem. Lett., 1, 55-8 (1972).
    e. Fukunaga, M., Arai, K., lwamura, H. and Oki, M.; Bull. Chem. Soc. Jap., 45,1,302
       (1972).
 
S
S
S
R1
R4
R2
R3
(XXI)
(XXII)
(XXIII)
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39.  Andrzejewska, E. and Andrzejewska, M.; Tetrahedron letters, 5, 451 (1977).
equatorial proton from a-TPT and results into carbanion which is slightly
symmetrically solvated by the solvent and relatively long lived due to low
concentration oh proton donors in the solvent and hence attains coplanarity
with the phenyl group. The solvated carbanion recaptures proton giving
stable b-TPT.
In another important study based on the
stereoselective behaviour of trithiane, the
key molecule of interest was 2,4,6-triphenyl-
s-tr i thiane (TPT, (XXIV)) .  The
stereoselective behaviour of TPT was
investigated in presence of methoxide ions.
In presence of dimethyl formamide  (DMF)
solution, the methoxide ions extracts
 
SS
S
Ph
CH3Ph
CH3
H OCH3
S
S
S
Ph
CH3
Ph
CH3
CH3
S
S
S
Ph
CH3
Ph
CH3
S
S
S
Ph
CH3
H
Ph
CH3
DMF
(XXIV)
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As mentioned earlier, trithianes have found their way into a variety of fields
of appilcations like photpolymerization, pharmaceuticals, intermediate for
many important chemical compounds, plastics and polymers.
Many 1,3,5-trithianes were recognized  as insecticide, acaracides, effective
against larvae of the clothes moth.
Applications of Trithianes
Qureshi 40 studied the relationship
between the antioxidant activity and
sulphur in sulphur containing organic
compounds (XXV). The compounds
having a R-S-H bond  as mercaptan or
a RSR bond like monosulfides had, in
 
general, no antioxidant activity, and in comparing these two types of
compounds., the former showed a little stronger activity. It was also
recognized that the compounds having two S atoms in the molecule had a
slight antioxidant activity and the cyclic compounds having three sulphur
atoms had the stronger activity.
S
S
S
R
R
R
R = H, NO2,
OCH3, OH,
Dimethoxy
48. Ahmad, K., Qureshi, A., Pakistan Journal of Scientific Research (1963), 15(2), 75-
     7; Chem Abst.; 60;45740
(XXV)
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Triazine
Pyrimidine
Cyclohexanone
Trithiane
Nuclear Receptors (NRs) are ligand-modulated Transcription factors that
mediate the action of steroid hormones (XXVI). The interaction of Nuclear
Receptors and Co-activators is blocked by using Co-activator Binding
Inhibitors (CBI). In a study41, a set of co-activators binding Inhibitors (CBIs)
having different heterocyclic cores (Triazines, Pyrimidines, Trithianes,
Cylcohexane) that mimics the sites of three leucines on the peptide helix. It
was realised that trithiane is poor structural mimic of the bound co-activator
peptide. This may be due to its wide structure (triequatorial).
41. Rodriguez, A., Tamrazi, A., Coliins, M. and Katzenellenbogen, J.; J. Med. Chem.,
     47, 600 (2004).
 
S
S
S
R1
R4
R2
R3
Trithianes of type (XXVII) had a cholesterol-reducing effect and anti-hyperlipemic
activity and were useful as antiarteriosclerotic agents and anti-hyperlipemic
agents.42
(XXVI)
(XXVII)
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Arteriosclerosis (atherosclerosis) is caused by deposition of lipid on arterial
wall which results in hyperplasia and sclerosis. Arteriosclerosis obstruct
blood flow and inhibits the supply of oxygen to tissues. Particulary in brain
or heart, it is known as the so-called “ischemic-pathosis”, namely, a main
dangerous factor of cerebral infarction and myocardial infarction.
Arteriosclerosis reduces the flexibility of artery and causes cerebral
hemorrhage. Therefore, the blood lipid reducing effect of these  compounds
results in depression of arteriosclerosis and hence useful in preventing
cerebral apoplexy.
Moreover compounds of this type were also found to have the effect of
reducing cholesterol in blood by inhibition of cholesterol absorption in
intestine and depression of cholesterol synthesis and promotion of
cholesterol excretion in liver.
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A series of 1,3,5-trithiane derivatives, including a- and b-isomers of the
methyl and phenyl derivatives was investigated for use as coinitiators in
benzophenone-induced photopolymerizations42(XXV). To study the
mechanism of the photoinduced production of init iating radicals,
nanosecond laser flash photolysis was used. The rate constants for
quenching the benzophenone triplet state by various trithianes and the
associated quantum yields of ketyl-radical formation were determined
Other Applications; Trithianes as Nonpharmaceuticals
42. Andrzejewska, E., Hug, G., Andrzejewski, M. and Marciniak, B.; Macromolecules,
     32, 2173 (1999)
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Among the compounds (trithianes) investigated, the most efficient
coinitiator is the trimethyl derivative. Activity of trithianes in accelarating
the BP-induced polymerization is a resultant of the efficiency of initiating
radical formation. The polymerization steps depend on the resonance
stabilization energy of the various trithiane radical (determining their
reactivity) and on the hydrogen-donating ability of the various-trithiane
derivatives (in the chain transfer to coinitiator).
(XXV)
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The mechanism for the photoreaction of beta-2,4,6-trimethyl-1,3,5-trithiane
(beta-TMT) in acetonitrile was investigated using steady-state and laser
flash photolysis.  The main photoproducts were determined to be the
thioester CH3C(=S)SCH(CH3)SCH2CH3 and the a-TMT isomer.  These
products were identified by analytical and spectroscopic methods.
43. Janeba-Bartoszewicz, Hug, G., Kozubek, H., Urjasz, W. and Marciniak, B.; J.
     Photochem. Photobiol. A: Chem. 140, 133 (2001).
44. Tsuyoshi, O. and Takamatsu, K.; US0114630 (2003).
Tri th iane of  type (XXIX)  has found i ts
application in making lens which are ex-
tremely thin and l ightweight 43.
 
S
S
S
(CH2)n
(CH2)n
(CH2)n
SH
SH
SH (XXIX)
Thus, trithianes have found the diverse applications in pharmaceutical
as well as nonpharmaceutical facets. The literature survey revealed the
crystallographic study and stereoselective study along with the detailed
study.
The current work includes the synthesis of eight different s-trithianes using
substituted benzaldehyde containing one or more methoxy group as the
substituent i.e.2, 3 or 4-methoxy benzaldehydes, 2,5-dimethoxy benzalde-
hyde, 3,4-dimethoxy benzaldehyde, 3,4,5-trimethoxy benzaldehyde, vanil-
lin, and ethylvanillin. The reaction was carried out by passing hydrogen
sulphide gas into the solution of substituted benzaldehyde in minimum quan-
tity of methanol. The hydrogen gas was prepared using ironpyrites and conc.
hydrochloric acid. While passing the hydrogen sulphide gas into the solu-
tion of aldehyde, the vapours of hydrochloric acid (hydrogen chloride gas)
also entered along with hydrogen sulphide gas into the reaction mixture.
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So the trimerization occured in acidic conditions (in presence of H+ ions).
This reaction was carried out at the room temperature. Various other
aldehydes like benzaldehyde, halogen substituted benzaldehydes, nitro
substituted benzaldehydes and hydroxy substituted benzaldehydes were
taken into consideration but unfortunately failed to produce results at
room temperature.
All the substituted benzaldehydes, iron pyrites, hydrochloric acid,
methanol were obtained from the commercial sources. Melting points
of the substituted s-trithianes were taken in open capillary bath on con-
trolled temperature (using standard Thermometer Zeal (England)). The
Trimerization was carried out in methanol as the solvent. The com-
mencement of the reaction and purity of the DHPMs  was monitored
using thin layer chromatography (TLC; silica gel-G, used as stationary
phase, the TLC plates were purchased from MERCK India Ltd., Ethyl
acetate and Hexane (5:5) were employed as mobile phase.
Crystallization (Single crystal development) was carried out in ethyl acetate
as the solvent and the structure was proved by single crystal diffraction
phenomenon. The other techniques used for structural characterization were
IR, NMR and Mass Spectroscopy.
 
 1,3,5-Trithianes..... 91
Reaction Scheme
O
R
H2S / H
+
SHOH
R
3 3
S-HOH
R
H-S
OH
R
S-H
OH
R +
SS
S
R
R
R
-3H2O
O
R33H2S S
S
S
RR
R
+
Methanol
Reaction Mechanism
HCl
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(General Method) Preparation of 2,4,6 tris-(Substituted Phenyl)-1,3,5-
trithiane
Method of Synthesis
Substituted benzaldehyde (0.01 m) is taken in minimum quantity of
methanol in a 100 ml conical flask. Iron pyrites are taken in a 2-neck
round bottom flask. Addition funnel is attached to one neck and the other
neck is used as an outlet (for hydrogen sulphide gas) which is attached to
an end of a glass tube. The other end of the glass tube is dipped in the
conical flask containing solution of subsituted benzaldehyde. The hydro-
chloric acid is added to the iron pyrites in the flask by means of the addi-
tion funnel. Hydrogen sulphide gas is evovled (flask is heated in waterbath
if necessary) which is passed into the solution of subsituted benzaldehyde
(vapours of hydrochloric acid also pass along with the hydrogen sulphide
gas) till solid residue is obtained. The product is filtered and washed with
chilled methanol. Recrystallization is carried out in ethyl acetate. The yield
of the trithiane derivatives, ranges from 70 - 80 %. This method was
accomplished to prepare verious trithiane derivatives using following
substituted benzaldehydes.
2,3 or  4 methoxy benzaldehyde,  2,5 d imethoxy benzaldehyde,
veratraldehyde, 3,4,5-tri-methoxy benzaldehyde, vanillin and ethyl vanillin.
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Whalley and coworkers45 reported the striking IR spectrum analysis results
for trithianes. This study reveals the effect of pressure on the molecular
conformations of the trithiane i.e the pressure results into flattening of
trithiane ring. At atmospheric pressure, s-trithiane molecule showed C-H
str (sym and asym) signals at 2850 - 2950 cm-1, also the -CH2 bending
vibrat ions were obsereved at 1375 and 1392 cm -1.  The Infra red
spectroscopic studies of  t r i th iane der ivat ives have also been wel l
reported in the literature46-49.
The IR spectrum of the the trithianes of the current study, also showed the
standard bending and stretching vibrations. In case of APT-1, APT-2 and
APT-3, -CH str (symmetric and asymmetric) signals were obtained between
2978 to 2830 cm-1, the C-O-C str (symmetric vibrations) between 1020 to
1030 cm-1, C-S stretching and bending vibrations at 1275 to 1030 cm-1,
and 650 to 700 cm-1 respectively. The aromatic C-C vibrations were
observed at 1600 to 1450 cm-1 in all the trithiane derivatives. In case
of  APT-7 ,  the presence of hydroxy group can be conf irmed by the
presence of  a speci f ic broad signal  at  3421 cm -1.
Spectral Analysis (IR)
45. Sim, P., Klug, D. nad Whalley, E.; J. Amer. Chem. Soc., 106, 502 (1983).
46. Mecke, R. and Speisecke, H.; Chem. Ber., 89, 2537 (1956).
47. Dalziel, J., Hewitt, T. and Ross, S.; Specfrochim. Acta, 22, 1267 (1966).
48. Hitch, M. and Ross, S.; Spectrochim. Acta, Part A , 25A, 1047 (1969).
49. Klaboe, P.; Spectrochim. Acta, Part A, 25A, 1437 (1969).
 
 1,3,5-Trithianes..... 96
APT-1
IR Spectrum of  2,4,6-tris(2’-methoxy phenyl)-1,3,5-trithiane
APT-2
APT-1
S
S
S O
CH3
O
CH3
O
CH3
APT-2
S
S
S
O
CH3
O
CH3
O
CH3
IR Spectrum of  2,4,6-tris(3’-methoxy phenyl)-1,3,5-trithiane
Type Vibration Mode Frequency (cm-1)
Methyl (-CH3)
-CH str (asym) 2935
-CH str (sym) 2835
Aromatic
C-C skeletal
vibrations
1596,1584,
1490,1462
C-H in plane
deformation
1190
C-H out of plane
deformation
750
Ether C-O-C st (asy) 1160
Mercaptans C-S str 1252
Type Vibration Mode Frequency (cm-1)
Methyl (-CH3) -CH str (asym) 2918, 2978
Aromatic
C-C skeletal
vibrations
1599, 1511,
1434
C-H in plane
deformation
1197
C-H out of plane
deformation
776
Mercaptans C-S str 1244, 1272
Ether C-O-C 1038
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
 671.4
 776.5
1038.1
1119.1
1197.2
1244.7
1272.4
1376.4
1434.5
1511.6
1599.4
2391.1
2918.1
2978.6
3444.6
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmAPT-2(new)
 464.8
 481.2
 693.4
 750.3
 839.0
 855.4
1024.1
1049.2
1097.4
1160.1
1190.0
1252.7
1288.4
1314.4
1434.9
1462.9
1490.9
1584.4
1596.9
2835.2
2935.5
3000.1
3442.7
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APT-3
IR Spectrum of  2,4,6-tris(4’-methoxy phenyl)-1,3,5-trithiane
APT-7
APT-3
S
S
S
O
CH3
O
CH3
O
CH3
S
S
S
O
CH3
O
CH3
O
CH3
OH
OH OH
IR Spectrum of  2,4,6-tris(4’-hydroxy-3’-methoxy phenyl)-1,3,5-trithiane
APT-7
Type Vibration Mode Frequency (cm-1)
Methyl (-OCH3) -CH str (asym) 2906, 2834
Aromatic
C-C skeletal
vibrations
1590, 1513,
1434
C-H in plane
deformation
1170
C-H out of plane
deformation
764
Ether C-O-C str (asym) 1032
Mercaptons C-S str 1240 1264, 650
Type Vibration Mode Frequency (cm-1)
Hydroxy -OH str (brd) 3421
Methyl (-OCH3) -CH str (asym) 2937, 2841,2335
Aromatic
C-C skeletal
vibrations
1602, 1514
1456,1429
C-H in plane
deformation
1151
C-H out of plane
deformation
933,862,779
Ether C-O-C str (asym) 1028
Mercaptons C-S str 1211 1276, 692
-10.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
%T
400.0600.0800.01000.01200.01400.01600.01800.02000.03000.04000.0
1/cmVanillin
 451.3
 551.6
 692.4
 779.2
 862.1
 933.5
1028.0
1120.6
1151.4
1211.2
1276.8
1369.4
1429.2
1456.2
1514.0
1602.7
1706.9
2335.6
2841.0
2937.4
3421.5
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Spectral Analysis (NMR)
Trithiane though a very simple molecule, shows very characteristic signals
in the NMR spectrum. Dating back to the literature of the trithiane49 it was
observed that in the NMR study of 2,4,6 tris (halophenyl)-1,3,5-trithiane,
the trithiane ring protons resonated at chemical shift; 5.1 - 6.3 d ppm. It
was also observed that equatorial ring protons are more shielded than the
axial protons in the phenyl or meta or para halophenyl substituted trithianes.
Andrejewskas50 in their study of stereoselective behaviour of trithiane
observed a sharp singlet at 5.6 d ppm which was assigned to the trithiane
ring hydrogen resonance and multiplet for aromatic ring protons at 7.4 -
7.18 d ppm for the b-isomer of triphenyl trithiane.
Looking to the  NMR spectra of the newly synthesized substituted trithianes
it is observed that the trithianes give a sharp singlet at 5.2 - 5.6 d ppm.
This signal is assigned to the trithiane ring hydrogen resonance.
In case of APT-3 (AKP-3), it is observed from the ORTEP diagram, that
the hydrogen atoms are axial hydrogens and the tr i thiane ring is in
puckered chair form. The tr i thiane ring hydrogen resonates at 5.3 d
ppm. The six protons adjacent to the methoxy groups resonates at 6.90 d
ppm (since they are more shielded as compared to the rest set of
s ix protons)  such that the signal  spl i t ted into doublet  of  doublet .
The coupling constants observed are 1.9 and 11.7 Hz for meta and
ortho coupling respectively.
49. Campaigne, E. and Georgiadis, M.; J. Het. Chem., 339 (1969).
50. Andrzejewska, E. and Andrzejewska, M.; Tet. Lett. No. 5, 451 (1977).
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The other set of protons also gave doublet of doublet at 7.43 d ppm with
coupling constants (J) for ortho coupling and meta coupling as 11.5 Hz  and
2.8 Hz  respectively. The three methoxy protons (nine protons) resonated
at 3.79 d ppm giving a sharp singlet.
In case of APT-4 the methoxy protons (eighteen protons) gave two sharp
singlets at 3.89 and 3.87 d ppm. The three proton, one on each phenyl ring
on the 2’ position showed the multiplet at 6.69 d ppm (J = 1.2 Hz) and  the
rest six protons also gave a multiplet at 6.97 d ppm (J = 2.1 Hz)
In case of APT-7, the methoxy group protons showed a sharp singlet at
3.74 d ppm. The nine protons adjacent to the methoxy and hydroxy groups
resonated  at 9.26 d ppm and gave a singlet. The three hydroxy protons
showed a singlet. The three protons at 6’ positions of the three phenyl resi-
dues,  showed a doublet of doublet due to ortho and meta coupl ing
(J = 11.5 Hz and J = 2.8 respect ively) at 6.93 d  ppm. The rest  s ix
protons gave multiplet at 9.25 d ppm  with coupling constants J = 11.7 Hz
and J = 1.9 Hz.
Spectral Analysis (Mass)
For the current study, Instrument used was JEOL SX 102/DA-6000 for FAB
(Fast atom Bombardenment) and . The molecular ion peaks (M+) of  the
compounds  in mass spectra  were in total agreement  with it’s molecular
weight.  The Mass spectra of the compounds are given on subsequent
pages.
In case of APT-6,  molecular weight, 636,  M+1 peak (m/e = 637)and M+2
(m/e = 638) are indicated.
In case of APT-7, molecular weight, 504, M+1 peak (m/e = 505) and peak
corresponding to the sodium adduct (m/e = 527) are indicated .
While in case of APT-2, molecular weight, 456, the spectrum shows the
presence of the M+ peaks at m/e = 456.
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APT-4
1H NMR Spectrum of 2,4,6-tris(3’,4’-dimethoxy phenyl)-1,3,5-trithiane
No.
Chemical
Shift
Multiplicity No. of Protons
Coupling
Constant(J)
1. 3.874 s 9H (26,30,34) -
2. 3.898 s 9H (28,32,36) -
3. 5.312 d 3H (2,4,6,<AX>) -
4. 6.865 t 3H (8,14,20) J = 1.2
5. 6.971 m
6H
(11,17,23,12,18,24)
J = 2.1
 
 1,3,5-Trithianes..... 101
S
1
2
6
S
3
S
5
4
19
24 20
23 21
22
7
12
8
11
9
10
13
18
14
17
15
16
O
29
CH3
30
O
25
CH3
26O
27
CH3
28
APT-3
1H NMR Spectrum of 2,4,6-tris(4’-methoxy phenyl)-1,3,5-trithiane
No.
Chemical
Shift
Multiplicity No. of Protons
Coupling
Constant(J)
1. 3.790 s 9H (26,28,30) -
2. 5.292 s 3H (2,4,6,<AX>) -
3. 7.426 d 6H (8,12,14.18,20,24)
J = 2.8
J = 11.5
4. 6.904 d 6H (9,11,15,17,21,23)
J = 1.9
J = 11.7
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1H NMR Spectrum of 2,4,6-tris(4’-hydroxy-3’methoxy phenyl)-1,3,5-trithiane
No.
Chemical
Shift
Multiplicity No. of Protons
Coupling
Constant(J)
1. 3.764 s 9H (26,29,32) -
2. 5.564 s 3H (2,4,6,<AX>) -
3. 6.785 s 3H (27a,30a,33a) -
4. 6.928 dd 3H (12,18,24)
J = 2.8
J = 11.5
5. 9.259 m
6H
(8,11,14,17,20,23)
J = 1.9
J = 11.7
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X-ray Crystallographic Study
A single crystal of APT-3 (AKP-3) with dimensions of 0.2 X 0.3 X 0.3 mm
was chosen for X-ray diffraction studies. The data were collected on a
IPLabo Image Plate system with graphite monochromated radiation MoKa
Thirty six frames of data were collected in oscillation mode with an
oscillation range of 5 degree. and processed using Denzo. The reflections
were merged with Scalepack. The crystal and experimental details are given
in Table~1. The hydrogen atoms were fixed at chemically acceptable
positions and were refined with isotropic temperature factors.
The ORTEP of the molecule at 50% probability is shown on pg no. 106.
The phenyl rings of the molecule are independently planar. The twisted ring
of the moiety adopts to a puckered chair conformation. The structure exhibits
intermolecular hydrogen bonds of the type C—H...O. The intermolecular
hydrogen bonds are C12..H12..O32 {2575 Angstrom, 128 degrees}. The
molecules are stacked in pairs when viewed down along the b axis.
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Identification code AKP-3 (APT-3)
Empirical formula C24H24S3O3
Formula weight 600.12
Temperature 293(2) K
Wavelength 0.71073 A
Crystal system, space group Monoclinic,  Pc
Unit cell dimensions a = 19.558(4) A   alpha = 90 deg.
b = 6.1210(5) A    beta = 113.482(3) deg.
c = 22.675(4) A   gamma = 90 deg.
Volume 2489.7(7) A^3
Z, Calculated density 5,  2.001 Mg/m^3
Absorption coefficient 0.877 mm^-1
F(000) 1524
Crystal size 0.3 x 0.3 x 0.35 mm
Theta range for data collection 2.63 to 32.50 deg.
Limiting indices -29<=h<=27, -6<=k<=6, -33<=l<=34
Reflections collected / unique 7663 / 7663 [R(int) = 0.0000]
Completeness to theta = 32.50 52.7 %
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 7663 / 2 / 547
Goodness-of-fit on F^2 2.167
Final R indices [I>2sigma(I)] R1 = 0.1255, wR2 = 0.3255
R indices (all data) R1 = 0.1866, wR2 = 0.3750
Absolute structure parameter 0.1(3)
Extinction coefficient 0.020(4)
Largest diff. peak and hole 1.985 and -0.505 e.A^-3
Table 1.  Crystal data and structure refinement for cel.
x y z U(eq)
S(1)  435(3) 6335(7) 4425(2) 71(1)
S(2) -3795(3) 8688(7) 5014(2) 71(1)
S(3) -3277(3) 8658(7) 3919(2) 69(1)
S(4)  1280(3) 3611(7) 5629(2) 68(1)
S(5) -2425(3) 11309(7) 5124(2) 72(1)
S(6)  1805(3) 3695(7) 4516(2) 70(1)
C(53) -2930(10) 10910(30) 6077(9) 55(4)
O(16) -1056(8) 8213(19) 6500(7) 83(4)
O(39) -893(7) 13207(19) 3058(6) 73(3)
C(38) -1268(9) 12490(20) 3401(8) 67(4)
C(44) -4502(11) 6410(30) 3928(9) 66(5)
C(12) -113(11) 8510(30) 6086(9) 72(5)
C(34) -2376(10) 9450(30) 4515(8) 62(4)
C(10) -17(11) 5530(30) 5405(9) 55(5)
C(13) -707(10) 7440(20) 6109(9) 58(5)
C(18)  2416(10) 1430(20) 5628(9) 61(4)
C(35) -1945(9) 10560(20) 4158(7) 63(4)
C(9)  394(10) 4470(30) 5029(9) 67(4)
C(26)  974(12) 5900(20) 3492(9) 75(5)
Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic displacement parameters (A^2 x
10^3) for cel. U(eq) is defined as one third of the trace of the orthogonalized  Uij tensor.
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O(48) -6511(9) 4510(20) 2592(7) 101(4)
C(46) -5759(11) 7380(20) 3251(8) 73(5)
C(36) -2169(11) 12570(30) 3828(8) 65(5)
O(57) -3420(9) 14020(20) 7483(7) 88(5)
C(37) -1866(10) 13530(20) 3501(9) 59(5)
O(24)  4549(7) -436(19) 6954(7) 82(4)
C(11)  281(10) 7560(20) 5694(9) 77(5)
C(54) -2689(9) 10150(20) 6665(8) 57(4)
C(8)  875(11) 4590(20) 4021(8) 70(5)
C(52) -2866(9) 9640(20) 5523(8) 66(4)
O(32)  1407(9) 9190(20) 2084(7) 99(5)
C(23)  3729(11) 2380(30) 6247(12) 129(9)
C(20)  3323(12) -1200(30) 6271(10) 77(5)
C(41) -1032(11) 10420(20) 3731(9) 71(5)
C(21)  3884(13) 160(30) 6519(11) 80(6)
C(47) -5848(9) 5320(30) 3032(8) 71(4)
C(31)  1307(10) 8230(20) 2600(8) 63(4)
C(42) -1349(10) 9550(20) 4094(8) 64(4)
C(50) -5273(12) 3790(20) 3184(11) 74(6)
C(27)  753(11) 5220(30) 2870(9) 85(5)
C(19)  2615(10) -650(20) 5852(8) 66(5)
C(51) -4588(11) 4350(30) 3655(11) 80(6)
C(7)  1719(10) 2060(30) 5176(9) 63(4)
C(15) -993(10) 5560(30) 5808(9) 67(5)
C(43) -3650(10) 7200(20) 4381(9) 70(5)
C(14) -605(11) 4580(30) 5452(9) 85(6)
C(56) -3192(11) 13140(40) 7025(11) 82(6)
C(28)  873(14) 6280(30) 2435(11) 94(7)
C(29)  1530(11) 8910(30) 3179(9) 65(4)
C(55) -2854(10) 11230(30) 7143(9) 68(5)
C(58) -3436(13) 14140(30) 6379(9) 77(5)
C(59) -3287(11) 12920(30) 5913(10) 81(5)
C(30)  1406(11) 7860(30) 3624(10) 85(6)
C(40) -1185(10) 15080(30) 2701(9) 74(5)
C(22)  3063(12) 3000(30) 5861(9) 101(7)
C(33)  1930(16) 11130(30) 2252(12) 101(7)
C(45) -5005(10) 7880(20) 3727(10) 75(5)
C(17) -800(13) 10260(30) 6864(10) 92(7)
C(49) -7174(12) 6120(30) 2357(12) 98(7)
C(25)  5139(11) 890(30) 7134(10) 99(7)
C(60) -3801(16) 15890(40) 7392(14) 117(9)
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I
S(1)-C(8) 1.830(19)
S(1)-C(9) 1.811(18)
S(2)-C(43) 1.814(17)
S(2)-C(52) 1.818(17)
S(3)-C(43) 1.741(18)
S(3)-C(34) 1.808(19)
S(4)-C(9) 1.802(19)
S(4)-C(7) 1.843(16)
S(5)-C(34) 1.821(17)
S(5)-C(52) 1.796(16)
S(6)-C(8) 1.80(2)
S(6)-C(7) 1.864(19)
C(53)-C(54) 1.31(2)
C(53)-C(59) 1.39(2)
C(53)-C(52) 1.52(2)
O(16)-C(13) 1.399(19)
O(16)-C(17) 1.47(2)
O(39)-C(38) 1.34(2)
O(39)-C(40) 1.39(2)
C(38)-C(37) 1.43(2)
C(38)-C(41) 1.45(2)
C(44)-C(45) 1.27(2)
C(44)-C(51) 1.38(2)
C(44)-C(43) 1.65(2)
C(12)-C(13) 1.35(2)
C(12)-C(11) 1.50(2)
C(12)-H(12) 0.9300
C(34)-C(35) 1.54(2)
C(34)-H(34) 0.9800
C(10)-C(14) 1.33(3)
C(10)-C(11) 1.42(2)
C(10)-C(9) 1.53(2)
C(13)-C(15) 1.34(2)
C(18)-C(7) 1.39(2)
C(18)-C(19) 1.367(19)
C(18)-C(22) 1.51(3)
C(35)-C(36) 1.42(2)
C(35)-C(42) 1.38(2)
C(9)-H(9) 0.9800
C(26)-C(27) 1.36(3)
C(26)-C(30) 1.43(2)
C(26)-C(8) 1.52(2)
O(48)-C(47) 1.38(2)
O(48)-C(49) 1.55(2)
C(46)-C(47) 1.34(2)
C(46)-C(45) 1.47(2)
C(46)-H(46) 0.9300
C(36)-C(37) 1.26(2)
C(36)-H(36) 0.9300
O(57)-C(60) 1.33(3)
O(57)-C(56) 1.39(3)
C(37)-H(37) 0.9300
O(24)-C(21) 1.33(2)
O(24)-C(25) 1.34(2)
II
C(11)-H(11A) 0.9700
C(11)-H(11B) 0.9700
C(54)-C(55) 1.41(2)
C(54)-H(54) 0.9300
C(8)-H(8) 0.9800
C(52)-H(52) 0.9800
O(32)-C(31) 1.39(2)
O(32)-C(33) 1.51(3)
C(23)-C(22) 1.30(2)
C(23)-C(21) 1.47(2)
C(23)-H(23) 0.9300
C(20)-C(21) 1.31(3)
C(20)-C(19) 1.37(3)
C(20)-H(20) 0.9300
C(41)-C(42) 1.32(2)
C(41)-H(41) 0.9300
C(47)-C(50) 1.40(2)
C(31)-C(29) 1.28(2)
C(31)-C(28) 1.42(2)
C(42)-H(42) 0.9300
C(50)-C(51) 1.38(3)
C(50)-H(50) 0.9300
C(27)-C(28) 1.28(3)
C(27)-H(27) 0.9300
C(19)-H(19) 0.9300
C(51)-H(51) 0.9300
C(7)-H(7) 0.9800
C(15)-C(14) 1.44(3)
C(15)-H(15) 0.9300
C(43)-H(43) 0.9800
C(14)-H(14) 0.9300
C(56)-C(55) 1.32(2)
C(56)-C(58) 1.48(3)
C(28)-H(28) 0.9300
C(29)-C(30) 1.30(2)
C(29)-H(29) 0.9300
C(55)-H(55) 0.9300
C(58)-C(59) 1.41(2)
C(58)-H(58A) 0.9700
C(58)-H(58B) 0.9700
C(59)-H(59) 0.9300
C(30)-H(30) 0.9300
C(40)-H(40A) 0.9677
C(40)-H(40B) 0.9679
C(40)-H(40C) 0.9672
C(22)-H(22) 0.9300
C(33)-H(33A) 0.9648
C(33)-H(33B) 0.9657
C(33)-H(33C) 0.9684
C(45)-H(45) 0.9300
C(17)-H(17A) 0.9742
C(17)-H(17B) 0.9735
C(17)-H(17C) 0.9751
III
C(49)-H(49A) 0.9603
C(49)-H(49B) 0.9603
C(49)-H(49C) 0.9605
C(25)-H(25A) 0.9300
C(25)-H(25B) 0.9300
C(60)-H(60A) 0.9661
C(60)-H(60B) 0.9651
C(60)-H(60C) 0.9635
C(8)-S(1)-C(9) 100.4(7)
C(43)-S(2)-C(52) 103.4(8)
C(43)-S(3)-C(34) 101.9(8)
C(9)-S(4)-C(7) 104.6(8)
C(34)-S(5)-C(52) 102.1(8)
C(8)-S(6)-C(7) 105.7(8)
C(54)-C(53)-C(59) 121.7(16)
C(54)-C(53)-C(52) 122.9(15)
C(59)-C(53)-C(52) 115.4(16)
C(13)-O(16)-C(17) 119.8(13)
C(38)-O(39)-C(40) 114.7(12)
O(39)-C(38)-C(37) 128.2(15)
O(39)-C(38)-C(41) 117.0(14)
C(37)-C(38)-C(41) 114.8(15)
C(45)-C(44)-C(51) 122.9(19)
C(45)-C(44)-C(43) 117.5(15)
C(51)-C(44)-C(43) 117.3(15)
C(13)-C(12)-C(11) 119.3(15)
C(13)-C(12)-H(12) 120.2
C(11)-C(12)-H(12) 120.5
C(35)-C(34)-S(5) 109.3(11)
C(35)-C(34)-S(3) 107.5(11)
S(5)-C(34)-S(3) 113.8(10)
C(35)-C(34)-H(34) 108.5
S(5)-C(34)-H(34) 108.5
S(3)-C(34)-H(34) 109.1
C(14)-C(10)-C(11) 123.8(17)
C(14)-C(10)-C(9) 121.4(17)
C(11)-C(10)-C(9) 114.9(15)
C(15)-C(13)-C(12) 125.7(15)
C(15)-C(13)-O(16) 113.7(14)
C(12)-C(13)-O(16) 120.5(15)
C(7)-C(18)-C(19) 125.7(16)
C(7)-C(18)-C(22) 121.1(14)
C(19)-C(18)-C(22) 112.9(15)
C(36)-C(35)-C(42) 115.4(14)
C(36)-C(35)-C(34) 122.8(15)
C(42)-C(35)-C(34) 121.6(13)
C(10)-C(9)-S(4) 105.4(12)
C(10)-C(9)-S(1) 110.1(11)
S(4)-C(9)-S(1) 115.8(9)
C(10)-C(9)-H(9) 108.6
S(4)-C(9)-H(9) 108.1
S(1)-C(9)-H(9) 108.6
Table 3.  Bond lengths [A] and angles [deg] for cel.
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C(27)-C(26)-C(30) 113.1(19)
C(27)-C(26)-C(8) 124.3(17)
C(30)-C(26)-C(8) 122.0(17)
C(47)-O(48)-C(49) 115.9(14)
C(47)-C(46)-C(45) 114.3(16)
C(47)-C(46)-H(46) 122.7
C(45)-C(46)-H(46) 123.0
C(37)-C(36)-C(35) 126.4(16)
C(37)-C(36)-H(36) 117.6
C(35)-C(36)-H(36) 116.0
C(60)-O(57)-C(56) 122.8(19)
C(36)-C(37)-C(38) 119.6(16)
C(36)-C(37)-H(37) 120.2
C(38)-C(37)-H(37) 120.1
C(21)-O(24)-C(25) 122.0(14)
C(10)-C(11)-C(12) 113.4(15)
C(10)-C(11)-H(11A) 110.0
C(12)-C(11)-H(11A) 109.6
C(10)-C(11)-H(11B) 109.3
C(12)-C(11)-H(11B) 106.8
H(11A)-C(11)-H(11B) 107.6
C(53)-C(54)-C(55) 121.0(15)
C(53)-C(54)-H(54) 119.6
C(55)-C(54)-H(54) 119.3
C(26)-C(8)-S(6) 103.7(13)
C(26)-C(8)-S(1) 108.5(11)
S(6)-C(8)-S(1) 115.2(10)
C(26)-C(8)-H(8) 109.9
S(6)-C(8)-H(8) 109.6
S(1)-C(8)-H(8) 109.6
C(53)-C(52)-S(2) 107.3(12)
C(53)-C(52)-S(5) 109.9(10)
S(2)-C(52)-S(5) 114.9(10)
C(53)-C(52)-H(52) 107.8
S(2)-C(52)-H(52) 108.4
S(5)-C(52)-H(52) 108.4
C(31)-O(32)-C(33) 115.4(16)
C(22)-C(23)-C(21) 122.2(18)
C(22)-C(23)-H(23) 119.7
C(21)-C(23)-H(23) 118.0
C(21)-C(20)-C(19) 125.6(17)
C(21)-C(20)-H(20) 116.4
C(19)-C(20)-H(20) 118.0
C(42)-C(41)-C(38) 122.7(16)
C(42)-C(41)-H(41) 118.5
C(38)-C(41)-H(41) 118.7
C(20)-C(21)-O(24) 123.0(16)
C(20)-C(21)-C(23) 114(2)
O(24)-C(21)-C(23) 122.7(18)
C(46)-C(47)-O(48) 123.7(16)
C(46)-C(47)-C(50) 124.6(16)
O(48)-C(47)-C(50) 111.6(15)
C(29)-C(31)-O(32) 128.4(16)
V
C(29)-C(31)-C(28) 117.9(17)
O(32)-C(31)-C(28) 113.7(16)
C(35)-C(42)-C(41) 120.9(15)
C(35)-C(42)-H(42) 118.7
C(41)-C(42)-H(42) 120.4
C(51)-C(50)-C(47) 117.3(15)
C(51)-C(50)-H(50) 121.0
C(47)-C(50)-H(50) 121.6
C(28)-C(27)-C(26) 124(2)
C(28)-C(27)-H(27) 117.6
C(26)-C(27)-H(27) 118.2
C(20)-C(19)-C(18) 123.0(17)
C(20)-C(19)-H(19) 118.7
C(18)-C(19)-H(19) 118.3
C(44)-C(51)-C(50) 118.6(17)
C(44)-C(51)-H(51) 121.0
C(50)-C(51)-H(51) 120.3
C(18)-C(7)-S(4) 105.7(12)
C(18)-C(7)-S(6) 111.4(13)
S(4)-C(7)-S(6) 112.5(8)
C(18)-C(7)-H(7) 109.1
S(4)-C(7)-H(7) 109.0
S(6)-C(7)-H(7) 108.9
C(13)-C(15)-C(14) 115.9(16)
C(13)-C(15)-H(15) 121.5
C(14)-C(15)-H(15) 122.6
C(44)-C(43)-S(2) 101.7(11)
C(44)-C(43)-S(3) 109.7(12)
S(2)-C(43)-S(3) 117.0(8)
C(44)-C(43)-H(43) 109.5
S(2)-C(43)-H(43) 109.4
S(3)-C(43)-H(43) 109.1
C(10)-C(14)-C(15) 121.8(16)
C(10)-C(14)-H(14) 120.3
C(15)-C(14)-H(14) 117.8
C(55)-C(56)-O(57) 118.6(19)
C(55)-C(56)-C(58) 120(2)
O(57)-C(56)-C(58) 120(2)
C(27)-C(28)-C(31) 120(2)
C(27)-C(28)-H(28) 121.1
C(31)-C(28)-H(28) 119.3
C(31)-C(29)-C(30) 123.0(18)
C(31)-C(29)-H(29) 118.3
C(30)-C(29)-H(29) 118.7
C(56)-C(55)-C(54) 120.7(17)
C(56)-C(55)-H(55) 120.2
C(54)-C(55)-H(55) 119.0
C(59)-C(58)-C(56) 116.2(18)
C(59)-C(58)-H(58A) 107.5
C(56)-C(58)-H(58A) 108.5
C(59)-C(58)-H(58B) 108.0
C(56)-C(58)-H(58B) 108.8
H(58A)-C(58)-H(58B) 107.4
Table 3. contd.  Bond lengths [A] and angles [deg].
 
 1,3,5-Trithianes..... 112
VI
C(53)-C(59)-C(58) 119.9(17)
C(53)-C(59)-H(59) 119.8
C(58)-C(59)-H(59) 120.3
C(29)-C(30)-C(26) 122.0(19)
C(29)-C(30)-H(30) 119.0
C(26)-C(30)-H(30) 118.9
O(39)-C(40)-H(40A) 110.4
O(39)-C(40)-H(40B) 110.7
H(40A)-C(40)-H(40B) 108.6
O(39)-C(40)-H(40C) 109.8
H(40A)-C(40)-H(40C) 108.7
H(40B)-C(40)-H(40C) 108.5
C(23)-C(22)-C(18) 121.6(15)
C(23)-C(22)-H(22) 118.7
C(18)-C(22)-H(22) 119.7
O(32)-C(33)-H(33A) 107.7
O(32)-C(33)-H(33B) 109.3
H(33A)-C(33)-H(33B) 109.1
O(32)-C(33)-H(33C) 113.2
H(33A)-C(33)-H(33C) 108.3
H(33B)-C(33)-H(33C) 109.2
C(44)-C(45)-C(46) 121.4(16)
C(44)-C(45)-H(45) 119.4
C(46)-C(45)-H(45) 119.2
O(16)-C(17)-H(17A) 110.9
O(16)-C(17)-H(17B) 110.4
H(17A)-C(17)-H(17B) 108.1
O(16)-C(17)-H(17C) 111.5
H(17A)-C(17)-H(17C) 108.0
H(17B)-C(17)-H(17C) 107.8
O(48)-C(49)-H(49A) 108.5
O(48)-C(49)-H(49B) 107.5
H(49A)-C(49)-H(49B) 109.5
O(48)-C(49)-H(49C) 112.5
H(49A)-C(49)-H(49C) 109.5
H(49B)-C(49)-H(49C) 109.3
O(24)-C(25)-H(25A) 117.2
O(24)-C(25)-H(25B) 122.7
H(25A)-C(25)-H(25B) 120.0
O(57)-C(60)-H(60A) 112.3
O(57)-C(60)-H(60B) 110.5
H(60A)-C(60)-H(60B) 109.0
O(57)-C(60)-H(60C) 107.2
H(60A)-C(60)-H(60C) 108.4
H(60B)-C(60)-H(60C)         109.3
S(1) 67(4) 82(3) 67(3) 6(2) 30(3) 13(2)
S(2) 65(4) 85(3) 65(3) -8(2) 27(3) -12(2)
S(3) 65(3) 79(3) 62(3) -5(2) 24(3) -7(2)
S(4) 68(4) 75(3) 57(3) 2(2) 20(3) 8(2)
S(5) 71(4) 78(3) 64(4) -9(2) 24(3) -16(2)
S(6) 63(4) 79(3) 68(4) 2(2) 25(3) 8(2)
C(53) 33(10) 82(9) 50(13) -10(8) 15(9) -10(7)
O(16) 69(11) 77(7) 110(11) -4(7) 43(9) -8(6)
O(39) 82(10) 73(7) 68(8) 18(6) 33(7) 7(6)
C(38) 42(10) 82(10) 58(9) 1(7) -1(7) 3(8)
C(44) 65(12) 76(10) 54(10) -4(7) 22(9) 3(8)
C(12) 77(15) 74(11) 73(14) -16(8) 39(11) -5(9)
C(34) 45(12) 68(8) 64(11) -10(7) 13(9) -7(7)
C(10) 40(13) 60(10) 63(13) -6(8) 18(10) -6(8)
C(13) 57(12) 67(9) 69(13) -10(8) 43(10) -8(8)
C(18) 36(10) 63(8) 73(11) -6(6) 10(8) 9(6)
C(35) 59(10) 81(8) 36(9) -5(7) 5(7) 4(7)
C(9) 60(11) 68(9) 83(13) -16(7) 36(9) -5(7)
C(26) 75(14) 55(9) 76(13) -13(8) 12(10) -10(8)
O(48) 92(11) 88(8) 79(9) -18(7) -11(8) -5(8)
C(46) 87(14) 65(9) 70(10) -3(7) 33(9) -5(8)
C(36) 62(12) 82(10) 51(11) 3(8) 24(9) 16(8)
O(57) 96(13) 103(9) 64(9) -16(6) 30(9) 11(8)
C(37) 52(14) 58(9) 65(13) -3(7) 20(10) 4(7)
O(24) 42(7) 84(7) 126(11) 9(7) 39(7) 12(6)
C(11) 66(11) 55(9) 106(14) 3(7) 30(9) 12(7)
C(54) 43(10) 70(8) 47(10) -1(7) 6(8) -1(7)
C(8) 104(15) 58(8) 39(10) 6(7) 17(10) -7(8)
C(52) 40(10) 82(9) 72(11) 9(7) 18(8) -16(7)
O(32) 115(13) 122(11) 76(10) 32(8) 56(9) 44(9)
C(23) 36(10) 90(11) 200(20) 60(11) -22(12) -24(8)
C(20) 69(12) 63(9) 89(13) 2(7) 21(10) 0(8)
C(41) 66(13) 58(8) 100(14) 13(8) 43(11) 15(7)
C(21) 75(17) 53(9) 125(17) 11(9) 54(14) 18(9)
C(47) 48(9) 91(10) 52(10) 1(7) -3(8) 3(7)
C(31) 76(13) 69(8) 48(9) 1(6) 30(8) 6(7)
C(42) 61(13) 57(7) 78(11) 12(7) 32(10) -3(7)
C(50) 65(14) 55(9) 89(17) -16(8) 17(12) 0(8)
C(27) 91(14) 102(12) 71(12) -36(10) 40(10) 0(10)
C(19) 80(14) 54(8) 60(10) 0(6) 24(9) 6(7)
C(51) 58(14) 54(9) 114(18) -22(9) 21(13) -1(8)
C(7) 36(11) 76(9) 76(12) -9(8) 19(9) 15(8)
C(15) 46(11) 92(12) 62(13) -16(9) 20(9) 2(8)
C(43) 65(11) 50(7) 77(12) -5(7) 11(9) 7(6)
C(14) 67(11) 70(10) 78(14) 17(9) -11(10) -22(8)
C(56) 54(12) 109(14) 55(14) -1(11) -6(10) -19(10)
C(28) 130(20) 98(14) 58(13) 9(9) 42(13) 11(11)
C(29) 59(11) 79(9) 65(13) 14(8) 32(9) 10(7)
C(55) 40(11) 99(11) 50(10) 20(7) 3(8) -8(8)
C(58) 95(16) 80(10) 54(12) 6(8) 28(11) -2(9)
C(59) 100(16) 85(11) 69(12) 2(9) 46(11) -12(10)
C(30) 92(16) 89(10) 59(12) -1(9) 15(11) -25(10)
C(40) 63(13) 87(11) 80(14) -2(9) 35(11) -11(9)
C(22) 103(16) 62(9) 88(13) 9(8) -13(11) -1(9)
C(33) 160(20) 71(11) 128(17) -4(9) 115(16) -5(10)
C(45) 48(10) 55(8) 119(16) 2(8) 29(10) 1(7)
C(17) 98(18) 77(10) 124(16) -43(9) 69(14) -17(9)
C(49) 80(15) 129(13) 93(17) 27(11) 43(13) 35(10)
C(25) 46(10) 98(14) 95(14) 15(10) -33(10) 6(9)
C(60) 100(20) 126(18) 110(20) -27(14) 27(17) 4(14)
Table 3. contd. Table 4.  Anisotropic displacement parameters (A^2 x
10^3) for cel. The anisotropic displacement factor
exponent takes the form: -2 pi^2 [ h^2 a*^2 U11 + ... + 2
h k a* b* U12 ]
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x y z U(eq)
H(12) 50 9809 6309 86
H(34) -2105 8135 4728 74
H(9) 116 3166 4812 81
H(46) -6142 8400 3114 88
H(36) -2579 13261 3856 78
H(37) -2031 14898 3326 71
H(11A) 250 8597 5361 92
H(11B) 804 7368 5970 92
H(54) -2406 8874 6768 69
H(8) 557 3315 3835 85
H(52) -2549 8363 5702 79
H(23) 4120 3378 6355 155
H(20) 3412 -2660 6390 93
H(41) -641 9674 3686 85
H(42) -1167 8248 4308 76
H(50) -5348 2441 2977 89
H(27) 498 3899 2756 102
H(19) 2255 -1742 5714 79
H(51) -4193 3365 3786 95
H(7) 1421 753 4993 76
H(15) -1415 4925 5829 81
H(43) -3339 5915 4565 84
H(14) -770 3247 5249 102
H(28) 679 5778 2012 113
H(29) 1792 10218 3287 78
H(55) -2722 10581 7544 81
H(58A) -3969 14392 6217 92
H(58B) -3196 15550 6423 92
H(59) -3428 13462 5498 97
H(30) 1606 8402 4042 102
H(40A) -1621 14703 2327 112
H(40B) -819 15718 2570 112
H(40C) -1317 16102 2958 112
H(22) 2985 4450 5726 121
H(33A) 1656 12442 2245 151
H(33B) 2152 11256 1945 151
H(33C) 2314 10935 2674 151
H(45) -4893 9293 3884 90
H(17A) -292 10536 6927 138
H(17B) -832 10131 7274 138
H(17C) -1109 11447 6628 138
H(49A) -7351 6341 2691 147
H(49B) -7569 5533 1983 147
H(49C) -7014 7492 2250 147
H(25A) 5094 2275 6955 119
H(25B) 5596 425 7439 119
H(60A) -3612 16912 7174 175
H(60B) -3747 16477 7800 175
H(60C) -4319 15611 7136 175
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic
displacement parameters (A^2 x 10^3)
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Packing of the AKP-3 (APT-3)
molecules down b axis
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Synthesis of 4-aryl-3,4-dihydropyrimidin-
2(1H)-ones, employing classical Biginelli
multicomponent condensation
CHAPTER-3
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I n  recen t  years ,  aza  ana logs  o f  d ihydropyr id ines  ( I ) ,  s u c h  a s
Dihydropyrimidines (II )  have carved their way as biologically important
molecules.
The acid catalysed cyclocondensation reaction of ethyl acetoacetate,
benzaldehyde and urea, so called simple one-pot reaction was first
reported in 1893 by Pietro Biginelli1
The one-pot Bignelli reaction is a type of three component reactions (TCRs)
which  is a subset of multicomponent reactions (MCRs). MCR condensations
involve three or more compounds reacting in a single event, but
consecutively to form a new product, which contains the essential parts of
all the starting materials.
A brief overview of MCR is given below to summarize important contribution
of some reactions.
Introduction
1. Biginelli, P.; Gazz. Chim. Ital. 23, 360 (1893).
N
H
R4 R1
R2R3
R H
N
H
N
R4 R1
R2R3
R H
(I) (II)
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O
R H
+ NH3 + CH N
NH2
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O
CH3
COOEt+ NH3 +
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F3C
NH
COOEt
COOEt
CH3
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Pioneer contribution of Multi Component Reactions in Chemistry.
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Strecker Synthesis
Hantzsch Dihydropyridine Synthesis
Radziszewski Imidazole Synthesis
Hantzsch Pyrrole Synthesis
Biginelli Reaction
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Passerini Reaction
N
H
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O
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N
H
O
O
T
T
Bucherer-Bergs Hydantoin Synthesis
+ + +R1 CHO R2 COOH R3 NC R4 NH2
O
R2 N
R4
R1
O
NH
R3
The Ugi Reaction
2.  St recker ,  A. ,
Liebigs Ann. Chem . ,
75,27 (1850).
3 .  Han tzsch ,  A . ;
Justus Liebegs Ann.
Chem. , 215, 1 (1882).
4 .  Han tzsch ,  A . ;
Justus Liebegs Ann.
Chem. , 215, 1 (1882).
6a. Kappe, C.; Acc .
Chem. Res., 33,879
(2000)
b.  Biginelli, P.; Ber.,
24,1317 (1891).
5.  Hantzsch, A.; Ber.
Desch. Chem. Ges.,
23, 1474 (1890).
7.  Manich,  C. ,
Krosche, W.,  Arch.
Pharm. ,  250,  647
(1912).
9.  Passer in i ,  M.;
Gazz. Chim. Ital., 53,
331 (1923).
10.  Manich,  C. ,
Krosche,  W.,  Arch.
Pharm., 250, 647
(1912).
8. Robinson, R.; J.
Chem. Soc. (London),
111, 876, (1917).
11. Ugi, I., Horl, W.,
Hanusch, C., Schmid,
T. ,  Herdtweck,  E. ;
Heterocycles, 47, 985
(1998).
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The Biginelli dihydropyrimidine MCR has come a long way since its
discovery. From the preparation of simple pyrimidine heterocycles in the
late 19th century, to the generation of targeted compound libraries of
biofunctional DHPMs and the enantioselective total synthesis of complex
natural products, the Biginelli MCR has adapted successfully to the needs
and expectations of modern organic chemistry.
This important one-pot condensation was largely ignored in the early part
of the 20th century. The synthetic potential of this core heterocyclic
methodology, therefore remained unexplored for quite some time. The
interest in Biginelli condensation was gradually elevated in 1970s and 1980s
allowing access to a large number of multifunctionalized dihydropyrimidine
derivatives 12.  Because of the pharmacological potency of the DHPM
scaffold, combinatorial synthesis and high-throughput screening techniques
have now become the golden target for many research groups.
The Chemical Evolution
Biginelli in his original work, carried out the all-encompassing study of the
tetra hydro pyrimidone compounds using numerous aldehydes, urea and a
b-keto ester. This study swaddles the constitutional proof of  formation of
the dihydropyrimidine tracing any of the following four ways depending upon
the various factors like catalyst, amount of catalyst, time of reaction etc.
A. Urea, benzaldehyde and ethyl acetoacetate.
B. Benzal-bisurea and ethyl acetoacetate.
C. Ethyl b-carbamido crotonate and benzaldehyde.
D. Urea and ethyl a-benzalacetoacetate.
12. Kappe, C.; Tetrahedron, 49, 6937 (1993)
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Later on the proposed structure of Biginelli’s dihydropyrimidine was
accepted by Hinkel and Hey13 and Folker and co-workers14 (III).
O
NH2NH2
+
O
HR
CH3
NH
NH
O
O
NH2
NH2
NH
N
H
O
Ph
CH3
EtOOC
R
NH
NH
O
O
NH
NH2
CH3
COOEt
CH3
To shed light on the the fact of formation of the Biginelli’s dihydropyrimidine,
evidences were proposed in favour of it with regards to the position of the
double bond 15. Folkers and Johnson in 193316, anticipated two following
observations.
1. When only one or two drops of acid were used in the reaction between
the three components, a few white particles, probably benzal-urea was
observed at the starting of refluxing , which soon disappeared. The
formation of this compound the only indication of the mechanism obtained
from the three component system.
2. The reaction between benzal-bis urea and ethyl acetoacetate in the higher
acid concentrations gave the highest yields of pyrimidines.
13. Hinkel and Hey; Rec. Trav. Chim., 48, 1280 (1929).
14. Folkers, Harwood and Johnson, J. Amer. Chem. Soc. 54, 3751 (1932).
15. a.Folkers and Johnson; J. Amer. Chem. Soc. 55, 1140 (1933).
      b.Folkers and Johnson; J. Amer. Chem. Soc.55, 2888 (1933).
16. Folkers, K. and Johnson, T.; J. Amer. Chem. Soc.  55, 3784 (1933).
17. Sweet, F. and Fissekis, J.; J. Amer. Chem. Soc. , 95, 8741 (1973).
The next proposal (figure )was put forward in 197317. In this study, the
Biginelli reaction was reinvestigated and it was found out that from a reaction
mixture of benzaldehyde, ethyl acetoacetate and urea containing a
catalytical amount of HCl, and after heating under reflux for 76 hrs, a
pyrimidine derivative separated out which was consistent to the Biginelli
structure.
(III)
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Lateron, Kappe18 showed that the original mechanistic proposal put forward
by Folkers and Johnson in 1933 involving an aldehyde-urea condensation
product as key intermediate in the Biginelli condensation  is essentially
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correct .  ( IV) .  After th is
proposal, the mechanistic
problem for the biginell i
react ion was no more a
question and was accepted
(V).
The major drawback associated with the above mentioned protocols is the
low yields, particularly for substituted aromatic and aliphatic aldehydes19,20.
To promote conditions that would increase the yield, a variety of alternative
ample number of synthetic stategies were investigated and accepted21-27.
18.  Kappe, C., J. Org. Chem., 62(21), 7203 (1997).
19.   Atwal, K., Rovnyak, G., O’Reilly, B. and Schwartz, J. J. Org. Chem. 54, 5898 (1989).
20. Barluenga, J., Tomas, M., Ballesteros, A. and Lopez, L.; Tetrahedron Lett. 30, 4573 (1989).
21. Kappe, C.; Tetrahedron, 49, 6937 (1993).
22. Kappe, C., Peters, K. and Peters, E., J. Org. Chem, 62, 2786 (1997).
23. Kappe, C., Fabian, W. and Semones, M.; Tetrahedron  53, 2803 (1997).
24. O’Reilly, B.and Atwal, K.; Heterocycles , 26, 1185 (1987)
25. Atwal, K., Rovnyak, G., O’Reilly, B. and Schwartz, J., J. Org. Chem., 54, 5898
     (1989).
26. Gupta, R., Gupta, A., Paul, S. and Kachroo, P.; Ind. J. Chem . 34B, 151 (1995).
27. Sar, C., Hankovszky, O., Jerkovich, G., Pallagi, I. and Hideg, K., ACH Models Chem.
     131, 363 (1994).
(IV)
(V)
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Various solid-phase modifications of the Biginelli reaction suitable for
combinatorial chemistry have also been convoluted28-30. The search of
variations in the one-pot synthesis so as to increase the yield of the desired
dihydropyrimidine, the utilization of polyphosphate ester came into the light
(VI) .   Polyphosphate ester  (PPE) was ut i l ized for  the Biginel l i ’s
condensation. PPE serves as an excellent reaction mediator in the three
component Biginelli reaction31. PPE is one of the phosphate-based
reagents that are related to polyphosphoric acid (PPA). In contrast to PPA,
PPE is aprotic and soluble in organic media.
28. Wipf, P. and Cunninggham, A.; Tetrahedron lett . 36, 7819 (1995).
29. Studer, A., Jeger, P., Wipf, P. and Curan, D.; J. Org. Chem ., 62, 2917 (1997).
30. Robinet, L., Yager, K. and Phelan, J.; 211th National Meeting of the American Chemical
     Society, New Orleans, 1996; American Chemical Society: Washington, DC, ORGN
     122 (1996).
31. Kappe, C. and Falsone, F.; Synlett, 718 (1998).
32. Dixon, L.; In Encyclopedia of Reagents for Organic Synthesis, Paquette, L., Ed.,
     Wiley, Chichester, 4, 4166 (1995).
33. Dixon, L.; In Encyclopedia of Reagents for Organic Synthesis, Paquette, L., Ed.,
     Wiley, Chichester, 4, 4166 (1995).
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X
So to be specific, the advantages of PPE include its solubility in organic
solvents, the mild conditions under which it is used and its relatively
nonhazardous in nature32. This reagent is not commercially available, but it
can be readily prepared by treatment of phosphorous oxide with anhydrous
ether. As a reagent, PPE has been used successfully in Bischler-Napieralski
reactions, Friedel-Craft acylation, Beckmann rearrangements and in
conversion of carboxylic acids to esters, thiol esters, amides and nitriles33.
(VI)
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Use of neat PPE as reaction mediator was described by Marson for the
similar reactions34. In this study, the reported yield was 80 %, but the only
major drawback is addition of water or ice to the reaction mixture. Addition
of water, leads to the precipitation of the desired product as well as the
unwanted by-products35. These problems have now overcomed by using
neat PPE effectively, in particular for small-scale synthesis of DHPM
libraries36. Variations were still effectuated in the reaction of DHPM
prepartion using PPE as mediator. By using a co-solvent along with PPE
and microwave-assisted protocol , the problems with neat PPE were also
eliminated and made the protocol more amenable to a large-scale
preparation of DHPMs.  It was observed that 1:1:1.5 ratio of beta ester,
aldehyde and urea derivatives with anhydrous refluxing THF as cosolvent
and PPE as mediator (150 mg per mole) provided the highest yields37.
34. Marson, C., Grabowska, U., Fallah, A., Walsgroove, T., Eggleston, D. and Baures,
     P.; J. Org. Chem., 59, 291 (1994).
35. Kappe, C.; J. Org. Chem. 62, 7201 (1997).
36. Kappe, C., Kumar, D. and Varma, R.; Synthesis , 1799 (1999).
37. Kappe, C. and Falsone, F.; Synlett, 718 (1998).
38. O’Reilly, B. C. and Atwal, K. S.; Heterocycles , 26,1185 (1987).
39.  Atwal, K., O’Reilly, B., Gougoutas, J. and Malley, M.; Heterocycles , 26, 1189 (1987).
40. Atwal, K., Rovnyak, G., O’Reilly, B. and Schwartz, J.; J. Org. Chem., 54, 5898 (1989)
In the case study of Atwal’s modification38-40, the benzylidine derivative is
made to react with the protected urea or thiourea under almost neutral
conditions. Deprotection of the resulting 1,4-dihydropyrimidine with HCl or
Trifluoro acetic acid / Thioethanol leads to the desired DHPM. Although
this method requires prior synthesis of enones, its reliability and broad
applicability make it an attractive alternative to the traditional one step
condensation (VII).
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(VII)
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The Solid Phase Protocols
Solid-phase modifications of MCRs are rapidly becoming one of the
corner stones of combinatorial synthesis of small-molecule libraries65-67.
Multicomponent reactions such as the Biginelli condensation leading to
heterocycles are particularly useful for the creation of d iverse  chemical
libraries, since the combination of small molecular weight building blocks in
a single operation leads to high combinatorial efficacy68,69.
Fre´chet and co-workers70,71 have described the generation of a 140-member
single-compound DHPM library by combination of 25 aldehydes, 6 ureas/
thioureas, and 7 acetoacetates or acetoamides under standard reaction
conditions (EtOH/HCl).
The first actual solid-phase modification of the Biginelli condensation was
reported by Wipf and Cunningham in 199572. In this sequence, g-aminobutyric
acid-derived urea was attached to Wang resin using standard proceures.
The resulting polymer-bound urea was condensed with excess a-ketoesters
and aromatic aldehydes in THF at 55 °C in the presence of a catalytic amount
of HCl to afford the corresponding immobilized DHPMs. Subsequent
cleavage of product from the resin by 50%
65. Armstrong, R., Combs, A. , Tempest, P., Brown, S. and Keating, T.; Acc. Chem.
     Res.29, 123 (1996).
66. Tietze, L. and Lieb, M.; Curr. Opin. Chem. Biol. 2, 363 (1998).
67. Dax, S., McNally, J. and Youngman, M.; Curr. Med.Chem., 6, 255 (1999).
68. Nefzi, A.; Ostreh, J. and Houghten, R.; Chem. Rev., 97, 449 (1997).
69. Corbett, J. W. Recent Progress in Solid-Phase Heterocycle Syn-theses. A Review.
     Org. Prep. Proced. Int., 30, 489 (1998).
70. Lewandowski, K., Murer, P., Svec, F., Fre´ chet, J., Chem. Commun., 2237 (1998).
71. Lewandowski, K., Murer, P., Svec, F., Fre´ chet, J., J. Comb. Chem., 1, 105 (1999).
72. Wipf, P. and  Cunninggham, A.; Tetrahedron letters , 36, 7819 (1995).
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Trifluoroacetic acid (TFA) provided DHPMs in high yields and excellent
purity. The key condensation step was further studied.(VIII)
Biginelli reaction was also adapted to fluorous-phase conditions by the Wipf
and Curran 73,74. In fluorous synthesis, an organic molecule is rendered
soluble in fluorocarbon solvents by attachment of a suitable fluorocarbon
group (“fluorous tag”). Fluorocarbon solvents are usually im-miscible with
organic solutions, and fluorous molecules partition out of an organic phase
and into a fluorous phase by standard liquid-liquid extraction. At the desired
stage of the synthesis, the fluorous label is cleaved and the product is
rendered “organic” again73. In the fluorous Biginelli reaction, the fluorous
urea derivative was prepared by attachment of a suitable fluorous tag to
hydroxyethylurea. The fluorous urea was then condensed with 10 equiv
alents each of the corresponding acetoacetates and aldehydes in
Tetrahydrofuran (THF)-benzotrif luoride (BTF) containing HCl. After
extraction of the fluorous DHPMs with fluorous solvent (perfluorohexanes,
FC-72), desilylation with
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O H
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73. Studer, A., Hadida, S., Ferritto, R., Kim, S.-Y., Jeger, P., Wipf, P., Curran, D. P.;
     Science , 275, 823 (1997).
74. Studer, A., Jeger, P., Wipf, P., Curran, D.; J. Org. Chem., 62, 2917 (1997).
(VIII)
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tetrabutylammonium fluoride (TBAF) followed by extractive purification
provided the “organic” Biginelli products (DHPMs) in good overall yields.
Considering the simple experimental techniques used in this fluorous
chemistry, automation should be feasible, thus allowing the preparation of
DHPM libraries74.(IX)
Garcia75 developed an alternative protocol, where the acetoacetate
building block is l inked to the solid support to get pharmacologically
active N1-unsubstituted DHPMs.(X)
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75. Garcia-Valverde, M. and Pernat, T.; Kappe, C. O. Unpublished results.
76. Bose. D. S.and Narsaiah, A. V. J. Chem. Research (S) , 36 (2001).
77. L. A. Paquette, Encyclopedia of reagents for organic synthesis. Chichester: John
     Wiley & Sons, 376 (1995).
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Looking to the increasing environmental and economical concerns in
recent years, recently a new facile solvent free synthesis of Bignelli-
dihydropyr imidine was carr ied out using phase transfer catalyst,
triethylbenzylammonium chloride (TEBA) which is one of many commonly
used phase transfer catalysts in organic synthesis76 in general and in
particular in the formation of carbenes in heterogeneous systems77.
(X)
(IX)
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This method78(XI) not only preserved the simplicity of Biginelli’s one-pot
condensation but also remarkably improved the yields (>85%) of
dihydropyrimidinones in shorter reaction times (30-90 min) as against the
longer reaction times required for other catalysts after the addition of a low
catalyst concentration.  The best results were obtained with a 0.1:1:1:1.5
ratio of TEBA, aldehyde, 1,3-dicarbonyl compound and urea or thiourea.
78. Bose, S., Sudharshan, M. and Chavhan, S.; ARKIVOC 228 (2005 ).
79. Shutalev, A. , Kishko, E., Sivova, N., Kuznetsov, A., ; Molecules , 3, 100 (1998).
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Triethylbenzyl ammonium chloride
          (10 mol%)
100 o C, 30 - 90 min
In an another approach to DHPMs, as described by Shutalev et al79(XI). The
synthesis is based on the condensation of readily available R-tosyl-substituted
(thio)ureas with the (in situ prepared) enolates of acetoacetates or 1,3-dicarbonyl
compounds.
The resulting hexahydropyrimidines
need not to be isolated and can be
converted directly into DHPMs. This
method works particularly well for
aliphatic aldehydes and thioureas
and produces high overall yields of
the desired target compounds (XII).
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(XI)
(XII)
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In another important work, 2-[[(4-Methoxyphenyl)methyl]thio]- and 2-
methoxy-1,4-dihydropyrimidines were prepared by the condensation
of benzyl idene with (C-methoxy-phenyl)methyl)-2-thiopseudourea
and  O-methylisourea, respectively. This reaction presumably proceeds
through the Michael addition product giving 1,4-dihydropyrimidines in
exce l lent  y ie lds 80.  Bo th  2 - (a lky1 th io )  py r im id ine  and 2-methoxy-
pyr imid ine  10 ex is t  in  so lu t ion  as  a  mix ture  o f  tau tomers  ( X I I I ) .
80. Karnail., A, George, R., O’Reilly, R. and Schwartz, J.; J.Org. Chem.,54, 5898 (1989).
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+
(XIII)
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The Loop of  Asymmetry
Dihydropyrimidines of the Biginelli type are inherently asymmetric molecules,
and the influence of the absolute configuration at the stereogenic center at
C4 on biological activity is well documented
81-85.
81. Atwal, K., Swanson, B., Unger, S., Floyd, D., Moreland, S., Hedberg, A. and O’Reilly,
     B.; J. Med. Chem ., 34, 806 (1991).
82. Rovnyak, G., Atwal, K., Hedberg, A., Kimball, S., Moreland, S., Gougoutas, J.,
     O’Reilly, B., Schwartz, J. and Malley, M.; J. Med. Chem., 35, 3254 (1992).
83. Grover, G., Dzwonczyk, S., McMullen, D., Normandin, D., Parham, C., Sleph, P.,
     and Moreland, S.; J. Cardiovasc. Pharmacol ., 26, 289 (1995).
84. Nagarathnam, D., Miao, S., Lagu, B., Chiu, G., Fang, J., Dhar, T., Zhang, J.,
     Tyagarajan, S., Marzabadi, M., Zhang, F., Wong, W., Sun, W., Tian, D.,
      Wetzel, J., Forray, C., Chang, R., Broten, T., Ransom, R., Schorn, T.
      W., Chen, T., O’Malley, S., Kling, P., Schneck, K., Benedesky, R., Harrell, C.
      M., Vyas, K. and Gluchowski, C.; J. Med. Chem., 42, 4764 (1999), and
       subsequent papers in the same issue. Barrow, J., Nantermet, P., Selnick, H., Glass,
      K., Rittle, K., Gilbert, K., Steele, T. , Homnick, C., Freidinger, R., Ransom, R.,
      Kling, P., Reiss, D., Broten, T., Schorn, T. , Chang, R., O’Malley, S., Olah, T.,
      Ellis, J., Barrish, A., Kassahun, K., Leppert, P., Nagarathnam, D. and Forray, C.;
      J. Med. Chem ., 43, 2703 (2000).
85. Rovnyak, G., Kimball, S., Beyer, B., Cucinotta, G., DiMarco, J., Gougoutas, J.,
     Hedberg, A., Malley, M., McMarthy, J., Zhang, R., Morleand, S.; J. Med. Chem. 38,
     119 (1995).
 In SQ 32926, for example, it is exclusively the
(R)-enantiomer that carries the therapeutically
desired antihypertensive effect81.  In other
DHPM analogues, individual enantiomers were
demonstrated to have opposing pharmacologi-
cal activities85. Access to enantiomerically pure
N
N
H
CH3O
N
+
O
-
O
O
CH3
CH3
O
CH3
DHPMs is therefore of considerable interest and a prerequisite for the
development of any drugs in this field (XIV).
SQ 32926
(XIV)
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In the absence of any known general
asymmetric synthesis for this heterocyclic
target system, resolution strategies have
so far been the method of choice to
obtain enantiomerically pure DHPMs.
Optically pure DHPMs were obtained
by resolut ion of the corresponding
 
N
N OCH3
O
OH
CH3
CH3
N
N OCH3
O
OH
CH3
CH3
racemic-5-carboxyx l ic  ac ids v ia  f ract ionaly  crysta l l izat ion of  the
corresponding d iastereomer ic  R-methyl  benzyl  ammonium sal ts85.
T h e absolute configuration of acid (S) was proven by single crystal
X-ray analysis of a suitable diastereomeric salt. This method may lead
to  bo th  enant iomers  (R)  and (S)  (XV)  but  unfor tunate ly ,  i t  i s  not
appl icable in general  to a l l  DHPMs.
Due to recent advances in preparative chromatographic enantioseparation
techniques, enantioselective HPLC and related methods have gained
impotance in the synthesis of single enantiomer drugs and intermediates.
In a recent study, the chromatographic enantioseparation of DHPM
derivatives accomplished by using a variety of commercially available
chiral stationary phases (CSPs) in normal and reversed-phase analytical
HPLC86is reported. Fre’chet and coworkers87,88 reported the separation
of DHPMs on a standard Pirkle-type 3,5-dinitrobenzoylated CSP and the
“reciprocal” preparation of a p-basic DHPM-based CSP.
85. Kappe, C., Uray, G., Roschger, P., Linder, W., Kratky, C. and Keller; Tetrahedron ,
     48, 5473 (1990)
86. Kleidernigg, C. and Kappe, O., Tetrahedron: Asymmetry, 8, 2057 (1997).
87. Lewandowski, K. Murer, P., Svec, F. and Fre’chet, J.; J. Chem. Commun ., 2237
     (1998).
88. Lewandowski, K., Murer, P., Svec, F. and Fre’chet, J.; J. Chem. Commun ., 1, 105
     (1999)
(XV)
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The chiral separation of DHPMs by capillary electro-phoresis (CE) using
quaternary ammonium-a -cyclodextrin as chiral buffer additive has also been
reported. 89
89. Wang, F., Loughling, T., Dowling, T., Bicker, G., Wyvratt,; J.Chromatogr.
     872,279,(2000).
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A preparatively  useful synthetic approach to the enantiomerically pure
antihypertensive agent (R)-SQ 32926(5) was disclosed by Atwal et al. In
the first step, the 1,4-dihydropyrimidine intermediate (XVI) is acylated at
N3 with 4-nitrophenyl chloroformate followed by hydrolysis with HCl in Tetra
hydro furan to give DHPM . Treatment with (R)-R-methylbenzileamine pro-
vided  a mixture of diastereomeric ureas from which the (R,R) isomer
was seperated by crystallization. Cleavage with trifluoroacetic acid (TFA)
provided SQ 32926(5) in high enantiomeric purity. Similar strategies have
been used to obtain a number of pharmacologically important DHPM
derivatives in enantiomerically pure form.
(XVI)
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As an alternative to the chemical resolution methods described by Atwal et
al., Kappe and co-workers developed a biocatalytic strategy toward the
preparation of enentiopure (R)- and (S)-SQ 32926 (XVII) . the key step in
the synthesis is the enzymatic resolution of an N3-acetoxymethyl-activated
dihydropyrimidone precursor  by Thermomyces lanuginosus lipase. 90
Readily available racemic DHPM91 was hydroxymethylated at N3 with
formaldehyde, followed by standard acetylation with acetyl chloride. The
r e s u l t i n g  N3 -ace toxymethy l -ac t i va ted  DHPM was  then  c leaved
enant iose lec t ive ly  by  Thermomyces lanug inosus wi th  exce l len t
selectivity(E>200). Degradation of unreacted (R) with aqueous ammonia
produced (R), which was converted into desired target structure (R) in
one step by N3-carbamoylation with trichloroacetyl isocyanate.
90. Scnell, B., Strauss, U., Verdino, P. Faber, K. and Kappe, C.; Tetrahedron:Asymetry,
      11, 1449(2000).
 91. Kappe, C., Kumar, D., Varma, R., Microwave assisted High-speed parallel
      synthesis of 4-Aryl-3,4-dihydropyrimidin-2(1H)-ones using a solventless Biginelli
      condensation Protocol, 1799 (1999).
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Over the past decade, dhydropyrimidin-2(1H)-ones and their derivatives
have attracted considerable attention in  organic and medicinal chemistry
as the dihydropyr imidine scaffold displays a fascinat ing array of
pharmacological and therapeutic properties.92,93
They have emerged as integral backbones of several calcium channel
blockers94. antihypertensive agents94a,b,c.,  antiaggregating activity. 95,
NYP-antagonist96,antiviral agents97, antitumor agents98 and cardiovascular
agents.99
Dihydropyrimidines as Pharmaceuticals.
92.   Kappe, C.; Tetrahedron 49, 6937(1999).
93.   Kappe, C. O. Acc. Chem. Res.,3 3, 879(2000 ).
94a. Cho, H., Ueda, M., Shima, K., Mizuno, A.,Hayashimatsu, M., Ohnaka, Y.,
       Takeuchi, Y., Hamaguchi, Aisaka, K., Hidaka, T., Kawai, M., Takeda, M.,
       Ishihara,T., Funahashi, K., Satah, F., Morita, M. and Noguchi, T.;
       J. Med. Chem.   32, 2399 J. Med. Chem  (1989)
   b. Atwal, K., Rovnyak, G. C., Schwartz, J., Moreland, S., Hedberg, A., Gougoutas,
       J., Malley, M. and Floyd, D. M. J. Med. Chem. 33, 1510 (1990).
   c. Atwal, K., Rovnyak, G., Kimball, S., Floyd, D. , Moreland, S., Swanson, B.,
      Gougoutas, J., Schwartz, J., Smile, K. and Malley, M. J. Med. Chem. 33, 2629
      (1990).
   d. Atwal, K., Swanson, B., Unger, S., Floyd, D., Moreland, S., Hedberg, A. and
       O’Reilly, B.; J. Med. Chem., 34, 806 (1991).
   e. Rovnyak, G., Atwal, K., Hedberg, A., Kimball, S., Moreland, S., Gougoutas,
       J., O’Reilly, B., Schwartz, J. and Malley, M.; J. Med. Chem. 35, 3254 (1992).
   f.  Grover, G., Dzwonczyk, S., McMullen, D., Normadinam, C., Sleph, P. and
       Moreland, S.; J. Cardiovasc. Pharmacol. 26, 289 (1995).
   g. Negwer, M.; Organic-Chemical Drugs and their Synonyms; Akademie Verlag:
       Berlin,  p.2558 (1994).
95a. Ertan, M., Balkan, A., Sarac, S., Uma, S., Rubseman, K., Renaud, J.;
       Arzneimittelforschung, 41(7), 725 (1991).
   b. Wong, W., Lagu, B., Nagaratham, D., Marzabadi, M., Gluchowski, C. PCT Int.
       Appl. WO 9742,956 and WO 9851311.
   c. Nagarathnam, D., Wong, W., Miao, S., Patane, M., Gluchowski, C., PCT Int. Appl.
      WO 9833,791
96.  Bruce, M., Pointdexter, G., Johnson, G., PCT Int Appl. WO 9833791
97a. Hull, R. and Swain, G.; GB 868030 (1961).
   b. McKinistry, D. and Reading, E.; J. Franklin Inst.  237, 203 (1944).
98.  Hurst, E. and Hull, R.; J. Med. Pharm. Chem. 3, 215 (1961).
99.  Khania, E., Sillinietse, G., Ozol, Ya, Dabur, G., Kimenis, A.; Khim. Pharm. Zh. 78,
      1321 (1978).
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Moreover, several alkaloids containing the dihydropyrimidine core unit have
been isolated from marine sources, which also exhibit  interesting biologi-
cal properties. Most notably, among these are the batzelladine alkaloids,
which were found to be potent as HIV gp-120-CD4 inhibitor100-103, carambine
and pentacyclic alkaloid ptilomycalin A. Ptilomycalin A was synthezised by
Overman and co-workers104,105
100. Snider, B. and Shi, Z., J. Org. Chem. 58, 3828 (1993)
101. Patil, A., Kumar, N., Vokke, W., Bean, M., Freyer, A., DeBrosse, C., Mai, S.,
       Truneh, A., Faulkner, D., Carte, B., Breen, A., Hertzberg, R., Johnson, R.,
       Westley,  J. and Pots, B; J. Org. Chem ., 60, 1182 (1995).
102. Kashman, Y., Hirsh, S., McConnel, O., Ohtani, I., Takenori, K. and Kakisawa, H.;
       J. Amer. Chem. Soc. , 111, 8925 (1989).
103. Ohtani, I., Kusumi, T., Kakisawa, H., Kashman, Y. and Hirsh, S.; J. Amer. Chem.
       Soc.,  114, 8472 (1992).
104. Overman, L., Rabinowitz, M.; J. Org. Chem. 58, 3235 (1993).
105. Overman, L., Rabinowitz, M. and Renhowe, P; J. Amer. Chem. Soc.,  117, 2657
       (1995).
106. Atwal, K., Rovnyak, G., Kimball, S., Floyd, D. , Moreland, S., Swanson, B.,
       Gougoutas, J., Schwartz, J., Smile, K. and Malley, M. J. Med. Chem. 33, 2629
       (1990)
Atwal and coworkers106 revealed that 3-substituted 1,4-dihydropyrimidines
of type (XVIII)  are potent calcium channel blocking agents in vitro . These
compounds  a re  s ign i f i can t l y  more  po ten t  than  2 -he te ro -1 ,4 -
dihydropyrimidines and sl ightly less potent than the classical 1,4-
dihydropyridines.
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In the same study it was found that ortho and / or meta aromatic substitution
(chloro, nitro, trifluoromethyl) was essential for optimal activity in vitro and that
the ester alkyl group was a major determinant of potency in vitro (isopropyl
> ehthyl > methyl). Both findings being in general accord with structure-
activity relationships previously established for dihydropyridine calcium
channel blockers, a substituent (alkyl, acyl, carbamate, sulphonyl, ureido)
on N3 of the dihydropyrimidine ring was found to be a strict requirement for
the activity and the order of the potency for the 2-hetero atom was S > O >
N .
The N3 alkyl carbamate analogs of 4-aryl-1,4-dihydro-2-thioxo(and 2-
oxo)pyrimidine generally possessed vasorelaxant potency in vitro.
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N
H
CH3 S
O
OCH3
CH3 CF3
CO2 F
The dihydropyimidone of
type (XIX)  was found to be
more  po ten t  than
amplodipine in the SHR,
causing a pronounced fall
in blood pressure that, likewise persists beyond 24 hrs. Certain analogs
bearing the sulphur atom show greater antihypertensive activity in the SHR
then the corresponding 2-oxo compounds. Another fascinating point
obsereved in this study was, that the dihydropyrimidine chiral i ty is
signif icant determinant of biological activity.
107. Rovnyak, G., Atwal, K., Hedberg, A., Kimball, D., Moreland, S., Gougoutas, J.,
       O’Reilly., B., Schwartz, J. and Malley, M., J. Med. Chem . 35, 3254 (1992).
(XIX)
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108a. Atwal, K., Swanson, B., Unger, S., Floyd, D., Morleand, S., Hedberg, A. and
         O’reilly, B.; J. Med. Chem. 34, 806 (1991).
     b. Rovnyak, G., Atwal, K., Hedberg, A., Kimball, S., Gougoutas, J., O’reilly, B.,
         Schwartz, J. and Malley, M.; J. Med. Chem ., 35, 3254 (1992).
     c. Grover, G., Dzwonczyk, S., McMullen, D., Normadinam, C., Sleph, P. and
         Moreland, S; J. Cardio. Pharmacol.,  26, 289 (1995).
109.   Goldman, S. and Stoltefuss, J.; Angew. Chem. Int. Ed. Engl., 30, 1559 (1991)
110.   Martin, P., Bachmann, B., Ganten, D. The Tissue Renin-Angiotensin System in
         Cardiovascular Disease; Trends Cardiovasc. Med. 2, 94 (1992).
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The renin-angiotensin system is also one of the important targets for the
further drug discovery110.  Renin inhibitors and angiotensin I I  (AII)
anatagonist have enjoyed considerable popularity among pharmaceutical
scentists.
 
N
N Z
CH3
H
CH3
O
O
R
X
N
N O
CONH2
H
CH3
NO2
O
OCH3
CH3
R = alkyl, Z = O, S
X = e.g. 2/3-NO2, 2-CF3
E = ester, acyl, amide
SQ 32,926
have proved to be superior
in potency and duration of
antihypertensive activity to
classical DHP drugs, and
compare favourably with
s e c o n d - g e n e r a t i o n
analogues such as
amlodipine, nicardipine108a,b
and nifedipine109
Further, it is interesting to note that dihydropyrimidines of type (XX)108
(XX)
(XXI)
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Use of both these classes of agents as potential cardiovascular drugs had
been hampered by their peptidic nature. Atwal and coworkers108 synthe-
s ized and ex tens ive ly  s tud ied the A - I I  antagon ism t ra i t s  o f
dihydropyrimidines of type (XXI). It was observed that these molecules are
potent A-II  antagonists in vitro , their potencies being similar to or better
than that of losartan (XXI-A) . So it can be said that the dihydropyrimidine
ring can mimic the imidazole ring of ,losartan (a first member of a well known
antihypertensive drugs).  Also, compound (XXI-A)  showed antihyperten-
sive activity.
The reverse transcriptase (RT) of
human immunodeficiency virus
(HIV) is an attractive target for the
development of selective inhibi-
tors. It is a multi functional enzyme
critical to the retroviral life cycle
with no counterpart in eukaryotic
systems. Currently, two functionally
distinct classes of HIV RT inhibitors
 
(nucleoside and nonnucleoside) have been discovered and are being used
clinically. Nucleoside Reverse Transcriptase Inhibitors (NRTIs), which in-
clude AZT, ddI, ddC, d4T, 3TC, abacavir, and tenofovir disoproxil fumarate,
act as DNA chain terminating analogues of the natural deoxynucleoside
triphosphates (dNTPs). They are equally active against HIV-1 and HIV-2
RT, and they can also be incorporated into cellular DNA by host DNA poly-
merases causing severe adverse reactions (XXII) . Their effectiveness is
limited by the emergence of drug-resistant mutants.
111. Yarchoan, R., Mitsuya, H., Thomas, R., Pluda, J., Hartman, N., Perno, C., Marczyk,
       K.; Allain, J., Johns, D. and Broder, S.; Science, 245, 412 (1989).
112. Richman, D.; Antimicrob. Agents Chemother., 37,  1207 (1993).
(XXII)
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On the other hand, Non-nucleoside Reverse Transcriptase inhibitors
(NNRTIs) are highly specific for HIV-1 and include more than 30 structurally
diverse classes of molecules including nevirapine, delavirdine, efavirenz,
HEPT, DABO, oxathalin carboxanilide etc as the representaives. These
molecules are highly potent inhibitors of HIV-1 RT, with low toxicity and
favourable pharmacokinetic characteristics, but are not capable of inhibiting
clinically resistant mutants.
 
NH
N
H
CH3 S
O
O
CH3
OH Another highlight in the context of the hypertensive
therapy has been the structurally simple DHPM drug
known as monastrol. It is a  novel lead molecule for
the development of new anticancer drugs. Monastrol
(±)  (XXIII)   has been identified as a compound that
specifically affects cell-division  (mitosis)  by a new
113. Mayer, T., Kapoor, T., Haggarty, S., King, R., Schreiber, S. and Mitchison, T.;
      Science, 286, 971 (1999).
114. Manvar, D.; Ph. D. Thesis, Saurashtra University (2005).
115. Biginelli, P.; Gazz. Chim. Ital. 23, 360 (1893).
Monastrol
mechanism which does not involve tubulin targeting. It has been established
that the activity of (±) consists of the specific and reversible inhibition of
the motility of the mitotic kinesin Eg5, a motor protein required for spindle
bipolarity.
In continuation of the search of molecules which gratifies the requirements
of dihydropyrimidines, compounds with novelty in the structure were
synthesised for the first time 114 using the classical Biginelli Reaction115 for
synthesis of DHPMs.  In the present chapter, the novelty of the structures
lies in the fifth carbon atom where the acetyl or ester group of the classical
DHPM is replaced by the phenyl carbamoyl moiety.
(XXIII)
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The phenyl carbamoyl moiety in case of dihydropyridine scaffold has proved
to be proficient in treatment of various disorders, already described in
chapter 1. In parallel to the study of DHP containing phenyl carbamoyl
residue, the title DHPM compounds were synthesized and evaluated for
the biological activity.
All the substituted anilines, ethyl acetoacetate, urea, hydrochloric acid,
methanol, substituted benzaldehydes were obtained from the commercial
sources. Melting points of the synthesized dihydropyrimidines were taken
in open capillary bath on controlled temperature (using standard Zeal’s
thermometer (UK)). The cyclization of the DHPMs were carried out in
methanol as the solvent. The corroborat ion of commencement of the
reaction and puri ty of the DHPMs  was carr ied out using thin layer
chromatography (TLC; sil ica gel-G, used as stationary phase, the TLC
plates were purchased from MERCK India Ltd., Ethyl acetate and Hexane
(5:5) were employed as mobile phase.
Mechanistic Study
The Key step in this reaction is the formation of an N-acyliminium ion inter-
mediate of type 5  from the aldehyde 2  and urea 3  precursors. Interception
of the iminium ion 5  by ethylacetoacetate 1  presumably through its enol
tautomer, produces an open chain ureid 6  which subsequently cyclizes to
hexahydropyrimidine 7 . Acid-catalysed elimination of water from 7 ultimately
leads to the final DHPM product 8 . The reaction mechanism can therefore
be classified as an a-amidoalkylation or as an  a -ureidoalkylation.
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Reaction Scheme
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Substituted anilines
Ethyl acetoacetate Substituted
acetoacetanilides
Substituted 6-methyl-2-oxo-N ,4-diphenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide
Urea
Substituted
acetoacetanilides
Substituted
benzaldehydes
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Synthesis of Substituted Acetoacetanilide (Reaction scheme 1)
It was prepared according to method mentioned in Chapter - 1 on page
no.31.
Synthesis of N-(substituted phenyl)-4-(substituted phenyl)-6-methyl-
2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (Reaction scheme
2)
A mixture of substituted acetoacetanilide (0.01 mole), substituted benzal-
dehyde (0.01 mole)  and urea (0.015 mole) in minimum quantity of metha-
nol was heated in waterbath for 10 minutes in a 100 ml round bottom flask.
Thereafter, catalytic amount of conc. HCl (5-6 drops) was added to the re-
action mixture, when the clear solution was obtained and refluxed for 10
hrs. The flask was removed form the waterbath and allowed to cool down
to room temperature. On cooling the crystal of dihydropyrimidines were
obtained which were filtered and recrystallized from DMF to give title com-
pounds (Dihydropyrimidines, APD-1 to APD-18)
All the compounds of the series were prepared according to above men-
tioned method.
The physical data of newly synthesized compounds are recorded and given
in Table 3.
It was observed that the elemental analysis of the compounds matched with
that of calculated elemental analysis.
Method of Synthesis
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Spectral data of only key intermediate and final compounds are included.
using the instrument, SHIMADZU  FT IR-8400, Sample technique,  KBr
pel let,  Frequency  range, 400-4000 cm-1
Looking to the spectral study of the newly synthesized (dihydropyrimidines)
molecules.   the carbonyl (>C=O) of the amidic  functionality stretching was
observed at 1655-1690 cm-1 and another ketonic group (NHCONHstr.) was
observed at approximately at 1700 - 1715 cm-1 due to the amidic carbonyl
of DHPM residue. The other confirmation of amide group (>C-N stretching )
was found in range of approximately 1500-1520 cm-1.
The stretching of secondary amine (>NH) appears approximately around
3100 - 3200 cm-1 which indicates the presence of -NH- in the compound.
The stretching C-N appears at 1501-1592 cm-1.
The C-H stretching of aromatic moiety was observed at approximately 2800-
2990 cm-1. C-C multiple bond stretching, C-H inplane bending and out of plane
bending were observed at 1400 - 1600 cm-1 and 810 - 730 cm-1 respectively.
Please refer to pg no. 147,148 for the IR spectra with the details of the
various frequencies for the compounds coded APD-3, APD-4, APD-8 and
APD-10.
Spectral Analysis (IR)
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IR Spectrum of N-(3-chloro-4-fluorophenyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide
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Type Vibration Mode Frequency (cm-1)
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Methyl C-H str (asym) 2853
Amide
C=O str 1652
C-N str 1510
NH-CO-NH str 1707
Aromatic
C=C ring
1580
1403
0op bending
855
769
Type Vibration Mode Frequency (cm-1)
Amine >NH-str 3114
Methyl C-H str (asym) 2924
Amide
C=O str 1698
C-N str 1500
NH-CO-NH str 1713
Aromatic
C=C ring 1601,1629
1394
0op bending 814
734
NH
N
H
O CH3
NH
O
N
+
O
-
O
C l
C l
APD-3
IR Spectrum of N-(3-chloro-4-fluorophenyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide.
APD-3
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IR Spectrum of N-(2,4-dimethylphenyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide
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IR Spectrum of N -(4-chlorophenyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide
Type Vibration Mode Frequency (cm-1)
Amine >NH-str 3117
Methyl
C-H str (asym) 2926
C-H str (sym) 2853
Amide
C=O str 1671
C-N str 1505
NH-CO-NH str 1703
Aromatic
C=C ring 1644, 1397
0op bending
815
756
Type Vibration Mode Frequency (cm-1)
Amine >NH-str 3109
Methyl C-H str (asym) 2926
Amide
C=O str 1667
C-N str 1515
NH-CO-NH str 1708
Aromatic
C=C ring 1626,1615
1592, 1492
0op bending 819
738
APD-4 APD-10
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Instrument used for the NMR spectroscopy of the newly synthesized DHPMs
was BRUKER AC 300 MHz FT-NMR, where TMS  was used as the Internal
reference and CDCl3 or DMSO d 6 were used as solvent. NMR also plays a
key role in prooving the enantiomeric purity which is evident in an impor-
tant study* where it was clearly observed that the signal due to C4 proton
(chiral carbon proton) at d 6.6 and d 6.7 showed baseline separation and
could be easily integrated for the two isomers. The other standard signals
for DHPM moiety were also observed in the same study.
Spectral Analysis (NMR)
Especially, the 3H of methyl group showed a singlet at approximately d
2.35. The two protons of the carbon atoms adjacent to the nitro group bearing
carbon atom are less shielded due to which they showed the multiplet in
the downfield d = 8.2.
In another such study**  it was observed that the two protons of N1 and N2
were observed in the downfield (d = 9.18 d = 9.82)because the downfield
absorptions are due to deshielding.
Now, looking to the newly synthesized DHPMs (APD-series ), there are
certain proton signals common in all the dihydropyrimidines which are as
follows.
* Atwal, K., Rovnyak, G. ,Kimball, B., Floyd, D., Moreland, S., Swanson, B., Gougoutas,
J., Schwartz, J., Smillie, K. and Malley, M.; J. Med. Chem. 33, 2629 (1990)
**Bose, S., Sudharshan, M. and Chavhan, S.; Arkivoc, 228 (2005)
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Following are the common signals observed in APD-1, APD-2, APD-3, APD-
4 and  APD-5
¨ The methylene protons (-CH3) adjacent to the N1, are most shielded and
gave a sharp singlet at approximately 1.5 - 4.0 d ppm is observed.
¨  The proton of the chiral carbon (>CH-) in all DHPM compounds was ob-
served between 4.0 - 6.0 d ppm depending on substitutions.
¨  The signals due to protons of N1, N3 and Nitrogen (N) of the carbamoyl
moiety were observed in the downfield i.e. around  7.0-10.0 d ppm. The
signals due to proton attached to nitrogen atom may not be traceable in
many cases as evident from the NMR spectra of different molecules in the
subsequent pages.
Now, in case of APD-1, the two protons adjacent to the carbon bearing
hydroxyl group gave a doublet due to ortho coupling which is evident from
the coupling constant J = 7.5 Hz. The two protons adjacent to the carbon
atoms attached to the chiral carbon are seen at the most upfield as com-
pared to the aromatic protons. It was evident from the J value of the dou-
blet, 8.1 Hz. The proton of C4 on the phenyl carbamoyl residue gave the
signal at 6.88 d ppm. This signal splitted into triplet due to ortho coupling
having J = 7.5 Hz. The ortho-meta coupling is not visible in the spectrum. A
multiplet was observed due to the protons of the C5’ and C 6’  of phenyl car-
bamoyl residue having coupling constants of 8.9 and 8.4 Hz
In case of APD-2, protons of the C 3’  and C 5’  of the phenylcarbamoyl residue
shows the most deshielded signals at 7.58 d ppm. and the C 2’  and C 6’  gave
a doublet at 7.49 d ppm. Proton adjacent to the carbon atom bearing
hydroxyl group showed a doublet  at 6.75 d ppm with coupling constant,
8.49. This gives the evidence of ortho coupling. Protons at C2 and C3
positons of the phenyl ring at C 4 (chiral carbon of DHPM nucleus) showed
a doublet at 7.11 d ppm with J = 8.49 Hz indicating the ortho coupling.
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In the NMR spectrum of APD-3 , the two protons adjacent to the carbon
bearing nitro group is the most deshielded in the downfield, at 8.22 d ppm.
This signal is seen to be splitted into a doublet due to ortho coupling and it
is further evident from the value of coupling constant J = 8.7 Hz.  Protons of
the third carbon atom of phenylcarbamoyl moiety gave doublet at 7.45 d
ppm due to ortho coupling with the neighbouring proton. The proton of the
C4 atom showed meta coupling (J = 2.1 Hz) as well as ortho coupling (J =
8.7 Hz) resulting into a doublet of doublet at 7.25 d ppm.
In the NMR spectrum of APD-4, a doublet was observed at 2.13 d ppm due
to the two methyl groups of the phenyl carbamoyl residue.  The three car-
bon atoms of the same phenyl ring showed a multiplet at 6.94 d ppm.Two
protons adjacent to the carbon atom bearing nitro group are seen in the
downfield. with J = 8.1 Hz.
In the NMR spectrum of APD-5, the two protons adjacent to carbon having
nitro group show the signal (doublet) due to ortho coupling (J = 9 Hz) at 8.14 d
ppm the coupling constant J = 7.5 Hz. The two protons adjacent to the car-
bon atom adjacent to the carbon atom attached to chiral carbon showed
the most upfield absorptions as compared to the aromatic protons. It was
evident from the J value of the doublet, 8.1Hz.
The proton of C 4’  of the phenylcarbamoyl residue gave the signal at 6.88 d
ppm. This signal splitted into a triplet due to ortho-ortho coupling, having
J = 7.5 Hz.
The proton of C 4 of the phenyl ring of DHPM nucleus shows a clear doublet
at 7.44 d ppm with J = 8.1 Hz indicating the ortho coupling. And the proton
at C6 of the same phenyl residue, show a multiplet at 7.26 d ppm due to
ortho coupling as well as two meta coupling.  Looking at the phenyl residue
of the phenylcarbamoyl moeity, it is observed that the fifth carbon atom
proton shows the absorption as a doublet due to the ortho coupling (J = 7.8
Hz) at 7.06 d ppm.
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And the rest three protons of the same phenyl residue shows at 7.71 d ppm
with J = 8.1 Hz  for ortho coupling. Hence the NMR spectrum gives a pic-
ture of the nuclei in the molecule.
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APD-1
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F
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4a
1H NMR Spectrum of N-(2-fluorophenyl)-4-(4-hydroxyphenyl)-6-methyl-2-oxo-
1,2,3,4-tetrahydropyrimidine-5-carboxamide.
No.
Chemical
Shift Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 3.79 s 3H (16) -
2. 5.19 s 1H (4a) -
3. 6.748 d 2H (9,13)
J9-10=J13-12 =
8.1
4. 6.880 t 1H (22) J22-23=J22-21
= 7.5
5. 7.013 m 2H (23,24)
J = 8.9
J = 8.4
6. 7.099 d 2H (10,12)
J10-9=J12-13 =
7.5
No.
Chemical
Shift Multiplicity
No. of
Protons
Coupling
Constant(J)
7. 7.604 s 1H (3) -
8. 7.911 d 1H (21) J21-22 = 7.5
9. 8.95 s 1H (18) -
10. 9.39 s 1H (1) -
11. 10.41 s 1H (17) -
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APD-2
1H NMR Spectrum of N-(4-chlorophenyl)-4-(4-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide.
No.
Chemical
Shift
Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 2.497 s 3H (8) -
2. 4.8901 s 1H (6a) -
3. 6.753 d 2H (13,15)
J13-12=J15-16
= 8.49
4. 7.112 d 2H (12,16)
J12-13=J16-15
= 8.49
5. 7.348 d 2H (20,22)
J22-23=J20-19
= 8.49
No.
Chemical
Shift
Multiplicity
No. of
Protons
Coupling
Constant(J)
6. 7.583 d 2H (19,23)
J23-22=J19-20
= 8.49
7. 7.674 s 1H (1) -
8. 9.413 s 1H (17) -
9. 9.929 s 1H (3) -
10. 10.378 s 1H (24) -
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APD-3
1H NMR Spectrum of N -(2,5-dichlorophenyl)-6-methyl-4-(4-nitrophenyl)-2-oxo-
1,2,3,4-tetrahydropyrimidine-5-carboxamide.
No.
Chemical
Shift
Multiplicity
No. of
Protons
Coupling Constant(J)
1. 2.178 s 3H (16) -
2. 5.480 s 1H (4a) -
3. 7.251 dd 1H (23) -
4. 7.454 d 1H (22) J23-22=8.7; J23-25=2.1
5. 7.587 m
3H
(9,13,25) J9-10=J13-12 =8.7; J25-23=1.7
6. 7.823 s 1H (3) -
7. 8.215 d
2H
(10,12) J10-9=J12-13=8.7
8. 9.006 s 1H (1) -
9. 9.270 s 1H (19) -
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1H NMR Spectrum of N-(2,4-dimethylphenyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide
No.
Chemical
Shift Multiplicity No. of Protons
Coupling
Constant(J)
1. 1.881 s 3H (15) -
2. 2.131 d 6H (27,28) -
3. 5.538 s 1H (2a) -
4. 6.940 m 3H (20,22,23) J = 8.1
5. 7.729 m 3H (22,25,24) J = 7.8
6. 8.175 d 2H (12,14) J = 10.5
7. 8.852 s 1H (17) -
8. 9.037 s 1H (5) -
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1H NMR Spectrum of 6-methyl-N-(3-methylphenyl)-4-(3-nitrophenyl)-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxamide
No.
Chemical
Shift
Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 2.081 s 3H (8) -
2. 5.521 s 1H (6a) -
3. 7.057 d 1H (21)
J24-23=J24-25
= 7.8
4. 7.259 m 1H (24) J = 8.1
5. 7.711 m
3H
(8,12,23)
J25-24=J23-24
= 8.1
No.
Chemical
Shift Multiplicity
No. of
Protons
Coupling
Constant(J)
6 7.438 d 1H (12) J = 8.1
7. 7.813 s 1H (3) -
8. 8.135 d 2H (9,11) J9-8=J11-12=9
9. 8.975 s 1H (19) -
10. 9.787 s 1H (1) -
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Spectral Analysis (Mass)
For the current study, Instrument used was JEOL SX 102/DA-6000 for FAB
(Fast atom Bombardenment). The molecular ion peaks (M+) of  the com-
pounds  in mass spectra  were in total agreement  with it’s molecular weight.
The Mass spectra of the compounds were given on page no.151-153.
In case of APD-7, molecular weight, 352,  M+1 peak (m/e = 353) and M+2
(m/e = 354) are observed.
In case of APD-2, molecular weight = 358, M+ peak (m/e = 358) and M-1
peak (m/e = 357) are observed.
And in case of APD-4, molecular weight = 380, the spectrum shows the
presence of the M+1 and M-1 peaks at m/e = 381 and m/e = 379 respec-
tively.
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Synthesis and X-Ray crystallographic Studies
of 3-nitro / 3-sulpho coumarins
CHAPTER-4
 Coumarins, 165
Coumarin (1,2-Benzopyrone) is structurally the least complex member of a
large class of compounds known as benzopyrones
Flavane is the progeniter of three important core molecules (I) i.e. Coumarin
(2H-1-benzopyran-2-one), the 1-benzopyrylium ion and the flavylium ion (2-
phenyl-1-benzopyrylium ion).
 
O O O
+ O O
Coumarin 1-benzopyrylium ion Flavylium ion
Coumarins comprise a very large class of compounds found throughout
the plant kingdom1,2. Particularly the plants belonging to the natural orders
of Orchidaceae, Leguminoceae, Rutaceae, Umbelliferae, and Labiatae are
rich sources of naturally occurring coumarins3. ( and also in strawberries,
apricots, cherries, and cinnamon. Coumarin smells like vanilla but has little
bitter flavour. It is found in high percentages in the tonka bean (Dipteryx
odorata,  Fabaceae (Pea) Family) from which it was first isolated in 1820.
1. R.D. Murray, J. Mendez, S.A. Brown, The Natural Coumarins: Occurrence Chemistry
and Biochemistry, Wiley, UK, (1982).
2. Egan, D., R. O’Kennedy, Moran, E.,  Thornes, R.; The pharmacology, metabolism,
analysis and applications of coumarin and coumarin related compounds, Drug Metab.
Rev . 22 (5), 503 (1990).
3. Spath, E.:  Ber.  70A. 53 (1937).
Introduction and the Exploration of Chemical Facets
(I)
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4-Hydroxycoumarin comprises the structural nucleus of an ample number
of important drug entities. The efficient synthesis of this simple but imerative
scaffold has been copiously reported in the literature.
The various synthetic methods of 4-hydroxy coumarin can be
summarised as follows.
Cl
O
O
COCH3
Na HC
COOEt
COOEt
aq. KOH-
Na HC
COOEt
COCH3
aq. KOH-
O O
R
OH
Anschutz’s method
4. Anshutz, R.; Ber., 36, 465
   (1903)
CH3
O
O
COCH 2R
+ R
EtOOC
EtOOC O O
R
OH
5. Stahmann, M., Wolff, T. and
    Link, K.; J. Amer. Chem.
    Soc., 65, 2285 (1943).
O
COCH 3
OR
O
Molten Sodium
O O
CH3
OH
6. Pauly, H., Lokemann, K.,
    Ber., 48, 28 (1915).
Pauli and Lockemann method
CH3
O
O
COCH2R
+ R
EtOOC
EtOOC O O
R
OH
Urbain and Mentzer’s method
7a.Urbain, G. and Mentzer, C.,
    Bull. Soc. Chim. , 11, 171
    (1944); C.A. 40, 2815
    (1945).
  b. Mentzer, C., Molho, D. and
    Vercier, P.; Bull. Soc. Chim.,
    749 (1949); Chem. Abstr.
    44, 3983 (1950)
OHOH
+
CN
COOEt
ZnCl2
HCl COOEt
OHOH
70% H2 SO4
O OOH
Hoesch reaction
8a.Hoesch, K.; Ber., 48, 1122
     (1915).
  b. Bauer, A. and Schoder, S.;
   Arch. Pharm., 259, 53   (1929)
 c. Sonn, A.; Ber. , 50, 1292
     (1917).
 d.  Amiard, G. and Allais, A.;
Bull. Soc. Chim.  512 (1947).
OCH 3
H3CO
+
Cl
Cl
O
O
AlCl
3
O O
OH
H3CO
Synthesis Method of Garden and Co-workers
9. Garden, J., Hayes, N. and
      Thomson, R.; J. Chem.
      Soc. 3315 (1956).
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Other synthetic approaches to coumarin derivatives, including pericyclic
reactions15, oxidations promoted by monoelectronic agents16, utilizing
iminium salts as intermediates17, functionalisation induced by transition-
metal catalysts18 and a variety of alkylation methods19. Apart from these, a
novel approach to coumarin derivative has been explored under high-
intensity ultra sound (US) catalysis, generally in aqueous heterogenous
systems.20 US  assisted reaction often boost rates and yields, sometimes
promoting unexpected regioselectivity. 21
15. a. Appendino, G., Cravotto, G., Tagliapietra, S., Nano, G. and Palmisano, G.; Helv.  Chim.
          Acta , 73, 1865 (1990)
      b. Appendino, G., Cravotto, G., Palmisano, G., Annunziata, G. and Toma, L.; J. Org. Chem . ,
         59, 5556 (1994)
16. a. Appendino, G., Cravotto, G., Palmisano, G., and Annunziata, R.; Synth. Commun.  26,
         3359 (1996)
       b. Appendino, G., Cravotto, G., Palmisano, G., and Annunziata, R.; Tetrahedron , 54, 10819
         (1998).
17. Cravotto, G., Nano, G., Tagliapietra, S.; Synthesis , 49 (2001).
18. Cenini, S., Cravotto, G., Giovenzana, G., Palmisano, G., and Tollari, S.; Tetrahedron , 55,
      6577 (1999).
19. a. Appendino, G., Cravotto, G., Nano, G., Palmisano, G., Synth. Commun.,  22, 2205 (1992)
      b. Cravotto, G., Tagliapietra, S., Nano, G., Palmisano, G.; Heterocycles  in press.
20. Cravotto, G., Nano, G., Palmisano, G. and Tagliapietra, S.
21. a. Cintas, P., Luche, J.-L., Green Chem ., 1, 115 (1999).
      b. Low, C., Ultrasonics Sonochem.  2,153 (1995).
      c. Luche, J.-L., Ultrasonics , 30, 163 (1992).
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The third and the fourth positions of the coumarin skeleton plays the key
role in the reactivity and biological activity of the molecule. The substitution
reactions like bromination, nitration, sulphonation, diazocoupliong etc of
the 4-hydroxy coumarin has been well revealed in the literature.
The nitration of 4-hydroxycoumarin (VII) was effectuated first time by
Huebner and Link31.
The suspension of 4-hydroxycoumarin in glacial acetic acid along with
concentrated nitric acid in acetic acid was heated at 80 o C to yield the
3-nitro 4-hydroxycoumarin. The prolonged nitration with fuming nitric acid
in sulphuric acid gives 3,6-dinitro-4-hydroxycoumarin.
In another method of synthesis32 of 3-nitro derivative, the fuming nitric acid
was added dropwise to the solution of 4-hydroxycoumarin in chloroform.
The reaction mixture was allowed to stand for several hours. Chloroform
was removed under vacuum to get 3-nitro 4-hydroxycoumarin.
31a. Huebner, C. and Link, K.; J. Amer. Chem. Soc. 67, 99 (1945); 39,
       1401 (1945).
   b. Mentzer, C. and Meunier, F.; Compt. Rend 225, 1329 (1947).
32.   Klosa, J., Pharmazie, 8, 221 (1953); Chem. Abst . 48, 7602f (1954).
O O
OH
O O
OH
N
+
O
-
O
Gl.AcOH, HNO3
(VII)
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which was t reated wi th
phophorous oxychloride in
dimethyl formamide to give
The latter condensed with
the appropriate amine to
g ive  a ry l  /  a l ky l  amine
der i va t i ve  o f  3 -n i t ro
coumarin36(XI). It was also
Govori and co-worker39 prepared different 4-heteroaryl-3-nitrocoumarins
(XII), by reacting 4-chloro-3-nitrocoumarin31a with 2-amino thiazole, 2-amino
pyridines and 2-amino pyrimidines, and studied the reactions of it with
either aqueous tetrabutylammonium bisulphate/sodium hydroxide in a two
phase system or 5% aqueous sodium hydroxide and obtained a product
wich is similar to starting product.
4-Hydroxycoumarin was nitrated in acetic acid by 72% Nitric acid to give
nitrocoumarin O O
OH
O O
OH
N
+
O
-
O
Gl.AcOH, HNO3
O O
Cl
N
+
O
-
O
POCl3 / DMF
O O
NH-R
N
+
O
-
O
R-NH2
4-Hydroxycoumarin 3-nitro 4-Hydroxycoumarin
4-chloro-3-nitro coumarinaryl / alkyl derivative
R = aryl / alkyl(XI)
found that the 3-acetyl-6-nitrocoummarin, when reacted with  indole, gave
ring cleavage decarbonyl addit ion product37.  Also when 3-nitro-4-
hydroxycoumarin was reduced using Na2S2O4, it efficiently yielded 3-amino-
4-hydroxycoumarin38
 O O
NH N
X
NO2
R
Bu4NHSO4
Aq. NaOH/ CH 2Cl2
O OH
N N
X
NO2
R
X=CH, N etc...
(XII)
36. Savel’ev, V., Artamonova, O., Troitskaya, V., Vinokurov, V., Zagorevskii,; Khimiya
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Coumarin (a benzopyrone), and its hydroxy derivatives of which have been
prominently accepted as natural  pharmaceuticals41 world-wide, has revealed
new biological activities with interesting therapeutic applications, besides their
traditional employment as anticoagulants (anti-vitamin K activity)42 and
suntanning agents (photosensitizing action of furocouamrins)43 and also as
antibiotics (novobiocin and analogs44) and anti-AIDS45.
Coumarins as Pharmaceutical Entities
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neurotropic54, immunosuppressive55, antiinflammatory56, antiulcerous57,
anti-PAF (anti platelet activating factor)58 and antimutagenic59 effects.
The other applications of coumarins have also been reported in the literature
like in manufacturing of laser dyes60 and pesticides61.
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Z CH2 N N Y CH2 X
O O
NO2
OH
R
As mentioned earlier, the 3-nitro coumarins of type (XV)67 are of value in
the prophylaxis and treatment of diseases whose symptoms are controlled
by the mediators of the allergic response, for example asthma, hay-fever,
rhinitis and allergic eczema. To be more specific, these compounds inhibit
rat passive peritoneal anaphylaxis and antagonise the spasmogenic effects
of histamine on isolated guinea pig ileum. These coumarins are prepared
by nitration of the substituted coumarin derivatives. The nitration was
effectuated by employing any of the two conventional methods.
1. Acetic acid  and concentrated nitric acid
2. Fuming nitric acid in chloroform.
The nitro derivative formed may be pure enantiomer as well as racemic
mixtures depending upon the substitution.
62.  Thornberry, N. , Chapman, K., and Nicholson, D.; Methods Enzymol.,322, 100 (2000).
63.  Rano, T., Timkey, T., Peterson, E., Rotonda, J., Nicholson, D., Becker, J., Chapman,
      K. and Thornberry, N.; Chem. Biol.,4, 149 (1997).
64.  Sheppeck, J., Kar, H., Gosink, L., Wheatley, J., Gjerstad, E., Loftus, S., Zubiria, A.
      and Janc, J.; Bioorg. Med. Chem. Lett., 10, 2639 (2000).
65.  Kelly, J., Slator, G., Tipton, K., Williams, C. and Bauer, K. J. Biol. Chem.,  275,
      16746 (2000).
66.  Lee, T. and Lawrence, D.; J. Med. Chem., 42, 784 (1999).
67.  Buckle, D. and Smith, H.; US4263299 (1981).
Z = Cl, Br, H; Y = Alkylenes and
hydroxyalkylenes; X = Alkylenes and
hydroxyalkylenes; R= alkyl or H
A variety of combinatorial libraries containing the coumarin ring have
appeared in the literature. A number of these libraries utilize this scaffold
to cap the N-terminus 62 and/or C-terminus of peptide-based libraries.63-66
In  the  la t te r  case,  the  s t ruc ture  most  commonly  used is  7 -amino-
4-methylcoumarin.
(XV)
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Finn and coworkers75 established that 6-nitro-7-hydroxy Coumarin and
3,6,8-tri nitro-7-hydroxycoumarin are capable of inhibiting the proliferation
of carcinoma derived skin cells, compared to those of noncarcinoma origin
75.  Finn, G., Creaven, B. and  Egan, D.; Study of the in vitro cytotoxic potential of
       natural and synthetic coumarin derivatives using human normal and neoplastic skin
      cell lines, Melanoma Res.,  11, 461 (2001).
76.  Finn, G.,  Creaven, B. and Egan, D.; Cancer Letters 214, 43 (2004).
77.  Finn, G., Emma, K., Creaven, B. and Egan, D.; In vitro cytotoxicity and mechanism
      of action of selected coumarins, using human renal cell lines, Cancer letters , 183,
      61 (2002).
The primary characteristic of any anticancer drug is to selectively inhibit
rapidly proliferating cancerous cells and the anti-proliferative capability of
a series of natural and synthetic coumarins in a malignant melanocyte cell
line was studied in detail77.
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OH
N
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+
O
-
O
(XVIII)
Later on, in continuation of this  study, the selectivity and reversibility of the
cytotoxic effects of drug exposure were evaluated along with elucidation of
the mechanism of action of these two novel nitro-derivatives (XVIII) . The
nature of the cytotoxicity effects were observed, along with their effects on
key cellular events such as DNA synthesis and regulation of cell cycle
progression 76.
 Coumarins, 183
The reactions of 4-hydroxycoumarin-3-sulphonic acid have been studied81,
in which the 4-hydroxycoumarin-3-sulphonic acid was prepared by the
standard method i.e dropwise addition of chlorosulphponic acid to the
solution of 4-hydroxycoumarin in dioxan. The potassium salts of substituted
sulphonic acids were reacted with POCl3 for 4 Hrs to get the corresponding
sulphonyl chlorides which were further allowed to react with the liquor
ammonia to yield the respective sulphonamides (XX).
The coumarin-6-sulphonyl chlor ide were also prepared by react ing
4-hydroxycoumarin with chlorosulphonic acid82.
 
O O
OH
SO3K
POCl3
O O
OH
SO2Cl
NH3
O O
OH
SO2NH2
81. Silvio, C., Vettori, P., Lorenzo, Alberti, B., Massimo; Gazzetta Chimica Italiana ,
     97(12), 1749 (1967).
82. Sen and Chakravarti, J. Indian. Chem. Soc., 5, 433 (1928).
This new revealations have thrown light on reinvestigation of entire work
done on nitrated 4-hydroxycoumarins especially at third and other positions.
The present work deals with synthesis, characterization and x-ray crystal
structure of these two bioactive series.
(XX)
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Method of Synthesis
Substituted 4-Hydroxycoumarins12a,b
Substituted Phenol (0.1mole) and malonic acid (0.1 mole) were added to a
mixture of phosphorous oxychloride (40 ml) and anhydrous zinc chloride
(30 g) and the reaction was heated on a waterbath at 70 o C for 12 hrs. It
was cooled and deomposed with ice and water to afford a yellow solid,
which was filtered and washed with water. It was then digested in 10 %
sidium carbonate and filtered. The filttrate was slowly acidified with dil.
hydrochloric acid. At the neutral point, some oily product separated, which
was removed and the filtrate further acidified to yield solid product which
was filtered, washed with water, dried and recrystallized from dilute ethanol.
The other compounds are also prepared and they were further used for
next steps. Various 4-hydroxycoumarins synthesized are as follows and their
melting points12a,b are also given.
M.P o C
4-hydroxy coumarin 210-212
4-hydroxy-6-methyl coumarin 253-254
4-hydroxy-8-methyl coumarin 227-229
4-hydroxy-7-methyl coumarin 226-227
4-hydroxy-5-methyl coumarin 232-233
4-hydroxy-5,7-dimethyl coumarin 210-211
4-hydroxy-5,8-dimethyl coumarin 261-262
4-hydroxy-6,7-dimethyl coumarin 246-247
4-hydroxy-6,8-dimethyl coumarin 244-245
4-hydroxy-7,8-dimethyl coumarin 236-237
4-hydroxy-6-phenyl coumarin 255-256
4-hydroxy-8-phenyl coumarin 235-237
5,6-benzo-4-hydroxycoumarin 280-281
4,7-dihydroxycoumarin 266-267
4,7-dihydroxy-5-methylcoumarin 265-266
4,5,7-trihydroxycoumarin 249-250
4,7,8-trihydroxycoumarin 256-257
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asymmetric and 1330 cm-1 for the symmetric vibrations. Also C-N stretching
vibrations at 786 cm-1
In case of APC-8, the lactonic carbonyl group which shows absorption at
1729 cm-1 , SO2 of the sulphonic acid group is readily identified by the two
strong bands at 1326 and 1346 cm-1 and two bands at 1346 and 1178 cm-1.
These are due to asymmetric and symmetric stretching vibrations respec-
tively. -SO3H group is also recognised by the broad -OH band at 3401 cm
-1.
In case of APC-9, the lactonic carbonyl group which shows absorption at
1699 cm-1, SO2 of the sulphonic acid group is readily identified by 
 two strong
bands at 1213 and 1159 cm-1 and two bands at 1041 and 1008 cm-1. These
are due to asymmetric and symmetric stretching vibrations respectively. -
SO3H group is also recognised by the broad -OH band at 3384 cm
-1.
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IR Spectrum of 4-hydroxy-6-methyl-2-oxo-2H-chromene-3-sulfonic acid
Type Vibration Mode Frequency (cm-1)
Hydroxy -OH b 3454
Aromatic
C-C skeletal
vibrations 1607, 1528
C-H in plane
deformation
1164
C-H out of plane
deformation
668
Carbonyl >C=O str 1729
Nitro
Aromatic, C-NO 2
str
1488 (asym)
C-N Str 834
Type Vibration Mode Frequency (cm-1)
Hydroxy (-OH
of lactone
residue and
that of SO3H
gropu)
-OH b 3384
Aromatic
C-C skeletal
vibrations 1612,1560
C-H in plane
deformation
1172
C-H out of plane
deformation
692
Carbonyl >C=O str 1699
Sulphonic acid
-SO2 asym and
sym str.
1213,1159 (sym)
APC- 8 APC- 9
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In case of APC-8, the two protons at seventh and eight carbon atom shows
a multiplet at 7.233 d ppm. Proton at ninth carbon atom couples with two
ortho protons and one meta proton resulting into splitting of the signal into
a triplet with J = 1.5 Hz. Also proton at tenth carbon atom shows a doublet
at 7.917 d ppm with J= 1.5 Hz (meta coupling).
In case of APC-9, the three methyl protons in the benzenoid part are at
2.409 d ppm. Protons at seventh and eight positions gives a sharp singlet
at 7.132 and 7.382  d ppm respectively. A sharp singlet at 7.709 d ppm is
obtained due to proton of C 8.
Spectral Analysis (Mass)
For the current study, Instrument used was JEOL SX 102/DA-6000 for FAB
(Fast atom Bombardment) . The molecular ion peaks (M+) of  the compounds
in mass spectra  were in total agreement  with it’s molecular weight.  The
Mass spectra of the compounds were given on subsequent pages.
In case of APC-1 , Molecular Weight, 201,  M+ peak (m/e = 201), potassium
adduct, (m/e = 246)
In case of APC-2 ,Molecular Weight, 221, M +  peak (m/e = 221),
And in case of APC-9, Molecular Weight, 256,  M +  peak (m/e = 256).
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1 HNMR Spectrum of 4-hydroxy-6-methyl-3-nitro-2H-chromen-2-one
No.
Chemical
Shift
Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 2.485 s 3H (15) -
2. 7.252 t 1H (7) J7-8 = 8.5
3. 7.673 dd 1H (8) J
8-10
 = 3.9
4. 7.908 s 1H (10) -
5. 14.394 s 1H (14) -
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APC-9
No.
Chemical
Shift
Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 2.409 s 3H (15) -
2. 7.709 s 1H (10) -
3. 7.387 d 1H (8) J8-7 = 9
4. 7.132 d 1H (7) J
7-8
 = 8.4
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O(1)-C(12) 1.366(2)
O(1)-C(15) 1.374(2)
N(2)-O(4) 1.203(2)
N(2)-O(7) 1.251(3)
N(2)-C(11) 1.433(2)
O(3)-C(15) 1.203(2)
O(5)-C(8) 1.300(3)
O(5)-H(5) 0.9600
C(6)-C(12) 1.389(3)
C(6)-C(14) 1.406(2)
C(6)-C(8) 1.441(3)
C(8)-C(11) 1.389(2)
C(9)-C(13) 1.379(4)
C(9)-C(12) 1.389(3)
C(9)-H(9) 0.9600
C(10)-C(13) 1.377(4)
C(10)-C(14) 1.382(4)
C(10)-H(10) 0.9599
C(11)-C(15) 1.447(3)
C(13)-H(13) 0.9599
C(14)-H(14) 0.9600
C(12)-O(1)-C(15) 123.44(16)
O(4)-N(2)-O(7) 120.81(18)
O(4)-N(2)-C(11) 121.38(19)
O(7)-N(2)-C(11) 117.80(16)
C(8)-O(5)-H(5) 179.8
C(12)-C(6)-C(14) 119.21(18)
C(12)-C(6)-C(8) 117.90(15)
C(14)-C(6)-C(8) 122.88(19)
O(5)-C(8)-C(11) 125.11(18)
O(5)-C(8)-C(6) 116.19(16)
C(11)-C(8)-C(6) 118.70(17)
C(13)-C(9)-C(12) 118.9(2)
C(13)-C(9)-H(9) 121.8
C(12)-C(9)-H(9) 119.3
C(13)-C(10)-C(14) 119.9(2)
C(13)-C(10)-H(10) 119.8
C(14)-C(10)-H(10) 120.3
C(8)-C(11)-N(2) 119.80(18)
C(8)-C(11)-C(15) 122.38(16)
N(2)-C(11)-C(15) 117.79(15)
O(1)-C(12)-C(9) 117.5(2)
O(1)-C(12)-C(6) 121.75(16)
C(9)-C(12)-C(6) 120.75(18)
C(10)-C(13)-C(9) 121.5(2)
C(10)-C(13)-H(13) 118.0
C(9)-C(13)-H(13) 120.6
C(10)-C(14)-C(6) 119.8(2)
C(10)-C(14)-H(14) 121.2
C(6)-C(14)-H(14) 119.0
O(3)-C(15)-O(1) 116.3(2)
O(3)-C(15)-C(11) 128.14(19)
O(1)-C(15)-C(11) 115.51(15)
Table 3.  Bond lengths [A] and angles [deg] for cel.
U11        U22        U33        U23        U13        U12
O(1) 46(1) 57(1) 56(1) -9(1) -2(1) -2(1)
N(2) 45(1) 59(1) 46(1) -1(1) 1(1) 1(1)
O(3) 46(1) 84(1) 65(1) -18(1) -2(1) -14(1)
O(4) 42(1) 95(1) 97(2) -25(1) -5(1) 6(1)
O(5) 52(1) 68(1) 56(1) -16(1) -2(1) -11(1)
C(6) 40(1) 54(1) 44(1) 4(1) -2(1) -3(1)
O(7) 62(1) 74(1) 61(1) -18(1) 6(1) 6(1)
C(8) 42(1) 54(1) 37(1) 1(1) -2(1) -5(1)
C(9) 57(1) 66(1) 61(2) -1(1) 4(1) 12(1)
C(10) 39(1) 88(2) 73(2) 15(1) -2(1) 2(1)
C(11) 38(1) 54(1) 38(1) 0(1) 0(1) -3(1)
C(12) 42(1) 52(1) 46(1) 4(1) 1(1) 3(1)
C(13) 48(1) 84(2) 69(2) 12(1) 8(1) 17(1)
C(14) 41(1) 74(2) 63(1) 6(1) -7(1) -4(1)
C(15) 41(1) 54(1) 42(1) 1(1) 0(1) -4(1)
Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for cel. The anisotropic
displacement factor exponent takes the form:  -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]
x             y             z           U(eq)
H(5) 8801 -1674 1044 70
H(9) 8157 7985 5635 74
H(10) 6700 3362 3435 80
H(13) 6952 6833 5049 80
H(14) 7648 936 2309 71
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic
         displacement parameters (A^2 x 10^3) for cel.
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Packing of the APC-1 molecules down b axis
Studies of Novel 3-cyano-4-styryl coumarin
derivatives
CHAPTER-5
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The history of coumarin synthesis began in the mid-19th century with Perkin’s
discovery of the famous synthesis, which now bears his name.1
Coumarins are simple molecules, with most of the derivatives having been
known for more than a century. Coumarins constitute an important class of
natural products, many of which exhibit useful drug activity.
To date, naturally occurring coumarins have been isolated from over 800
species of plants and microorganisms, and more than 1,000 coumarin
derivatives have been described.2
Scrutinizing the history of Coumarin literature, it can be deciphered that
Styryl-Cyano coumarins still remain unexposed to quite an extent.
1. J. R. Johnson, Org. Reaction , 1, 210 (1942).
2. U. S. Dept. of Health and Human Services, National Toxicology Program Technical
    Report on the Toxicology and Carcinogenesis of Coumarin in F 344/N Rates and
    B6C3F1 Mice (Gavage Studies), NIH Publ. No. 92–3153 (1992).
Introduction and Literature Survey
Dating back to the literature survey, there are few methods reported for the
synthesis of coumarin moieties containing alkyl group at  the fourth position
and other functional groups at  the third position. These methods of synthesis
can be summarised as follows.
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OH
O
CH3
+
CH3
O
OC2H5
Br
O O
CH3
CH3
Reformatsky 
reaction
3. Chakravarti, D. and Majumdar, B.; J. In
     dian Chem. Soc. , 15, 136 (1935).
4.. Chakravarti, D. and Dutta, N.; J. Indian
     Chem. Soc., 17, 65 (1940).
OH
R
O
CH3
OC2H5
O
Cl
+
O O
CH3
Cl
R
5.. Chakravarti, D.; J. Indian Chem. Soc.,
      8, 407 (1931).
OH
O
CH3
+
NC
O
OC2H5
O O
CH3
CN
Sodium Ethylate
6. Schroeder, C. and Link, K.; J. Amer.
     Chem. Soc. , 75, 1886 (1952).
O O
CH3
CN
Sodium Hydroxide
O O
CH3
COOH
7. Schroeder, C. and Link, K.; J. Amer.
     Chem. Soc. , 75, 1886 (1952).
OH
O
R
+
NC
O
OC2H 5
O O
R
CN
Acetic Acid + 
Ammonium Acetate in
 Benzene 
R = Alkyl group
8. Wiener, C., Schroeder, C. and Link, K.;
     J. Amer. Chem. Soc. , 79, 5301 (1957).
R = Alkyl group
9. Wiener, C., Schroeder, C. and Link, K.;
   J. Amer. Chem. Soc. , 79, 5301 (1957).
1-2% Fuming Nitric acid
O O
R
CN
O O
R
CONH2
O O
R
COOH
dil. alkali
O O
R
COCl
Thionyl
 Chloride
O O
R
COOEt
EtOH
OH
O
CH3
+
NC
O
OC2H5
O O
CH3
CN
Triethyl amine
10. Kendall, J. and Axford, A.; Brit. Pat.
     672,741; Chem. Abst. 49, 84g (1955).
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O
CH3
N
O
O
OO
R3
R2R2
R3
R1CHO
O
N
O
O
O
R3
R2R2
R3
O
N
O
R1
O
N
O
O
R3
R2R2
R3
O
O OO
R3
R2R2
R3
3-cyano-4-methyl coumarin is condensed with aromatic aldehydes as
mentioned in presence of sodium acetate to yield corresponding styryl
derivatives (I) . And the fusion of 3-cyano-4-methyl coumarin  with phthalic
anhydrides resulted into formation of phthalidylidenemethyl coumarins (II)
and dioxoindanyl coumarins (III).11
R1 = C
6
H
4
, 4HOC
6
H
4
,
2,4-(HO) 2C6H3, 4-MeOC6H4,
4-Me
2
NC
6
H
4
, 2-ClC
6
H
4
R2 = R3 = H, R2 = H, R3 = Cl
R2 = R3 = Cl, Br
O O
R
N
Shah and  Par thasara th i  s tud ied  the  x - ray
crystallographic studies of styryl coumarins of type
(IVa)12 and (IVb)13. In case of (IVa) the configuration
about the ethylenic double bond is E.
a. R = 4-SCH
3
 phenyl
b. R =  naphthyl
11. Aly, F., Bedair, A. and Selim, M.; Afinidad (1987), 44(412), 489-91.
12. Vijayalakshmi, L., Parthasarathi, V., Varu, B. and Shah,  A.;  Acta Crystallographica,
     Section E: Structure Reports Online E57(5), o436-o438 (2001).
13. Vijayalakshmi, L.,  Parthasarathi, V.,  Varu, B., Dodia, N., Shah, A.; Acta
     Crystallographica, Section C: Crystal Structure Communications, C56(9),
     E401-E402 (2000).
(I)
(II)
(III)
(IV)
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 On the  o the r  hand ,  6 -ch lo ro -3 -cyano-4 -
methylcoumarin reacted with 3-phenyl-1-aryl-2-
propyn-1-ones to give the corresponding 3-
amino-4-aroyl  or carbomethoxy-8-chloro-5-
ary lbenzo[c ]coumar ins  (V)14 as  we l l  as
propenylcoumarins and benzo[c]coumarins. Here
the reaction seems to take place via Michael
addition.
O O
N
Ph
O
Cl
Cl
14. Youssef, A. S. A.; Kandeel, K. A.; Madkour, M. F., J. Ind. Chem. Soc. , 72(2), 103
      (1995); Chem. Abst . 123:340023.
15. Madkour, Hassan M. F.; Heterocycles , 36(5), 947 (1993); 120:8440  CA
16. Takakusa, Michio; J. Phy. Chem., 83(7), 810-13 (1979) Chem. Abst. 90:186012.
O-hydroxy  ace tophenones  were  conver ted 15 i n to  3 -cyano-4-
methylcoumarins, via condensation with ethyl cyanoacetate in the presence
of piperidine or ammonium acetate as a catalyst. 4-Styryl derivatives were
obtained by condensation of the 3-cyano-4-methylcoumarins with different
aromatic and heterocyclic aldehydes.
Fluorescence spectra of 3-cyano-4-methyl-7-hydroxycoumarin were
measured in ethanolic solutions containing various amounts of water and
acid16.  Spectra composed of two bands, one from the undissociated
molecule and the other from the phenolate anion, were observed by excitation
of the undissociated molecule in most of the solutions studied.  The excited
state pKa values varied from 2.3 to 0.01 with variation of the water content
from 0.2 to 80%.  The rate constants of excited-state dissociation and its
reverse reaction were also determined.  With highly acidic solutions the
fluorescence band due to the excited state proton adduct at the carbonyl
was observed in the spectral region between the above-mentioned  two bands.
(V)
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Fleck18 synthesised of styryl derivatives of the type (VII). These compounds
absorbs in the UV part of the spectrum. These compounds carved their
way as optical brightners for natural, synthetic textile material or for non-
textile material, synthetic or semi synthetic high molecular weight polymers
such as polyester, polyamide, polyurethane, polyolefin, polyvinylchloride and
cellulose esters and certain plastic materials.
17. Subba R., Sundaramurthy, V. Proceedings - Indian Academy of Sciences, Section A
     , 54, 321 (1961).
18.  Fleck, F., US4386200 (1983).
19. Mustafa, A., Kamel, M. and Allam, M.; J. Org. Chem., 22, 888 (1957).
linkages, one of which constitutes a part of the heterocyclic ring.  6-methyl
/ 7-methyl / 7,8-benzo coumarin undergo photodimerization to yield adducts
(VIIa), (VIIb) and (VIIc) respectively. 18
Analogues of the styryl coumarins (VI) were synthesized
by Sundaramurthy17. In this work, 3-nitro-2-hydroxy
acetophenone, ethyl cyanoacetate and sodium ethoxide
(NaOEt )  a f te r  re f l uxed  in  me thano l ,pa le  ye l l ow
 
O
O
CH3R
R R
O
O
CH3
O
O
4-Styrylcoumarins are considered
to be inner lactones of beta-(o-
hydroxypheny l )c innamyl idene
acetic acid, contains two ethylenicR = 6-Me (a); R = 7-Me (b); R = 7,8benzo (c)
 
O O
CH3
N
N
+
O
-
O
(VI)
(VII)
 
O OCH3 O O
Br
O O
O
O O
P
H5C2O
OC2H5
O
O OOO
NBS, 
benzoyl peroxide HMTA
Triethyl Phosphite
O O
O
DMF, 
Na, Methanol
(VII)
needles of 8-nitro-4-methyl-3-cyanocoumarin were obtained (Ethanol).
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20a. Chen, F., Chang, C. and Lin, C.; J. Formosan.  Sci., 6, 81 (1952).
    b. Corse, J. and Ingraham, L.; J. Org. Chem ., 16, 1345 (1951).
    c. Amin, G. and Shah, N.; Org. Synth. Collct.  Vol. III, 281.
    d. Chang, C. and Chen, F.; J. Chem. Soc ., 3155 (1961).
    e. Joshi, U., Kelkar, R. and Paradkar, M.; J. Ind. Chem. Soc., 22, 151 (1983).
21.  Vishnumurthy, K., Guru Row, T., Venkatesan, K.; Photochem. Photobiol. Sci., 1, 799 (2002).
22.  Joshi, U., Kelkar, R. and Paradkar, M.; Indian J. Chem., Sect. B , 22, 1151 (1983)
23.  Moorthy, N. and Venkatesan, K.; Bull. Chem. Soc. Jpn. , 67, 1 (1994).
24a. Vishnumurthy, K., Guru Row, T. and Venkatesan, K.; J. Chem. Soc., Perkin
        Trans. 2 , 1475 (1996).
    b. Vishnumurthy, K., Guru Row, T. and Venkatesan, K.; Tetrahedron , 55, 4095 (1999)
    c.  Vishnumurthy, K., Guru Row, T. and Venkatesan, K., Tetrahedron , 54, 11235 (1998).
The compounds (VIII 1-4)  were preapared20,24b by condensing the
corresponding fluoro-2-hydroxy chalcones using the Wittig reagent,
Ph 3P=CHCOOEt. The powder samples of the styryl compounds were
simultaneously irradiated in a Rayonet photochemical reactor to give the
dimers of the styryl compounds.
The 4-styrylcoumarin has two potentially reactive double bonds-the pyrone
and the styrenic double bond leading to the formation of eight possible dimers.
 
O O
Y
Z X
A
B
hv, solid, 35 - 40 H
O
OH
Y
Z X
A
B
PH3C=CHCOOEt
Wittig
O O
Y
Z X
A
B O O
Y
Z X
A
B
1. A = Y = F; X = Z = B = H
2. A = X = Z = F; B = Y = H
3. A = X = F; Y = Z = B = H
4. X = Z = F; A = B = Y = H
 
O O
OO
O O
hv, solid
Here, the 4-Styrylcoumarin
and 4-(3-fluorostyryl) coumarin
(IX) were  p repared  and
characterised according to
literature procedures.22-24
Very recently, concomitant polymorphism study  (Polymorphism is the ability
of a chemical substance to exist in at least two different crystal forms, which
usually display different physical and chemical properties.) has been carried
out  in the 4-styrylcoumarin16 and its 3-fluoro derivative.21
(VIII)
(IX)
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 Mohamed Kamel and
coworkers25,26 s tud ied the
Diels’ Alder reaction of styryl
coumarins. In this study, 6-
methyl-4-styryl couamrins and
O
O
CH
CH
CH3
Maleic anhydride
O
O
H
H
H
O
O
R R
7,8-benzo-4-styryl coumarin react with maleic anhydride in boiling xylene,
it results into adduct formation i.e (Xa), (Xb) and (Xc) respectively.
R = 6-Me (a); R = 7-Me (b); R = 7,8benzo (c)
25. Mustafa, A., Kamel, M. and Allam, M.; J. Amer. Chem. Soc. , 78, 4692 (1956).
26. Mustafa, A. and Kamel, M.; J. Amer. Chem. Soc.,  77, 1828 (1954).
27. Shenoy, V.; Doctoral Dissertation, Bombay University, (1988).
28. Harnish, H.; Ger. Offen., 2413317 (1975); Chem. Abst. 84, 46052f (1976).
29. Harnish, H.; Ger. Offen., 2413281 (1975); Chem. Abst. 84, 19193w (1976).
30. Harnish, H.; Ger. Offen., 3033159 (1982); Chem. Abst. 97, 25160t (1982).
O
O
CH
CH
R
ArSH
O
O
CH2
CH
R
S
Ar
R R
R = 7-Me (a); R = 7,8benzo (b)
7-methyl 4-styryl coumarin
and  7 ,8 -benzo-4 -s ty ry l -
coumarin readily react with
aromat ic  th io ls  to  g ive
addition products (XIa) and
(XIb)  respectively. Photophysical propertiesof 7-ethylamino-3-styryl
derivatives in solvents such as chloroform (CHCl3), DMF (Dimethyl
formamide) nad Dimethyl sulphoxide (DMSO) were studied27. The idea of
l inking coumarin and styryl systems originated28 from the potential
application of coumarins, substituted in the 3-position with various styryl
derivatives of heterocycles as fluorescent dyes for polyester, acrylic and
polyamide fabrics29-30. These dyes have there applications in bioanalytical
study too.
(X)
(XI)
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Coumarins compounds bearing styryl group or cyano group have diverse
applications from pharma sector to non-pharma sector.  Khellinone reacts
with the acetic acid ester in presence of sodium in anhydrous ether. During
the reaction, the mixture is maintained at boil ing point of ether. While
maintaining the temperature, small  quanti t ies of sodium are  added
in successive fractions. The heating was continued for several hours.
After the termination of the reaction, the diketone is formed which is
in equil ibrium with its enol form.
Khel l in  was or ig inal ly  ut i l ized for  three pr inc ipal  act ions Coronary
vasod i la to r  ac t ion ,  An t i spasmod ic  ac t ion  o f  smooth  musc le  and
Cent ra l  depressant  and  gang l iop leg ic .
 
3-cyano-4-methyl coumarin also found
their way into the the preparation of
methine dyes31. Variety of dyes were
synthesized by reacting the 3-cyano-4-O
CH3
N
O
D1
methyl coumarin with different dye intermediates. Very recently, 4-cyano
couamr in  der i va t i ves  found  the i r  app l i ca t ion  in  pho tochemica l
polymerization, dye lasers and electroluminescent elements32.
31. GB672741, Kendall, J. and Joseph, A. (1950)
32.  Yoshio, T., Toshiki, K., Chihaya, A., Tomoyashu, S., Makoto, S., Akira, S., Sadaharu,
     S., Shizuo, T., Hisayoshi, F., Koji, N., Atsushi, M., Yasunori, T.; US3176520 (2003)
(XII)
 
O
CH3
O
OH
O
CH3
O
CH3
Acetic acid ester, A
O
CH3
R
OO
O
CH3
O
CH3
1. A = ethyl cyano acetate, R = CN ()
       2. A = ethyl phenyl acetate, R = phenyl ()
Khellinone
(XIII)
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Hence Khellins were utilized as analgesic,hypnotics and antihistaminics.
And in this study it was found that compounds (XIII) , i.e 3-cyano-5,8-
dimethoxy-4-methyl-6,7-furanocoumarin has more intense neuroplegic
properties than khellin. Specifically these compounds relax the autonomous
system i.e neurovegetative dystonias, depressive states such as anxiety,
hyperemotional, hypernervousness. In combination with barbiturates, these
derivatives are indicative in profound depressive states with loss of
muscular  tonus,  obst inate insomnias,  extraordinary pains (urethral
l i thiasis). In combination with antihistaminics they show gangliolegic
power.  being more prec ise,  act ive against  asthma, common and
obst inate coughs,  f ive day fevers of  whooping cough.
33. GB1024385, Chemetron Crop (1966)
34. Clinging, R., Dean, F. and Houghton, L.; J. Chem. Soc.  (C)., 897 (1970).
35. Clinging, R., Dean, F., Houghton, L. and Park, B.; Tet. Lett., 15, 1227(1976).
 
O O
N
R3
R1R2C:N2
O O
N
R1 R2
R3
R
1
R
2
R
3
H CH
3
H
H CH
3
6 - CH
3
H CH
3
8 - OCH
3
CH
3
CH
3
H
H CH
2
=CH
2
H
H Ph H
H C(CH
3
)
3
H
(XIV)
Moreover, another method for synthesis of 4-alkyl-3-cyano-coumarin
derivatives were reported which deviates from the classical way. Alkylation
of various 3-substituted coumarins were carried out and it was observed
that cyano group at third position efficiently promoted 4-methylation34 and
in cont inuat ion  of  th is ,  a lky lat ion was carr ied out  by d iazo ethene,
2-diazopropane, etc to g ive diverse 4-alkyl  3-cyano coumarins35.
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36. El-Gaby, M., Ghorab, M., Abdel-Gawad, S.; Acta Pharm. (Zagreb), 49(4),
      257 (1999).
37. Talapatra, S., Mandal, K. Biswas, K., Mandal, S. and Talapatra, B.; J. Ind. Chem.
      Soc., 76(11-12), 733 (1999).
38. Selleri, R., Orzalesi, G., Caldini, O., Spano, R., Cascio, G., Palazzoadriano, M. and
     Mantia, G.; Arz.Fors. , 16(8), 1073 (1966).
ethylcyano acetate to yield 3-
cyano-4-methyl coumarinwhich
on further rection with aromatic
a ldehydes gave 4-s ty ry l
der iva t ives (XV).  These
compounds were tested for
their antibacterial activities.
O
CH3
OHOH
CNCH2COOC 2H5
Base
OOH
CH3
N
O
O
R
N
OOH
Aromatic Aldehydes
R-CHO
4-methyl-3-cyano coumarin have also been studied by the Soad and
coworkers36. In this study, the 2,4-dihydroxyacetophenone is fused with the
Also, K 2CO3 mediated condensation of ethyl cyanoacetate with 2-hydroxy-
4,6-dimethyl acetophenone to afforded to give 3-cyano-4,5,7-trimethyl
coumarin37 (XVI).
 
O
CH3
OHCH3
CH3
CNCH2COOC2H5
OCH3
CH3
N
O
CH3
K2CO3
 
O O
R1
R2
R3
R4A series of dicarbalkoxy and cyanocarbalkoxy
coumarins of the general formula (XVII) was
synthesized and tested for saluretic and choleretic
activity. 38
(XV)
(XVI)
(XVII)
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 O
CH3
OH
R
Piperidine / Ammonnium acetate
O
CH3
N
O
O
R1
N
O
Aromatic / Heterocyclic Aldehydes
R
R
O-hyd roxy  ace tophenones  we re  t r ans fo rmed  i n to  3 - cyano -4 -
methylcoumarins by means of condensation with ethyl cyanoacetate in
the presence of piperidine or ammonium acetate as a catalyst. Further,
4-styryl derivatives (XVII) were obtained by condensation of the 3-cyano-
4-methylcoumarins with different aromatic and heterocyclic aldehydes.37
Linear furocoumarins, also called psoralens, have been used for the
treatment of  prol i ferat ive skin diseases such as v i t i l igo,  eczema,
m y c os i s  f ungo ides  and  pso r i as i s .  A l l  p so ra l ens  con ta i n  two
photoactivable functions (absorbing in the UVA range) an aryl conjugated
unsaturated pyrone (coumarin portion) and an aryl-conjugated vinyl ether
(furan portion). In a study, new type of psoralens containg the styryl and
cyano group were synthesized.39 (XIX).
 
OH
O
CH3
OH
CH3
O O
N
CH3
CH3
O
R
CH2
O O
N
CH3
CH3
O
Br
R
Br
Br2
1. K2CO3
2. Pyridine
O O
N
CH3
CH3
O
Br
39. Heindel, N., LaskiccD., Rapp, R., Whittemore, M., McNeel, T. and Jabin, I.; US6255324
     (2001)
(XVIII)
(XIX)
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O O
R N N
N
H
N
R1
R2
R3
R4
O O
RR1
R2
R3
R4
N
NH4CN
DMF
4-Methyl-3-(terazol-yl) coumarin is already known in  the literature, where it
was shown that these compounds did not show any antiallergic activity, but
in the compounds of type (XX) showed substantial antiallergic activity40.
These compounds are preapred by reacting the substituted cyano coumarin
with ammonium azide in inert  organic solvent such as DMF at a
temperature above room temperature. The ammonium azide is formed
in-situ by reacting sodium azide with ammonium chloride.
40. Buckle, Derek R.; Cantello, Barrie C. C.; Smith, Harry; GB1434645 (1976); Chem.
     Abst.  83:9730441,(1976).
41. Kawase, M., Varu, B., Shah, A., Motohashi, N., Tania, S., Saito, S., Debnath, S.,
      Mahapatra, S.; Dastidar, S., Chakrabarty, A.; Arz.Fors., 51(1), 67(2001).
A exploration of coumarin analogs of
type (XXI) as novel antimicrobial agents
was carried out41  to determine the basic
features of the structure responsible for
the observed  biological activity.
 
O O O O
R
NR1
R2
R
1 
= 3-COOH, R
2
 = H (a)
R
1 
= 3-COOEt, R
2
 = H (b)
R
1 
=4-CH
2
COOH, R
2
 = 7-OMe (c)
R = 2,4-dichlorophenyl (d)
       2-nitrophenyl (e)
(XXI)
Gram positive bacteria were grown in nutrient broth (NB, Difco, detroit,
USA) and gram negative bacteria were grown in peptone water. And this
gave an optimum growth of the test bacteria. Each compound was dissolved
in the dimethyl sulphoxide (minimum concentration of DMSO which which
is not sufficient to inhibit the bacterial growth), sterilized by filtration by
using sintered glass filter, and each agent added to molten agar in different
concentrations which was then poured into sterile petri dishes.
(XX)
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pH of the media was maintained at 7.2 to 7.4. The inoculum was then spot
inoculated and the petri dishes were incubated at 37 o C for 72 hr to
determine the minimum inhibitory concentration (MIC). It was observed that
compound (XXIa) , (XXIb) , (XXIc)  showed potent inhibitory activity against
both Gram posiitive and Gram negative  bacteria.  Where as compounds
(XXId)  moderately active against these molecules.
The results demonstrated that a) compounds with carboxylic acid or ester
groups could exhibit potent antibacterial activities. b) derivatives with
phenolic hydroxyl group could display much lower activities.
In continuation with  work on the styryl coumarins in this laboratory, which
sparkled as potent antibacterial, the current work encompasses the similar
type of compund with chloro and methyl substitutions in the benzenoid part
so as to study the changes in the biological activity. The current work
presents a direct, efficient and operationally convenient approach to the
synthesis of some novel styryl derivatives of the substituted 3-cyano-4-
methyl coumarins. The final compounds (6-chloro-7-methyl-2-oxo-4-[(E)-2-
substituted phenylvinyl]-2H-chromene-3-carbonitrile) synthezised in four
steps. In the first two steps the acetyl group introduces in the  sixth position
of p-chloro-m-cresol so as to get the corresponding acetophenone which
is further condensed with ethyl cyanoacetate to synthesize the  6-chloro-
4,7-dimethyl-2-oxo-2H-chromene-3-carbonitrile which, on condensation
with substituted benzaldehydes  yield the target compounds. The catalyst
used for condensation was sodium methoxide.It is important to mention
that  the reaction commenced in shorter period of time and gave pure cyano
coumarin as compared to the triethyl amine and piperidine catalysed
reactions. The use of Dean-Stark Apparatus was eliminated since the
removal of water from the reaction mixture was not required.
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All the starting materials, p-chloro-m-cresol, acetic anhydride, ethylcyano
acetate, sodium, methanol and substituted benzaldehydes were obtained
from the commercia l  sources.  Mel t ing points of  the synthesized
dihydropyrimidines were taken in open capi l lary bath on control led
temperature (using standard Zeal’s thermometer). The cyclization of the
DHPMs were carried out in methanol as the solvent. The commencement
of the reaction and purity of the DHPMs  was carried out using thin layer
chromatography (TLC; silica gel-G, used as stationary phase, the TLC plates
were purchased from MERCK India Ltd. acetone and benzene (2 : 8) was
used as the mobile phase.
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Reaction Scheme
Step  1
Step  2
CH3
Cl
OH
CH3
O
+
H5C2O
N
O
NaOCH3
O O
CH3
N
Cl
CH3
-CH3OH
1-(5-chloro-2-hydroxy-4-methylphenyl)ethanone ethyl cyanoacetate
7-chloro-4,6-dimethyl-2-oxo-2H-chromene-3-carbonitrile
Step  3
OH
Cl
CH3
(CH3CO)2O
H2SO4
OCOCH3
Cl
CH3
AlCl3
Fries Migration
OH
Cl
CH3
O
CH34-chloro-3-methylphenol 4-chloro-3-methylphenol
1-(5-chloro-2-hydroxy-4-
methylphenyl)ethanone
O
N
CH3
O
Cl
CH3 O
N
O
Cl
CH3
CHO
R+
R
6-chloro-4,7-dimethyl-2-oxo-
2H-chromene-3-carbonitrile
Substituted
benzaldehyde
6-chloro-7-methyl-2-oxo-4-[(E)-2-
substitutedphenylvinyl]-2H-
chromene-3-carbonitrile
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Method of Synthesis
Synthesis of 1-(4-chloro-2-hydroxy-5-methylphenyl)ethanone (sub-
stituted o-hydroxy acetophenone)
A mixture of p-chloro-m-cresol (0.1 mole, 14.6 gm), acetic anhydride (14
ml) is refluxed in methanol for 2 hrs. The reaction is monitored by TLC (ethyl
acetated: Hexane, 3 : 7). After completion of the reaction, the reaction mass
is transferred to the a round bottom flask containing 40 gm of AlCl3.  The
reaction mixture is heated at 120-150 o C in oil bath for 4-6 hrs, followed by
dumping the reaction mass into crushed ice. This results into formation of
1-(4-chloro-2-hydroxy-5-methylphenyl)ethanone which is recrystallized from
methanol.
Mol. For., C12 H8 Cl N O2; Mol Wt., 102; M.P., 79 
o C; Yield, 60 %; TLC;
Ethyl acetate : Hexane; 2 : 8.
Synthes is  o f  7 -ch loro -4 ,6 -d imethy l -2 -oxo-2H- c h r o m e n e - 3 -
carbonitrile.
A mixture of 1-(4-chloro-2-hydroxy-5-methylphenyl)ethanone (0.01 mol), ethyl
cyano acetate (0.01 mol) and sodium methoxide in methanol (which was
synthesized in situ) was heated to reflux for 2 hrs. After the reaction mixture
was cooled, the product that separated in the reaction mass was filtered,
crystallized from chloroform to give pure 7-chloro-4,6-dimethyl-2-oxo-2H-
chromene-3-carbonitrile.
Mol. For., C12 H8 Cl N O2; Mol Wt., 234; M.P., 221 
o C; Yield, 80-90 %
TLC; Acetone : Benzene; 2 : 8
Elemental Analysis; C(61.7 %) H(3.5 %) Cl(15.2 %) N(6 %) O(13.7 %)
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Synthesis of 7-chloro-6-methyl-2-oxo-4-[substituted phenylvinyl]-
2H-chromene-3-carbonitrile (General method)
A mixture of 7-chloro-4,6-dimethyl-2-oxo-2H-chromene-3-carbonitrile  (0.01
mole), substituted aromatic / heterocyclic aldehyde were dissolved in
minimum quantity of dichloro methane. Catalytic amount was added when
no solid left in the solution and was stirred for 2 - 3 hrs till solid product
separated. The separated product was filtered and thoroughly washed with
chilled methanol and recrystallized from hot dichloro methane.
This method was employed to synthesize various 7-chloro-6-methyl-2-oxo-
4-[substituted phenylvinyl]-2H-chromene-3-carbonitriles using diverse
substituted benzaldehydes like benzaldehyde, o-/m-/p-nitro benzaldehyde,
o-/m-/p-hydroxy benzaldehyde, o-/m-/p-chloro benzaldehyde, o-/m-/p-nitro
benzaldehyde, m-bromo, 4-N,N-dimethyl benzaldehyde, cinnamaldehyde,
furfural, 4-thiomethyl benzaldehyde and indole-3-carbaldehyde.
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Spectral data of only key intermediate and final compounds are included.
using the instrument, SHIMADZU FT IR-8400 , Sample technique,  KBr
pellet, Frequency  range, 400-4000 cm-1
The IR Spectrum holds great importance in structure elucidation of the
compounds of the current chapter. These cyano / styryl coumarin consists
of very specific functional groups which absorb IR radiations and show
signals and hence supports in identi f ict ion and confirmation of the
molecule.
The IR spectrum of 6-chloro-7-methyl-2-oxo-4-[(E)-2-substitutedphenylvinyl]-2H-
chromene-3-carbonitrile) indicates the presence of cyano group, methyl group,
the vinyl group of styryl residue and carbonyl group of the lactone residue
which can be clearly identified from the IR spectrum.
In case of APS-1, APS-11, APS-7, APS-8,  the methyl group of the
benzenoid part shows IR absorption at 2940-2830 cm-1which indicates the
symmetric and asymmetric -CH stretching vibrations. The vinyl group can
be confirmed by the presence of IR absorbtion at 3010-3050 cm-1 and along
with this, out of plane deformation vibrations are observed at approximately
850 cm-1. These two frequencies indicates the presence of a vinyl group in
the molecule. The carbonyl group shows the signals at 1700-1730 cm-1.
The nitrile group shows the infra red absorbtion at 2229-2333 cm-1.  The
aromatic C-C skeletal vibrations are observed at 1600 - 1450 cm-1. The C-
H in plane deformations are observed at approximately 1160 cm-1 and the
out of plane deformations are observed at 650 - 900 cm-1. The -C-Cl
stretch ing vibrations are observed at 700 - 760 cm-1.
 In case of APS-8 and APS-7, the hydroxy group of the phenyl residue
attached to the vinyl group, shows a broad band at 3300-3400 cm-1.  In
case of APS-11 , -C-O-C signals are also observed at 1200-1250 cm-1. This
is due to the phenoxy substitution at the meta position of the phenyl group
attached to the vinyl group.
Spectral Analysis (IR)
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IR Spectrum of 6-chloro-7-methyl-2-oxo-4-[(E)-2-(3-phenoxyphenyl)vinyl]-2H-
chromene-3-carbonitrile
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IR Spectrum of 6-chloro-7-methyl-2-oxo-4-[(E)-2-phenylvinyl]-2H -chromene-3-
carbonitrile
Type Vibration Mode Frequency (cm-1)
Methyl
-CH str (asym) 2948
-CH str (sym) 2845
Vinyl
-CH=CH (str) 3051
-CH=CH out of plane
deformation
850
Aromatic
C-C skeletal vibrations
1617, 1584
1536,1492
C-H in plane
deformation 1162
C-H out of plane
deformation
768
Carbonyl >C=O str 1721
Cyano -C=N 2229,2340
Halogen -C-Cl str 765
Type Vibration Mode Frequency (cm-1)
Methyl
-CH str (asym) 2948
-CH str (sym) 2845
Vinyl
-CH=CH (str) 3051
-CH=CH out of
plane deformation 889
Aromatic
C-C skeletal
vibrations
1611, 1587
1537,1486
C-H in plane
deformation
1163
C-H out of plane
deformation
671
Carbonyl >C=O str 1736
Cyano -C=N 2229
Ether -C-O-C- 1246,1215
APS- 1 APS- 11
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IR Spectrum of 6-chloro-4-[(E)-2-(3-hydroxyphenyl)vinyl]-7-methyl-2-oxo-2H-
chromene-3-carbonitrile
APS- 7
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IR Spectrum of 6-chloro-4-[(E)-2-(4-hydroxyphenyl)vinyl]-7-methyl-2-oxo-2H-
chromene-3-carbonitrile
O O
N
Cl
CH3
O H
APS- 8
APS- 8 APS- 7
Type Vibration Mode
Frequency
(cm-1)
Hydroxy -OH b 3418
Vinyl
-CH=CH (str) 3051
-CH=CH out of plane
deformation
827
Aromatic
C-C skeletal
vibrations
1603, 1528
1513,1455
C-H in plane
deformation
1169
C-H out of plane
deformation
670
Carbonyl >C=O str 1703
Cyano -C=N 2223,2340
Halogen -C-Cl 765
Type Vibration Mode
Frequency
(cm-1)
Methyl -OH b 3444
Vinyl
-CH=CH (str) 3172
-CH=CH out of plane
deformation
840
Aromatic
C-C skeletal
vibrations
1620, 1585
1539,1455
C-H in plane
deformation
1164
C-H out of plane
deformation
668
Carbonyl >C=O str 1717
Cyano -C=N 2227,2341
Halogen -C-Cl 762
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Spectral Analysis (NMR)
Instrument used for the NMR spectroscopy of the newly synthesized DHPMs
was BRUKER AC 300 MHz FT-NMR, where TMS  was used as the Internal
reference and CDCl3 or DMSO d6 were used as solvent.
We have already seen that IR spectroscopy is a very supportive tool for the
structure elucidation of the styryl , cyano coumarin compounds.
In addition to that, considering the NMR spectrum of APS-7, the three
protons of the methyl group shows a sharp singlet at 3.361 d ppm  being
highly shielded. The proton adjacent to the methyl group does not show
any coupling because donot have any neighbouring protons and hence
resonate  at 6.88 d ppm. The hydroxy proton is highly deshielded and
hence resonates at downfield  i.e at 9. 703 d ppm. The proton adjacent to
the carbon atom bearing hydroxy group is also deshielded hence shows
a sharp singlet at 8.230. The two vinylic protons were quite in the downfield
and shows a doublet at 7.301 d ppm with coupling constant J = 4.2 Hz.
The rest three protons resonate and gives a multiplet at 7.618 d ppm with
J = 2.4, J = 3.9 and J = 8.1 Hz. The proton adjacent to the carbon atom
bearing the chloro group shows a singlet at 7.216. This proton is more
deshielded as compared to the one adjacent to hydroxy group.
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In case of the NMR spectrum of APS-12, the three protons of the methyl
group of bonded to the sulphur atom shows a sharp singlet at 2.549 d ppm
and the three protons of the methyl group of the benzenoid residue of the
coumarin ring resonate at 2.521 d ppm. The two vinylic protons are
observed at 7.567 d ppm giving a doublet with coupling constant J = 8.1
Hz. The proton adjacent to the carbon bearing methyl group in the
benzenoid part shows a singlet at 7.653 d ppm.  The four protons of the
phenyl residue   bonded to the vinyl group shows a multiplet at 7.263 d
ppm.
Looking at the NMR spectrum of APS-13, it can be predicted that the three
protons of the methyl group ofthe benzenoid part resonates at 2.39 d ppm
and gives a sharp singlet. The five protons of the phenyl residue bonded to
the vinyl group shows a multiplet at 7.088 d ppm with J = 2.7, J = 12 Hz.
The four vinylic protons resonate at 7.376 d ppm giving a doublet of dou-
blet with J = 7.8 Hz.
For the current study, Instrument used was JEOL SX 102/DA-6000 for FAB
(Fast atom Bombardenment).  The molecular ion peaks (M+) of  the
compounds  in mass spectra  were in total agreement  with it’s molecular
weight.  The Mass spectra of the compounds were given on page no.233-
236.
In case of APS-1 having molecular weight, 321,  M+1 peak (m/e = 322),  M+1-
*CH3 (m/e = 307), M
+1- *Cl (m/e = 289) are indicated. In case of APS-7, having
molecular weight, 337, M +  peak (m/e = 337), M+1 peak  (m/e = 338) and so-
dium adduct (m/e = 360), M+1 - *OH, -*CH3 peak  (m/e = 307), M
+1 - *Cl, -*CH3
peak  (m/e = 288) are indicated . And in case of APS-9,  having molecular
weight, 352,  M +  peak (m/e = 352), M-1peak  (m/e = 351), M+1 - *OCH3, -*Cl
peak (m/e = 305), M+1 - *OCH3, -*Cl - CH3 peak  (m/e = 270). In case of APS-12
molecular weight, 368, M + peak (m/e = 368), M-1peak  (m/e = 367), M+1 - *OSH3,
- CH3 peak  (m/e = 307), Sodium adduct (m/e = 391).
Spectral Analysis (Mass)
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1 HNMR Spectrum of 6-chloro-7-methyl-4-[(E)-2-(3-hydroxy phenyl)vinyl]-2-oxo-
2H -chromene-3-carbonitrile
6
5
7
10
8
9
O
1 2
4
3
O
11
14
15
16
21
20
19
17
18
12
N
13
Cl
23
CH3 22
OH
24
APS-7
No.
Chemical
Shift Multiplicity No. of Protons Coupling Constant(J Hz)
1. 3.361 s 3H (22) -
2. 9.703 s 1H (24a) -
3. 8.230 s 1H (21) -
4. 7.216 s 1H (10) -
5. 7.301 d 2H (14a,15a) J = 4.2
6. 7.618 m 3H (17,18,19) J = 3.9, J = 2.4, J = 8.1
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1 HNMR Spectrum of 6-chloro-7-methyl-4-{(E)-2-[4-(methylthio)phenyl]vinyl}-2-
oxo-2H-chromene-3-carbonitrile
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O
1 2
4
3
O
11
14
15
16
21
20
19
17
18
12
N
13
Cl
23
CH3
22
S
24 CH325
APS-12
No.
Chemical
Shift Multiplicity No. of Protons Coupling Constant(J)
1. 2.549 s 3H (25) -
2. 2.521 s 3H (22) -
3. 7.263 m
4H
(17,18,20,21) J = 3.9, J = 2.4,  J = 8.1
4. 7.567 d 2H (14a,15a) J14a-15a = J15a-14a = 8.1
5. 7.653 s 1H (7) -
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1 HNMR Spectrum of 6-chloro-7-methyl-2-oxo-4-[(1E,3E)-4-phenylbuta-1,3-
dienyl]-2H -chromene-3-carbonitrile
6
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O
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3
O
11
14
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N
13
Cl
25
CH3
24
16
17
18
23
22
21
19
20
APS-13
No.
Chemical
Shift Multiplicity No. of Protons Coupling Constant(J Hz)
1. 2.39 s 3H (24) -
2. 6.905 s 1H (7) -
3. 7.263 s 1H (10) -
4. 7.088 m
5H
(19,20,21,22,23)
J = 2.7, J = 12
5. 7.513 d 2H (19,23) J = 7.2
6. 7.376 dd
4H
(14a,15a,16a,17a)
J = 7.8
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“Meerwein Reaction” (I)  in the most general form can be defined as
the reaction of an aromatic diazonium halide with an aliphatic unsatur-
ated compound to yield substituted a -halo-b-phenyl alkanes and alkenes.
Advances during the last decade in understanding the mechanisms of dia-
zonium decomposition, especially with regards to the catalyse reactions
have been well highlighted in the literature.
ArN2
+X- +
CH3
CH3 CH3
CH3
CH3 CH3
XAr
C C
Exploring the literature for Reductive dediazonization1, four impetus reac-
tions are observed.
1.Gomberg-Bechmann Arylation of aromatics.
2. Pschorr Synthesis.
3. Sandmeyer Reaction
4. Meerwein Arylation
1. Gomberg-Bachmann Arylation2
It includes the phenylation of substituted aromatic solvents.  General method
for Gomberg reaction includes initially, diazotizing the amine and than adding
this diazotized solution to the cold solvent substrate by vigorous stirr ing, fol-
lowed by addtion of aq. sodium acetate solution. Then after the solution on
stirring at room temperature results into evolution of nitrogen gas with fizz-
ing. This reaction results into formation of substituted biphenyls.
1. Zollinger, H., “Diazo and Azo Chemistry”, Interscience Publishers, Inc., New York, N.
   Y., (1961).
2. Gomberg, M. and Bechmann, W.; J. Amer. Chem. Soc., 46, 2339 (1924).
Introduction
(I)
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N2
+
O
O
2. Pschorr Synthesis3,4
This is an enigmatic example of intra molecular arylation (II) which can
be carried out under diverse conditions and occurs in either a radical or
electrophilic fashion. Thermal decomposition of diazonium salts in acidic
solution produces phenyl cations (depending on the choice of anions, i.e.
chloride ion causes radical reaction2,3,5,6,7). On the other hand decomposition
in alkaline solutions8 are radical reactions especially those which are
catalysed by copper metal or cuprous compounds.
3. DeTar, D.; Org. Reactions , 9, 409 (1957).
4. Leake, P.; Chem. Rev. , 56, 27 (1956).
5. a. Nesmeyanov, A., Makarova, L. and Tolstaya, T.; Tetrahedron, 1, 145 (1957);
    b. Olah, G. and Tolgyesi, W.; J. Org. Chem., 26, 2053 (1961).
6. a. Cohen, T. and Lipowitz, J.;  J. Am. Chem. Soc., 86, 2514 (1964)
    b. Cohen, T., Dinwoodie, A. and McKeever, L.; J. Org. Chem., 21 , 3385 (1962).
7. Lewin, A., Dinwoodie, A. and Cohen, T.; Tetrahedron, 42, 1527 (1966).
8. a. Riichardt, C. and Merz, E.; Tetr. Lett., 2431 (1964)
    b. Williams, G., “Homolytic Aromatic Substitution,” Pergamon Press Inc., New York,
    N. Y.,  p. 28 (1960).
9. Waters, W.; J. Chem. Soc. , 266 (1942).
10.Dickermann, S, Weiss, K. and Ingerman, A; Communications, 21, 381 (1956)
3. Sandmeyer Reactions9
The definite radical character of the Sandmeyer reaction in acetone
confirms Waters9 view that these are oxidation-reduction reactions and
proceeds via stepwise mechanism. In the proposed mechanism (III) ,
reaction 1 to 6 are applicable to Sandmeyer reaction in aq. acetone10
(II)
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 Formation of arylated olefins (IV)  on
treatment of olefins with diazonium
salts in the presence of cupric salts
is all about this reaction.11
The reaction is carried out in aq. acetone solutions in which the diazotised
amine solution has been neutralized with sodium acetate. Catalytic amounts
of cupric chloride are necessary for the reaction.
11. a.Sutter, P. and Weis, C.;  J. Heterocyclic Chem. 24, 69 (1987)
     b.Wurm, G. and Gurka, H.;  Pharmazie  52, 739 (1997).
     c.Brunner, H. et al.;  J. Organometal. Chem. 541, 89 (1997).
     d.Obushak, M. et al.;  Tetrahedron Letters  39, 9567 (1998).
     e.Rondestvedt, C.; J. Org. React.,  11, 189 (1960).
     f.Rondestvedt, C., J. Org. React.,  24, 225 (1976).
     g.Weis, C.; Dyes Pigment 9, 1-20 (1988).
 CH3COCH3 2CuCl2 2CuCl ClCH2COCH3 HCl+ + +
ArN2
++ ArN=N*+ CuCl2CuCl2-
Ar* N2ArN=N* +
ArCl + CuClCuCl2Ar*+
ArH + *CH2COCH3CH3COCH3Ar*+
ClCH2COCH3 + CuClCuCl2*CH2COCH3+
+ CuClAr* + C C
CH3 CH3
CH3CH3 C C
CH3 CH3
CH3Ar
Ar* + C6H6 Ar
CH3
+Ar
CH3
CuCl2 ArC6H5 + H
+
CuCl+
C C
CH3 CH3
CH3
CH3 CH3
+ CuCl2
CH3 CH3
ClAr
CH3CH3
+ CuCl
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(7’)
(8’)
(8)
4. Meerwein Reactions
(III)
(IV)
Meerwein Arylations, The Cupric induced reactions....
 245
“A Mechanistic Approach”
The mechanism of this very interesting and versatile reaction has been the
the subject of speculation and is yet prooves to be the moot point. The
myriad unsaturation compounds to which this reaction can be applicable
are ethy lenes12, a , b-unsaturated carbonyl  compounds,  inc luding
chalcones13, cinnamic acid and its derivatives14, coumarins14a, acrylic
acids15, ketones16, acrylonitri les13,16,17 acetylenes14a,16 and conjugated
dienes 18.
12. a.Brunner, W. and Kustascher, J.; Monatsh., 82, 100 (1951).
     b.Dale, W. and Ise, C.; J. Amer. Chem. Soc., 76, 2234 (1954).
     c.Freund, W.; J . Chem. Soc., 3068 (1952); 2889 (1953).
     d.Bergmann, F., Dimant, E. and Japhe, H.; J. Amer. Chem. Soc.,  70, 1618 (1948).
     e.Brown, D. and Kon, G.; J . Chem. Soc., 224, 2147 (1948).
13. P. L’Ecuyer and Olivier, C.; Can. J. Research, 27B, 689 (1949).
14. a.Meerwein, H., Buchner, E. and K. van Emster, J. Prakt. Chem ., 152, 237 (1939).
     b.Bergmann, F. and Schapiro, D.; J. Org. Chem., 1 2 , 57 (1947);
     c.Bergmann, F. et al; J. Org. Chem., 9, 408, 415 (1944)
      d.P. L’Ecuyer, Oliver, C., Giguere, G., Turcotte, F. and Roberge, P.; Can. J. Research.
     26B, 70 (1948).
     e.Fuson, R. and Cooke, H.; J. Amer. Chem. Soc. , 62, 1180 (1940).
     f.P. L’Ecuyer and C. Oliver; Can. J. Research. 28B, 648 (1950).
     g.F. Waring and D. Bell; J. Chem. Soc . 1025 (1948).
15. a.Rai, J. and Mathur, K.; J. Ind. Chem. Soc., 24, 413 (1947).
     b.Fusco, R. and Rossi, S.; Gazz. chim. ital., 78, 524 (1948); (c) W. Brunner and H.
     Perger, .Iloizotsh., 79, 187 (1948).
16. Muller, E.; Angew. Chem., 61, 179 (1949).
17. a.Brunner, W. and Perger, H.; Monatsh., 79, 187 (1948).
     b.Koelsch, C. and Boekelheide, V.; J. Amer. Chem. Soc.,  66, 412 (1944).
     c.Koelsch. C.; J. Amer. Chem. Soc.  66, 37 (1943).
18 . a.Coyner, E. and Ropp, G.; J. Amer. Chem. Soc ., 70, 2283 (1948).
     b.Muller, E.,  “Action of Aromatic Diazo Compounds on Aliphatic Unsaturated
     Compounds,” PB 737, Office of Technical Services, Department of Commerce,
     Washington, D. C.
     c.Braude, E. and Fawcett, J.; J Chem. Soc., 3113 (1951).
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Meerwein, Buchner and van Emster19 had considered that in these
reactions, the aryl group always became attached to the a -carbon of b-
substituted a,b-unsaturated compounds.
The facts of the mechanism were reinvestigated in 1944 by Koesch and
Boekelheide 20. They suggested a radical mechanism for the Merwein
Reaction. The steps can be summarised as follows.(V)
It is clearly seen that the volume occupied by the group on the b-carbon
atom of the unsaturated compound is not a factor in determining the point
of entry of the aryl group. A methyl group occupies at least as large a portion
of the space in the immediate vicinity of the a -carbon atom as does a vinyl
group, yet crotonic acid and its derivatives undergo a -coupling, whereas
b-coupling takes place with the vinyl compounds
In the above mechanism Equation 1  shows the utility of buffer.
Equation 2  epitomize the “electron pairing” attack21 of the free radical on
the unsaturated compound.
19. Meerwein, Buchner and van Emster; J. Prakt. Chem, 152, 237 (1939).
20. Boekelheide, V. and Koelsch, C.; J. Amer. Chem. Soc., 66, 412 (1943).
21. Remick, “Elec tronic Interpretations of Organic Chemistry”, John Wiley and Sons,
Inc., New York, N. Y., p259 (1943).
 
C6H5N2
+
C6H5N=NOCOCH 3+
C6H5*+ C6H5CHR-C*HR'
Cu
+
Cu
++ +
Cu
++
+Cu
++
C6H5CHR-CHClR'(II) +
H
++ C6H5CR=CHClR'(II)
CH3COO
- C6H5*+ N2 + CH3COO-
RCH=CHR' (I)
+(I) CH3COO- (II)
CH3COO
-CH 3COO*
Cl-
(1)
(2)
(3)
(3a)
(4)
(4a) (V)
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with respect to the equation 2, if R is saturated and R’ contains C=O (C=N),
the free radical (I)  will be stabilized by resonance of the odd electron into
R’. But if R is vinyl or phenyl, then the more stable free radical (I) will be the
one with the odd electron on the carbon attached to R.
Equations 3 and 3a represents the function of cupric salt.
Equat ion 4 and 4a exempl i f ies how two character ist ic  products are
ob tained. In this case, if R in (II) is COOH and if a -coupling takes place
(eg.  c innamic  ac id ,  c innamal  acet ic  ac id  and sorb ic  ac id)  then
decarboxylation is observed (II). But if in (II) R’ is COOH (eg. crotonic
acid)and if b-coupling takes place then in that case, the carboxyl group
retains the chloride ion.
Apart from these, the evolution of nitrogen gas is also the key point in the
case of Meerwein reaction. The rate of evolution of nitrogen gas highly
depends upon the nature of the unsaturated compounds used. A complex
is first formed between the unsaturated compound and the nitrogen con-
taining compound and then it is followed by the evolution of nitrogen gas.
Further studies were carried out by the same author22 to determine the
effect of various substituents in the unsaturated component on the proportion
of  a -  to  b-arylat ion which i t  undergoes. Also steric factors are very
important than the direction of polarization of the a ,b-unsaturation in
determining the carbon atom to which the aryl group attaches.
In this study, acrylonitrile or methyl acrylate were reacted with diazonium
salts to give a -chloro hydrocinnamic acid derivatives. This a -arylation is in
contrast with the a -arylation reported earlier.
22. Koelsch, C.; J. Amer. Chem. Soc. 65, 57 (1943).
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Later on, Dickermann and co-workers23 suggested that there are two key
points around which the mechanism of the Meerwein reaction swirls (VI).
1. The Homolytic or the Heterolytic character of the reaction.
2. The role of the divalent copper and the specif ic i ty of acetone in
promoting the decompostion of the diazonium salt.
The cuprous chloride in these experiments was generated in the reaction
mixture from cupric chloride and acetone. This observation was reported
by Kochi in 195524. Complexing of cupric and or cuprous chloride with the
unsaturate may explain the observed dependence of the rate of evolution
of nitrogen on the nature of the the unsaturate.20,23
The contribution of Waters24 in the mechanism of the Meerwein’s reaction
was that, he explained the electron transfer ability of cuprous salts. Cowdrey
and Davies25 ellaborated on the Kinetic work. Vogl and Rondestvedt26 have
suggested an intermediate complex type of “radicaloid” mechanism for the
Meerwein reaction.
 
CH3COCH3 2CuCl2 2CuCl ClCH2COCH3 HCl+ + +
ArN2
++ ArN=N*+ CuCl2CuCl2-
Ar* N2ArN=N* +
ArCl + CuClCuCl2Ar*+
ArH + *CH2COCH3CH3COCH3Ar*+
ClCH2COCH3 + CuClCuCl2*CH2COCH3+
+ CuClAr* + C C
CH3 CH3
CH3CH3 C C
CH3 CH3
Ar
CH3 CH3
C C
CH3 CH3
CH3
CH3 CH3
+ CuCl2
3 3
ClAr
CH3CH3
+ CuCl
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
Mechanism proposed by Dickermann, Weiss and Ingbermann
23. Dickermann, S., Weiss, K. and Ingberman, A; Communications , 21, 381 (1956).
24. Waters, W.; J. Chem. Soc . 266 (1942).
25. Cowdrey, W. nad Davies, D.; J. Chem. Soc. S 48 (1949).
26. Vogl, O. and Rondestvedt, C.; J. Amer. Chem. Soc ., 77, 3067 (1955).
27. Kochi, J.; J. Amer. Chem. Soc . 77, 5274 (1955).
(VI)
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Kochi28 also investigated that decomposition of diazonium salts in acetone
with cuprous chloride as in (VII) showed that the ratio of the chloroacetone
(or A-H) to Ar-X fromed as in equation (2) and (3) in figure (VII) is inversely
proportional to the concentration of cupric chloride.
When olef in is present, no or l i t t le chloroacetone is formed. When
molecular Iodine was used to trap the aryl radical,  the product was
exclusively Ar-I even in the presence of an excess of chloride ion
Apart from all the above observation in mechanism of Meerwein reaction,
in another important study, 29 it was established that arylene is probably the
ma jo r  p roduc t  o f  a l l  Meerwe in  reac t i ons .  He re  pheny la t i on  was
accomplished in aq. acetone solut ion of arene or arenes, benzene
diazonium chlor ide and cuprous and cupr ic  chlor ides.  Though the
classical methods of arylation have now become obsolete, Huisgen and
Grashey30 obtained similar results as that of Meerwein reaction, in case of
N-nitrosoacetanilide. Meerwein arylation of anthracene routinely yields
arylanthracenes and not dimers31,32. Dimerization is supressed due to
copper salts. Eberhardt and Eliel33 observed that presence of oxygen ,
28. Kochi, J.; J. Amer. Chem. Soc., 78, 4815 (1956).
29. Dickermann, S. and Vermont, G; J. Amer. Chem. Soc., 84, 4151 (1962).
30. Huisgen, R. and Grashey, R.; Ann., 607, 46 (1957).
31. Dickerman, S., Levy, L. and Schwartz, A.; Chem. and Ind., 360 (1958).
32. Dickerman, S., Felix, A, Klein, M and Vermont, G; J. Org. Chem., 21, 380 (1956); J.
     Amer. Chem. Soc. , 80, 1904 (1958).
33. Eberhardt, M. and Eliel, E.; J. Org. Chem., 27, 2289 (1962).
 Ar* + Ar-CH2-CHYCH2=CHY
Y = CN or C6H5
Ar-CH2-CHY + MXn Ar-CH2-CHYX + MXn-1
X = Halides
Ar* + MXn Ar-X MXn-1+
Ar* + CH3COCH3 Ar-H CH3COCH2*+
CH3COCH2*+ MXn CH3COCH2Cl MXn-1+
(1)
(2)
(3)(VII)
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34. Kahlbaum, S.; GB480617 (1938).
35. Hodgson and Marsden; J. Chem. Soc., 274 (1945).
36. Oda and Nakano, Repts. Inst. Chem. Res., Kyoto Univ., 19, 91 (1949); Chem. Abst.
      45, 7543 (1951); Oda, Mem. FAc. Eng. Kyoto Unvi., 14, 195 (1952); Chem. Abst.,
      48, 1935c (1952)
 O O
+ Aryl.N2.Cl
O O
Aryl
+ N2 + HCl
COCH 3
+ Aryl.N2 .Cl
COCH3
Aryl
+ N2 + HCl
Kahlbaum, S.34 in  1938
scrutinized the Meerwein
arylation of cinnamic acid,
cinnamldehyde, and cou-
marin. These react ions
were carried out in strong acetic acid, aq. alcoholic or aq. acetone
solution with the addition of alkali acetates or alkali salts of weak acids.
Instead of water miscible solvents, solvents such as methylene dichloride,
acetylene tetrachloride etc, which are water immiscible can also be
employed but in these cases, presence of negative substituents favours
the course of the reaction.
Very few studies have been made of the reaction of aryl diazonium salts
with organometallic such as the Grignard Reagent.
It was found that addition of zinc chloride double salts of several diazonium
chlorides to methyl - ethyl or phenyl magnesium bromide  in refluxing ether
gave azocompounds in low yields35. p-chloromagnesium bromide with zinc
chloride was carried out under conditions according to Oda36 led to the
biphenyl derivative.(IX)
 
p-ClC6H4ZnCl + p-ClC6H4N=NC6H5N+ NH5C6 BF4-
di-p-chlorophenylcadmium gave 16 % of the azo compound and diphenyl
mercury gave no reaction in refluxing ether.
also supresses the side reactions. So the conversion of  intermediate
radicals into phenylarenes by cupric copper can be termed as “Oxida-
tive Elimination”
(VIII)
(IX)
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Very interestingly, the novel class coumarins, i.e. 4-hydroxy coumarin also
became the part of Meerwein reactions though a no. of methods have been
described in the literature for the synthesis of 3-phenyl-4-hydroxy coumarin.
An aryl group is introduced in 4-hydroxy coumarin by Meerwein arylation37,38.
Earlier this method was used for introducing phenyl group in unsubstituted
coumarin39 and 4-alkyl-coumarin40 in the third position. Though third posi-
tion of 4-hydroxy coumarin is highly active as compared to that of coumarin
and 4-alkyl coumarin, Meerwein arylation can be applied to synthesize only
alkyl and nitro substituted 3-phenyl-4-hydroxycoumarin.
Direct Arylation of 4-hydroxycoumarin by aryl bismuth reagents was also
reported in the literature.41. The limitation in this arylation method is the
l imited availabi l i ty of substituted alkoxy phenyl bismuth because of
diff iculty in its preparation.
Another method of arylation 42. was using organometallic compounds
namely aryllead triacetates which like aryl bismuth compounds43,44 were
shown to act as aryl cation equivalents under mild conditions.44,45.
O
1 2
3
O
OH
R1
R2
R3
R4
"Ar"
O
1 2
3
O
OH
R1
R2
R3
R4
Ar
37. Zanten, B. van, Brinkman, U. and Nauta, W; Recueil, 79, 1223 (1960).
38.a.Zanten, B. van and Nauta, W; Recueil, 79, 1211 (1960); 80, 95 (1961).
    b.Zanten, B. van and NAuta, W.T., Recl. Trav. Chim. Pays Bas 1961, 80, 95
39. Meerwein, H., Buchner, E. and K. van Emster, J. Prakt. Chem ., 152, 237 (1939).
40. Sawhney, P. and Seshadri, T.; J. Sci. Indust. Res. India 11B, 157 (1952); 13B, 316
     (1954).
41. Mathur, K. and Sawhney, K.; Indian J. Chem. 14B, 518 (1976).
42. Barton, D., Donnelly, D., Finet, J. and Guiry, P.; Tet. Let., 30, 12, 1539 (1989).
43. Kozyrod, R. and Pinhey, J.; Aust. J. Chem. 38, 1115 (1985).
44. Barton, D., Donnelly, D., Finet, J. and Stenson, P.; Terahedron, 44,6387 (1988)
45. Barton, D., Bhatnagar, N.,Finet, J. and Motherwell, W.; Tetrahedron,, 42, 3111 (1986)
(X)
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Brepoels46 in 1979, carried out the arylation of olefins and proposed a new
procedure which is benificial as compared to the classical one. This method
had added following advantages.
1. Improved Yield
2. Arylation occurs at optimum temperature and shorter time.
3. Smaller Quantities of cuprous halide are required.
4. Large no. of aryl amines can be utilized for arylation.
5. Diverse olefins can be utilized for arylation reaction.
In this method, the novelty lies in the production of aryldiazonium salts. i.e.
aryl amine are diazotized in presence of an alkanoic acid which is used as
co-solvent. eg. acetic acid, formic acid, propionic acids. etc. Being more
specific, alkanoic acids replaces some of the considerable quantities of
water, and gives advantageous organic atmosphere to the olefin to react
with diazonium ion leading to improved yield and reduced reaction time.
46. Brepoels, J., and Vanegham, J.; US4145362 (1979).
47. Nock, H. nad Schottenberger, H.; J. Org. Chem. 58, 7045 (1993).
48. Anderson, M., Handoo, K., Parker, K; Acta Chem. Scand., 45, 983 (1991).
Schottenberger and Nock47 highl ighted the appl icat ion of Meerwein
reaction to ferrocene derivatives, which serve as reducing agents for the
diazonium ions48. They can generate the required active aryl radicals in a
self supplying manner(IX).
 
Fe
C CH
+ N+
O
-
O
N2
+
Fe
C
Cl
N
+
O
-
O
Fe
C
N
+
O
-
O
+
(XI)
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It has already been well revealed in the literature that copper-catalysed
decomposition of arene diazonium salts show that in these reaction cop-
per containing complex intermediatees are formed49-52.
Ganushchak and coworkers53 found that complex arenediazonium salts with
CuCl2 are formed during the initial steps of the interaction of diazonium
chlorides and unsaturated compounds using copper (II) chlorides as the
catalysts. When isolated from the medium it was found to be arenediazonium
tetrachlorocuprates (II) i.e. (ArN=N+)2CuCl4
2-
49. Saunders, K. and Allen, R.; Aromatic Diazo Compound: 3-d Ed.; Edward Arnold:
     London, pp. 144-150 (1985)
50. Ganushchak, N., Golik, V. and Migaychuk, I.; Zh. Org. Khim. 8, 2356-2361 (1972).
51. Ganushchak, N., Obushak, N., Kovalchuk, E., Trifonova, G.; Zh. Obshch. Khim.
     54, 2334 (1984).
52. Pfeil, E.; Angew. Chem, 65, 155 (1953).
53. Obushak, N., Ganushchak, N., Lyakhovich, M., Zh. Org. Khim., 27, 1757 (1991).
54. Kazitzina, L., Reutov, O., Buchkovskii, Z.; Zh. Obshch. Khim. 31, 2943 (1961).
 
N2
+
R
CuCl 2
-
Cl
R
2 + CuCl2 2N2+
These diazonium metal double salts also found their application in other
reactions such as Nesmeyanar reaction.54
(XII)
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In 1998, it was cited in the l iterature that phenyl cations formed via
photoinduced dediazonization could be trapped by arenes55. Albini and
co-workers56 in 1999 investigated the photoinduced heterolysis of 4-
chloroaniline and its N,N-dimethyl derivative. These gave corresponding
4-amino phenyl cations which could be trapped by arenes. And this
methodology proved to be ionic analogue of Meerwein reaction. Then
after,  profuse variations were effectuated57.
55. Steenken, S., Ashkkuna, M, Maruthamuthu, P. and McClelland, R.; J. Amer. Chem.
     Soc.,  120, 11925 (1998).
56. Milanesi, S., Fagnoni, M. and Albini, A.; Chem. Comm.,  216 (2003).
57. a.Fagnoni, M., Mella, M., Albini, A; Org. Letters ., 1, 1299 (1999).
     b.Coppo, P., Fagnoni, M., Albini, A., Tetrahedron Letters. , 42, 4271 (2001).
58. Mella, M., Coppo, P., Benedetta, G., Maurizio, F., Mauro, F. and Albini, A.; J. Org.
     Chem., 66, 6344 (2001).
NR2
Cl
hv
Solvent
C
+
NR2
R''''
R'''R'
R''
NR2
R''
R'
R''''
R'''
+
NR2
R''''
R'''
R''R'
NR2
R''
R'
R''''
R'''
NR2
R''
R'
R''''
CH2
NR2
R''
R''''
R'''
Later on in 2001, Albini et al,58
explored the photochemical
reaction in presence of alkene
i.e. they found an ionic analogue
of Meerwein reaction of alkenes
in which the phenyl cation at-
tacks electron rich olefin, contra-
dictory to classical arylation in
which, electron poor olefin was
employed. (XIII)  This versatile
photo chemical generation of intermediate phenyl cation allows for arylation
olefins employing moderatele polar to polar medium.
Albini et al reported56 photodecomposition of some para substituted
d iazonium tet raf luoroborates in  acetoni t r i le  in  presence of  a l ly l
trimethylsilane and benzene as pi nucleophiles. Here reduction of diazo-
nium cation is avoided.
(XIII)
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Bergmann and Weinberg59 obtained 1-
styryl-4-nitronaphthalene arylation of
cinnamic acid with 4-nitro-1-naphthy-
lamine.
CH CH N
+
O
-
O
59. Bergmann, F. and Weinberg, Z.; J. Org. Chem ., 134 (1941).
(XIII)
The present chapter deals with the synthesis and Meerwein arylation study
of some of the diversely substituted aromatic amines via diazocoupling
conditions followed by nitrogen elimination.
In all 12 compounds were synthesized to get 3-substituted coumarins which
are otherwise difficult to synthesize in one step method. All the Meerwein
arylations of the current chapter were carried out under the optimum
conditions of reaction within 4-7 hrs.
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Reaction Scheme
NH2
R
NaNO2, HCl
Diazotization
N2Cl
R
N2Cl
R
O O
Acetone
CuCl2, CH3COONa
+
O O
R
Substituted anilines Diazonium salts of
substituted anilines
Coumarin
 3-Substitutedphenyl-2H-chromen-2-ones
Diazonium salts of
substituted anilines
Meerwein conditions
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+ CH3COO-
+ N2 + CH3COO-
(I)
N
+
N
R
N
NOCOCH3
R
C
R
C
R
O O
+
O
CH
O
Cu
+
Cu
++ ++(I) CH3COO- (II)
Cu
+++Cu++ CH3COO-CH3COO*
C6H5CHR-CHClR'(II) + Cl-
H
++ C6H5CR=CHClR'(II)
1.
2 .
3 .
3a.
4 .
4a.
In the following mechanism equation 1  shows the utility of buffer.
Equation 2  epitomize the “electron pairing” attack of the free radical on
the unsaturation of the coumarin ring.
Equations 3 and 3a represents the function of cupric salt.
Apart from these the evolution of nitrogen gas is also the key point in the
case of Meerwein reaction.
A complex is first formed between the unsaturated compound and the
nitrogen containing compound and then it is followed by the evolution of
nitrogen gas.
Reaction Mechanism
Intermediate reactions involved in Meerwein arylation
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Method of Synthesis
(General Method) Preparation of  3-substituted phenyl-2H-chromen-
2-one
Substituted aniline (0.01 mole) is taken into 50 % HCl (minimum quantity
required). The mixture is warmed till the amine hydrochloride dissolves.
Then the mixture is cooled to 0 o C. To this mixture, is slowly added
(dropwise) the aq. solution of sodium nitr i te (50 %) such that the
temperature is maintained below 5 o C. The diazonium salt solution is filtered
and then added simultaneoulsy with aq. solution of hydrated cupric chloride
to a mixture of 0.01 mole coumarin (1.5 gm) in 15 ml acetone. The
temperature is maintained at 22 o C. The commencement of the reaction
can be observed by the elimination of nitrogen gas. When the evolution of
nitrogen gas ceases i.e effervescence ceases, the two layers of the reaction
mixture obtained are separated. The aqeous layer is washed with methylene
dichloride and mixed with the organic layer. On evaporation of the solvent
from the organic layer, an oily liquid is left behind which slowly solidifies
into solid product and recrystallized from ethanol so as to remove the
impurities.
The yield of the reaction ranges between 50 - 70 %.
Please refer to the table for the physical constants of various 3-substituted
coumarins obtained from the above general method on the subsequent
pages. TLC; methanol:chloroform; 1:9.
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Spectral data of only key intermediate and final compounds are included.
using the instrument, SHIMADZU FT IR-8400, Sample technique,  KBr
pel let, Frequency  range, 400-4000 cm-1
The 3-substitutedphenyl-2H-chromen-2-ones synthesized in the current
chapter can be elucidated using the various spectral characterization. The
IR spectra helps in identifying the the various frequencies shown by the
absorbtion of the functional groups and the ring residues.
Spectral Analysis (IR)
Following are the common peaks observed in APM-9, APM-5, APM-4 and
APM-7.
¨ All the compounds contain coumarin ring nucleus. Hence shows a sharp
peak at 1700 - 1680 cm-1 which indicated the presence of the lactonic car-
bonyl group (C=O stretching vibrations), accompanied by the the C-O
stretching vibrations d ue to the lactone ring residue in the range of 1100 to
1300 cm-1.
¨  The aromatic skelatal stretching vibrations due to the benzenoid part of
the coumarin nucleus as well as the phenyl ring attached to the third posi-
tion of the coumarin ring are observed at 1600 - 1450 cm-1. These are ac-
companied by the inplane (950 - 1200 cm-1 ) and out of plane deformations
at 770 - 735  cm-1.
Now in case of  APM-9 , there are two chloro groups in the phenyl residue
of the third position of the coumarin nulceus, which shows characteristic
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absorption for C-Cl stretching at 574 and 617 cm-1. Apart from this, it shows
out of plane -CH deformation at 825 cm-1.
In case of APM-5 , apart from the peaks which are mentioned above, there
is a nitro group in the phenyl r ing of the third posit ion. This can be
identified by the aymmetric and symmetric stretching vibrations at 1528
and 1352 cm-1 respectively which are accompanied by the C-N stretching
vibrations between 857 - 830 cm-1and out of plane deformation is seen at
807 cm-1.
In case of APM-5, presence of chloro in the phenyl ring is indicated by
the absorpt ion at 688 cm-1 due to the C-Cl stretching vibrat ions. Out
of plane deformations of the -CH is observed at 790 cm-1.
In case of APM-7,  two methyl groups shows asymmetric and symmetric
stretching vibrat ions at 2920 and 2820 cm-1 respectively.
Please refer for the Ir spectra and the details of the frequencies on the
subsequent pages.
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 724.2
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1158.2
1233.4
1299.9
1352.0
1452.3
1513.1
1569.9
1605.6
1692.4
1710.7
2398.3
APM-5
IR Spectrum of 3-(3-nitrophenyl)-2H -chromen-2-one
APM-9
IR Spectrum of 3-(2,4-dimethylphenyl)-2H-chromen-2-one
Type Vibration Mode Frequency (cm-1)
Lactone
-C=O str 1668
-C-O str
1352,1299,
1233
Aromatic
-C-C skeletal
vibrations
1605,1569
1513,1454
-CH in plane
deformation
1158,1124,951
-CH out of  plane
deformation
747
Chloro C-Cl str 574,617
Type Vibration Mode Frequency (cm-1)
Lactone
-C=O str 1700
-C-O str 1301,1276
Aromatic
-C-C skeletal
vibrations
1610,1578
1454
-CH in plane
deformation
1086
-CH out of
plane
deformation
754,807
Nitro
C-NO2str (asym) 1528
C-NO2str (asym) 1352
C-N str 857-830
APM-9 APM-5
O O
CH3 CH3
O O
N
+
O
-
O
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IR Spectrum of 3-(2,3-dimethylphenyl)-2H-chromen-2-one
APM-4
IR Spectrum of 3-(3-chlorophenyl)-2H -chromen-2-one
Type Vibration Mode Frequency (cm-1)
Lactone
-C=O str 1718
-C-O str 1296,1120
Aromatic
-C-C skeletal
vibrations
1607,1566
1452
-CH in plane
deformation
1227,953,971
-CH out of
plane
deformation
754,790
Chloro -C-Cl str 688
Type Vibration Mode Frequency (cm-1)
Methyl -CH3 str (asym) 2920
-CH3 str (sym) 2820
Lactone
-C=O str 1677
-C-O str 1220,1100
Aromatic
-C-C skeletal
vibrations
1628,1585
1502,1454
-CH in plane
deformation
975,1035
-CH out of
plane
deformation
755
APM-4
O O
Cl
APM-7
O O
CH3
CH3
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Spectral Analysis (NMR)
Instrument used for the NMR spectroscopy of the newly synthesized
compounds was BRUKER AC 300 MHz FT-NMR, where TMS  was used as
the Internal reference and CDCl3 or DMSO d 6 were used as solvent.
In the IR spectra, there were few peaks observed due to the benzenoid
part of the coumarin ring which were common in all the spectra. Similarly,
in the NMR spectra of Meerwein arylated coumarin compounds, there are
few pattern signals observed in almost all the spectra which are cited as
follows.
¨ The proton of the fourth carbon atom of the coumarin scaffold is highly
deshielded hences it resonates and give sharp singlet in the downfield at
8.3 to 8.5 d ppm.
¨  The two protons each at the seventh and eighth carbon atom of the ben-
zenoid part of coumarin nucleus, resonates giving a doublet at approxi-
mately 7.0 to 7.5 d ppm. The doublet is obtained due to the ortho coupling
with each other and it is evident from the coupling constant value, 8.1 to 9
Hz.
¨  The rest two protons of the benzenoid part of the coumarin ring also
gives doublet with coupling constant, 7.8 to 8.7 Hz indicating the ortho
coupling.
The value of the chemical shifts due to the protons in the phenyl residue
attached to the third carbon atom of the coumarin nucleus depends on the
type of substitution on the phenyl ring.
In case of APM-1, nitro group is present on the fourth position on the
phenyl ring, hence the protons adjacent to it are highly deshielded and as
a result of this, they resonate in the downfield giving a doublet at 8.32 d
ppm and ortho coupling takes place in each case, which is evident from
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the coupling constant, 8.7Hz. The other two protons also shows a doublet
with J = 8.7 Hz indicating the ortho coupling.
In case of APM-2, Chloro substitution in the phenyl residue of the coumarin
is present and the protons adjacent to the carbon atom bearing chloro group
are deshielded and hence resonate in the down field, i.e at 7.559 d ppm.
The signal splitted into a doublet due to the ortho coupling with coupling
constant of 8.4 Hz. Rest three aromatic protons together give a multiplet
with coupling constant 4.2 and 8.1 Hz which shows the presence of ortho
coupling  as well as meta coupling.
In case of APM-4 , the chloro group is present on the third position of the
phenyl ring. Apart from the common signals mentioned above, the proton
adjacent to the carbon atom bearing chloro atom resonates to give a
triplet. And the rest three protons give a multiplet with coupling constant
8.1 and 4.2 Hz.
In case of APM-5 , the proton on the second carbon atom is in the effect of
the adjacent nitro group hence it is highly deshielded  and resonates in the
down field ie. 8.28  d ppm. The  other proton adjacent to the carbon
bearing nitro group is also deshielded giving a  triplet  at 7.68 d ppm with
coupling constant, 1.2 and 8.4 Hz for meta coupling and ortho coupling
respectively.  The proton on the sixth carbon atom of the phenyl residue
resonates at 8.641 d ppm. The proton on the fifth carbon of the phenyl
residue resonates at 8.201 d ppm giving a doublet due to ortho coupling,
which is evident from coupling constant, 7.8 d ppm.
The protons present in each molecule is in agreement with the constitution
of the synthesized compounds.
Meerwein Arylations, The Cupric induced reactions....
 267
1H NMR Spectrum of 3-(4-nitrophenyl)-2H -chromen-2-one
APM-1
No.
Chemical
Shift Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 7.426 m 2H (7,8) J = 8.1
2. 7.691 t 1H (9) J9-10 = J9-8 = 7.8
3. 7.823 d 1H (10) J10-9 = 7.8
4. 8.055 d 2H (13,17) J13-14  = J17-16 = 8.7
5. 8.317 s 2H (14,16) J16-17 = J14-13 = 8.7
6. 8.478 s 1H (4) -
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APM-2
No.
Chemical
Shift Multiplicity No. of Protons
Coupling
Constant(J)
1. 7.396 m 2H (7,8) J = 8.4, J = 4.8
2. 7.559 d 2H (14,16) J14-13 = J16-17 = 8.4
J15-16  = 8.4
3. 7.645 t 1H (9) J = 7.5
4. 7.762 t 3H (10,13,17)
J = 4.2
J = 8.1
5. 8.318 s 1H (4) -
1H NMR Spectrum of 3-(4-chlorophenyl)-2H-chromen-2-one
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1H NMR Spectrum of 3-(3-chlorophenyl)-2H-chromen-2-one
APM-4
6
5
7
10
8
9
O
1 2
4
3
12
13
17
14
16
15
O
11
Cl
18
No.
Chemical
Shift Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 7.481 m 4H
(7,8,9,10)
J = 8.4
J = 4.8
2. 7.640 m 2H (16,17) J9-10 = J10-9 =
8.4
3. 7.645 t 1H (16) J = 7.5
4. 7.800 d 2H (13,15)
J = 8.1
J = 4.2
5. 8.346 s 1H (4) -
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No.
Chemical
Shift Multiplicity
No. of
Protons
Coupling
Constant(J)
1. 7.501 m 2H (7,8) J = 8.1
2. 7.684 t 1H (15)
J15-17 = J15-13 = 1.2
J15-16 = 8.4
3. 7.817 m 2H (9,10) J = 8.4
4. 8.201 d 1H (16) J = 7.8
5. 8.277 d 1H (17) J17-13 = J17-15= 1.2
6. 8.497 s 1H (4) -
7. 8.641 s 1H (13) -
APM-5
6
5
7
10
8
9
O
1 2
4
3
O
11
12
13
17
14
16
15
N
+
18 O
-
20
O
19
1H NMR Spectrum of 3-(3-nitrophenyl)-2H -chromen-2-one
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Spectral Analysis (Mass)
For the current study, Instrument used was JEOL SX 102/DA-6000 for FAB
(Fast atom Bombardenment).  The molecular ion peaks (M+) of  the
compounds  in mass spectra  were in total agreement  with it’s molecular
weight.  The Mass spectra of the compounds were given on page no.151-
153.
In case of APM-1, having molecular weight, 267,  M+ peak (m/e = 268) and
M+ (m/e = 354) are indicated.
In case of APM-2 , having molecular weight, 256, M+ peak (m/e = 256) and
M+1 (m/e = 257) are indicated .
And in case of APM-3 ,  having molecular weight, 256, the spectrum shows
the presence of the M+  and M+1 peaks at m/e = 256 and m/e = 257
respectively.
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Pharmacological Screening
CHAPTER-7
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NOTES:
(1)  The preliminary screening data of antiHIV and antibacterial activity of
approximately 35 heterocyclic compounds comprising of chapters 1, 2, & 5.
(3)  All of these compounds were screened for their antibacterial activity
using strains like E. Coli, S. aureus.
For these screening:
• All compounds were dissolved in 10% DMSO in methanol.
• Fluconazole (0.5 mg/ml) was used as control.
• (h) denotes hazy zone.
• Solvent control was taken into consideration 10% DMSO in methanol.
Protocols for the activity
Antibacterial Activity:
It was carried out by using cup-plate method1- 3 which has been described
as under:
The purified products were screened for their antibacterial activity. The
nutrient agar broth prepared by the usual method was inoculated espeticallly
with 0.5 ml for 24 hrs. Old subcultures of E. coli/ S. aureus/ S. aureus 209p
were taken in separate conical flask at 40o-50 oC and mixed well by gentle
shaking. About 25ml of the content of the flask were poured and evenly
spread in petridish (13 cm in diameter) and 10mm bore in agar medium
and filled with 0.05ml solution of sample in 10% DMSO in methanol.
Pharmacological Screening
1.  F. Simoncini et al.; Farmaco, 23, 559 (1968); C. A.   69, 109851 (1968).
2.  Bhatt, S., Deo, K., Kundu, P., Chavda, M. & Shah, A.; Indian J. Chem. , Sect 42B, 1502
     (2003).
3.  Chavda, M., Shah, A., Bhatt, S., Deo, K. & Kundu, P.; Arzneim-Forsch, Drug, Res ., 53, 196
      (2003).
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The plates were incubated at 37oC for 24 hrs and the control was also main-
tained with 10% DMSO in methanol in similar manner. The zones of inhibi-
tion of the bacterial growth were measured in mm diameter.
Anti HIV activity:
35 compounds were screened for inhibition of HIV-1 reverse transcriptase
act iv i ty .  In i t ia l ly  a l l  the compounds were screened by c lass ica l
trichloroacetic acid (TCA) precipitation assay using Poly-rA/oligo-dT as
template.
These compounds were fur ther tested by newly developed SPA
(Streptav id ine prox imi ty  af f in i ty  bead) assay us ing  50mM drug
concentration as described by Shaw-Reid et al.1 . However following series
indicate less than 75% of inhibition towards HIV-1 reverse transcriptase by
trichloroacetic acid precipitation assay and therefore they were not
screened further. The series are : APU, APT, APC
Assay procedure:
1. Trichloroacetic acid precipitation assay:
The reactions were carried out in a final volume of 100ml containing 50mM
Tris-HCl buffer, pH 8.0, 1mM dithiothrietol, 0.1mg of bovine serum albu-
min/ml, 50mM KCl , and  100 nM   poly rA/oligo dT18 template-primer com-
bination. HIV-1 reverse transcriptase ( 100ng) was preincubated in the re-
action buffer along with 1-20 mM  test compounds on ice for 30 minute.
Polymerase reaction was initiated with a mixture consisting  of 10mM dTTP,
1mCi tritiated dTTP and 5mM MgCl2 and incubated  at 37o C for 3 minutes
1. Shaw-Reid et al  Biochemistry  vol. 44, p1595-1606 (2005 .)
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Reaction was terminated by adding 2ml of ice cold 5% trichloroacetic acid
filtered through Whatman GF/B glass fiber filter, washed with 5ml of suc-
cessively 5% trichloroacetic acid and 70% ethanol. Filters were air dried
and counted for incorporated radioactivity in a liquid scintillation counter.
2. SPA bead assay:
HIV-1 reverse transcriptase (100ng ) were incubated with assay buffer con-
taining 50mM Tris-HCl buffer,pH 8.0, 5mM MgCl2 , 50mg/ ml bovine serum
albumin, 50mM KCl, 1mM dithiothrietol and test compounds      ( 50mM
concentration) for 30 minutes on ice. Polymerase reaction was initiated by
adding 10nM heterodimeric nucleic acid substrate generated by annealing
234bp HIV RNA corresponding to the primer binding site region primed
with biotinylated 18 mer DNA oligo along with all the four nucleotide triph-
osphates (each nucleotide 0.6mM ) and 1mCi tritiated dTTP in a final re-
action volume of 100ml and incubated for 1h at 37oC. Reaction was termi-
nated by a suspension of 10ml of Streptavidine Proximity Assay bead sus-
pension ( SPA beads 10mg/ml in 100mM EDTA ). After further incubation
at room temperature for 30 minutes the whole mixture was counted in Scin-
tillation counter without any subsequent manipulation.
The results of the compounds screened for antibacterial and anti HIV ac-
tivity are as follows. It can be clearly observed that none of the molecules
showeds more than 75 % inhibition for the reverse transcriptase and hence
were not considered for the further screening.
Looking at the results for the antibacterial activity it can be observed that
in case of  APC series (Chapter 5), three nitro coumarins were feebly
active against the gram negative strain, S. aureus, ie 7-methyl-3-nitro 4-
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hydroxycoumarin, 8-methyl-3-nitro-4-hydroxycoumarin and 7,8-benzo-4-
hydroxycoumarin. From the coumarin sulphonic acids, it is can be said that,
the coumarin sulphonic acid derivatives, the 7,8-benzo and 8-methyl group
bearing compounds are said to have activity against the gram negative
strain, S. aureus, as compared to the other compounds. So we can
conclude that the 7,8 benzo derivative of both the types of coumarin shows
some activity on both the strains of the bacteria ie. gram positive as well
as gram negative.
In case of APT-series, the compound with 2-methoxy group in the phenyl
ring showed some activity against the gram positive strain i.e. E. coli,  and
in the case of APU series, the compound with chloro and nitro substitu-
tions on the phenyl ring residue are said to show little activity against the
gram negative strain, S. aureus .
Antiviral Screening Results:
In case of inhibition against reverse transcriptase, all the compounds in
the three series preliminary shows inhibition only up to 75%, which
eliminates their possibility to use for detailed anti HIV study. However the
study with the modified structures of these three series will be necessary
& to be tested at lower drug concentration to determine their Ki value.
The protocol may necessiate further investigation on compounds where
more than 90 % inhibition is observed by TCA precipitation method & further
supported by SPA bead assay procedure.
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O O
OH
NO2
Sample Code Structure
Gram positive Gram negative % inhibition
Escherichia coli Staphylococus aureus Reverse Transcriptase
APC-1 0 0 <75 %
APC-2 0 0 <75 %
APC-3 0 18 <75 %
APC-4 0 0 <75 %
APC-5 0 12 <75 %
APC-6 0 8 <75 %
APC-7 0 0 <75 %
APC-8 0 0 <75 %
APC-9 0 0 <75 %
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Sample Code Structure
Gram positive Gram negative % inhibition
Escherichia coli Staphylococus aureus Reverse Transcriptase
APC-10 0 0 <75 %
APC-11 0 0 <75 %
APC-12 0 18 <75 %
APC-13 0 0 <75 %
APC-14 0 12 <75 %
APC-15 0 8 <75 %
APC-16 0 0 <75 %
APC-17 0 0 <75 %
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Sample Code Structure
Gram positive Gram negative % Inhibition
Escherichia coli Staphylococus aureus
Reverse Transcriptase (Anti
HIV)
APT-1 8 0 <75 %
APT-3 0 0 <75 %
APT-4 0 0 <75 %
APT-5 0 0 <75 %
APT-6 0 0 <75 %
APT-7 0 0 <75 %
APT-8 0 0 <75 %
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Sample Code Structure
Gram positive Gram negative % Inhibition
Escherichia coli Staphylococus aureus Reverse Transcriptase
APU-1 0 0 <75 %
APU-2 0 12 <75 %
APU-3 0 0 <75 %
APU-4 0 0 <75 %
APU-5 0 0 <75 %
APU-6 0 0 <75 %
APU-7 0 0 <75 %
APU-10 0 0 <75 %
APU-17 0 0 <75 %
APU-21 0 0 <75 %
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